View Filing Data

$ 347.6

$ 570.2

$ 800.6

$ 1,123.4

168.6

243.9

366.4

481.7

179.0

326.3

434.2

641.7

194.4

331.0

481.8

661.8

1.2

0.0

3.3

0.6

20.7

3.2

45.5

8.7

19.8

0.0

144.1

0.0

(0.2)

0.0

0.6

0.0

(56.9)

(7.9)

(241.1)

(29.4)

Other expenses:

Interest expense, net

60.9

47.8

109.3

95.5

6.0

3.5

10.0

6.7

Foreign currency losses, net

(11.9)

0.0

(11.9)

0.0

2.3

1.2

18.9

1.4

20.6

4.6

16.5

5.9

Loss from continuing operations before income taxes

77.9

57.1

142.8

109.5

(134.8)

(65.0)

(383.9)

(138.9)

(Loss) income from continuing operations, net of taxes

(9.6)

(0.9)

(46.5)

(0.6)

(125.2)

(64.1)

(337.4)

(138.3)

(Loss) income from discontinued operations, net of taxes

0.0

1.6

0.0

2.3

Foreign currency translation adjustments

(125.2)

$ (212.2)

(62.5)

$ (73.5)

(337.4)

(136.0)

Other comprehensive (loss) income:

10.3

2.6

5.1

1.3

Amortization of pension related costs, net of tax

^[1],[2]

4.0

2.7

6.5

4.9

14.3

^[3]

$ (2.7)

^[3]

5.3

^[3]

$ 0.9

^[3]

11.6

6.2

Basic and Diluted (loss) earnings per common share:

$ (110.9)

$ (57.2)

$ (325.8)

$ (129.8)

Continuing operations (in dollars per share)

$ (2.37)

$ (1.23)

$ (6.39)

$ (2.66)

Discontinued operations (in dollars per share)

0.03

0.04

Net loss (in dollars per share)

$ (2.37)

$ (1.20)

$ (6.39)

$ (2.62)

Weighted average number of common shares outstanding:

Basic (in shares)

53,471,004

53,126,700

53,319,228

53,020,633

Diluted (in shares)

53,471,004

53,126,700

53,319,228

53,020,633

[1]	Net of a $1.5 million tax benefit and $0.3 million of tax expense for the three months ended June 30, 2020 and 2019, respectively, and net of a $1.2 million tax benefit and $0.6 million of tax expense for the six months ended June 30, 2020 and 2019, respectively.
[2]	This amount is included in the computation of net periodic benefit costs (income). See Note 10, "Pension and Post-Retirement Benefits," for additional information regarding net periodic benefit costs (income).
[3]	See Note 13, "Accumulated Other Comprehensive Loss," regarding the changes in the accumulated balances for each component of other comprehensive loss during the three months ended June 30, 2020 and 2019, respectively.

UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Parenthetical) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Amortization of pension related costs, tax expense (benefit)	$ (1.5)	$ 0.3	$ (1.2)	$ 0.6

UNAUDITED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIENCY - USD ($)
$ in Millions

3 Months Ended

6 Months Ended

Jun. 30, 2020

Mar. 31, 2020

Jun. 30, 2019

Mar. 31, 2019

Jun. 30, 2020

Jun. 30, 2019

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Treasury stock acquired, at cost

$ (1,301.9)

$ (1,089.4)

$ (1,005.3)

$ (933.1)

$ (1,089.4)

$ (933.1)

^[1]

(1.3)

(0.4)

0.0

(1.6)

Stock-based compensation amortization

1.1

2.4

3.4

0.4

Net loss

(125.2)

(212.2)

(62.5)

(73.5)

(337.4)

(136.0)

14.3

^[2]

(2.7)

^[2]

5.3

^[2]

0.9

^[2]

11.6

6.2

Increase (Decrease) in Stockholders' Equity [Roll Forward]

(1,411.7)

(1,301.9)

(1,059.1)

(1,005.3)

(1,411.7)

(1,059.1)

Preferred Stock

54.6

Increase (Decrease) in Stockholders' Equity [Roll Forward]

54.6

Common Stock

0.5

Additional Paid-In Capital

0.5

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Stock-based compensation amortization

998.9

996.5

988.8

988.4

996.5

988.4

1.1

2.4

3.4

0.4

Increase (Decrease) in Stockholders' Equity [Roll Forward]

1,000.0

998.9

992.2

988.8

1,000.0

992.2

Treasury Stock

Treasury stock acquired, at cost

(33.9)

(33.5)

(31.9)

(33.5)

(31.9)

^[1]

(1.3)

(0.4)

0.0

(1.6)

Increase (Decrease) in Stockholders' Equity [Roll Forward]

(35.2)

(33.9)

(33.5)

(35.2)

(33.5)

Accumulated Deficit

(2,105.3)

(1,893.1)

(1,815.4)

(1,741.9)

(1,893.1)

(1,741.9)

Net loss

(125.2)

(212.2)

(62.5)

(73.5)

Accumulated Other Comprehensive (Loss) Income

(2,230.5)

(2,105.3)

(1,877.9)

(1,815.4)

(2,230.5)

(1,877.9)

Increase (Decrease) in Stockholders' Equity [Roll Forward]

(250.1)

(247.4)

(233.3)

(234.2)

(247.4)

(234.2)

^[2]

14.3

(2.7)

5.3

0.9

$ (235.8)

$ (250.1)

$ (228.0)

$ (233.3)

$ (235.8)

$ (228.0)

[1]

Pursuant to the share withholding provisions of the Fourth Amended and Restated Revlon, Inc. Stock Plan (as amended, the "Stock Plan"), the Company withheld an aggregate of 79,554 and nil shares of Revlon Class A Common Stock during the three months ended June 30, 2020 and 2019, and 94,531 and 85,607 shares of Revlon Class A Common Stock during the six months ended June 30, 2020 and 2019, respectively, to satisfy certain minimum statutory tax withholding requirements related to the vesting of restricted shares and restricted stock units ("RSUs") for certain senior executives and employees. These withheld shares were recorded as treasury stock using the cost method, at a weighted-average price per share of $11.76 and nil during the three months ended June 30, 2020 and 2019, and $13.62 and $18.86 during the six months ended June 30, 2020 and 2019, respectively, based on the closing price of Revlon Class A Common Stock as reported on the New York Stock Exchange (the "NYSE") consolidated tape on each respective vesting date, for a total of $1.2 million and nil during the three months ended June 30, 2020 and 2019, $1.6 million and $1.6 million during the six months ended June 30, 2020 and 2019, See Note 11, "Stock Compensation Plan," for details regarding restricted stock awards and RSUs under the Stock Plan.

[2]

See Note 13, "Accumulated Other Comprehensive Loss," regarding the changes in the accumulated balances for each component of other comprehensive loss during the three months ended June 30, 2020 and 2019, respectively.

UNAUDITED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIENCY (Parenthetical) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Tax withholdings related to net share settlements of restricted stock units and awards	$ 1,200,000	$ 0	$ 1,600,000	$ 1,600,000
Treasury Stock
Shares withheld for withholding taxes (in shares)	79,554	0	94,531	85,607
Restricted Stock and Restricted Stock Units \| Treasury Stock \| Class A Common Stock
Share repurchase price (in usd per share)	$ 11.76	$ 0	$ 13.62	$ 18.86

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS
€ in Millions

6 Months Ended

Jun. 30, 2020

USD ($)

Jun. 30, 2019

USD ($)

Adjustments to reconcile net loss to net cash used in operating activities:

Net loss

$ (337,400,000)

$ (136,000,000.0)

Depreciation and amortization

73,200,000

85,700,000

Foreign currency losses from re-measurement

18,900,000

1,400,000

Amortization of debt discount

800,000

Stock-based compensation amortization

3,500,000

3,800,000

Benefit from deferred income taxes

144,100,000

(55,700,000)

(11,600,000)

Pension and other post-retirement cost

10,000,000.0

6,700,000

Loss on divested assets

600,000

2,700,000

4,100,000

Paid-in-kind interest accrued on the 2020 BrandCo Facilities

(11,900,000)

1,500,000

Change in assets and liabilities:

Decrease in trade receivables

126,300,000

42,800,000

Increase in inventories

(70,600,000)

(36,700,000)

Increase in prepaid expenses and other current assets

(13,000,000.0)

(16,400,000)

(Decrease) increase in accounts payable

(13,300,000)

73,300,000

Decrease in accrued expenses and other current liabilities

(22,100,000)

(54,100,000)

Pension and other post-retirement plan contributions

(5,500,000)

(4,500,000)

Purchases of permanent displays

(12,700,000)

(20,100,000)

Other, net

(3,600,000)

19,600,000

Net cash used in operating activities

(164,200,000)

(41,200,000)

Net cash used in investing activities

Capital expenditures

(2,700,000)

(12,200,000)

(2,700,000)

(12,200,000)

Net decrease in short-term borrowings and overdraft

(7,000,000.0)

(18,800,000)

Tax withholdings related to net share settlements of restricted stock and RSUs

(101,200,000)

(1,400,000)

(1,600,000)

Net cash provided by (used in) financing activities

(1,000,000.0)

(500,000)

408,400,000

28,600,000

Effect of exchange rate changes on cash, cash equivalents and restricted cash

(2,100,000)

500,000

Net increase (decrease) in cash, cash equivalents and restricted cash

239,400,000

(24,300,000)

Cash, cash equivalents and restricted cash at beginning of period

^[1]

104,500,000

87,500,000

Cash, cash equivalents and restricted cash at end of period

^[1]

343,900,000

63,200,000

Cash paid during the period for:

Interest

^[2]

105,900,000

94,800,000

Income taxes, net of refunds

^[2]

8,000,000.0

600,000

Supplemental schedule of non-cash investing and financing activities:

Non-cash roll-up of participating lenders from the 2016 Term Loan Facility to the 2020 BrandCo Facilities

809,800,000

Paid-in-kind debt issuance costs capitalized to the 2020 BrandCo Facilities

29,100,000

2020 BrandCo Term Loan Facility due 2025

Adjustments to reconcile net loss to net cash used in operating activities:

880,000,000.0

5.75% Senior Notes

(11,900,000)

Revolving Credit Facility Due 2021

(99,600,000)

59,900,000

(22,900,000)

2019 Term Loan Facility

2018 Foreign Asset-Based Term Loan

(200,000,000.0)

(31,400,000)

2016 Term Loan Facility

Restructuring and Related Activities [Abstract]

$ (6,900,000)

$ (9,000,000.0)

[1]

These amounts include restricted cash of $5.4 million and $0.2 million as of June 30, 2020 and 2019, respectively, The balance as of June 30, 2020 represents: (i) cash on deposit in lieu of a mandatory prepayment under the 2018 Foreign Asset-Based Term Facility; and (ii) cash on deposit to support outstanding undrawn letters of credit. The balance as of June 30, 2019 represents: (i) cash on deposit in lieu of a mandatory prepayment under the 2018 Foreign Asset-Based Term Facility; and (ii) cash on deposit to support outstanding undrawn letters of credit. These balances were included within prepaid expenses and other current assets and other assets in the Company's Unaudited Consolidated Balance Sheets as of June 30, 2020 and June 30, 2019, respectively

[2]

See Note 4, "Leases," for supplemental disclosure of non-cash financing and investing activities in relation to the lease liabilities arising from obtaining right-of-use assets following the implementation of ASC Topic 842, Leases.

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($) $ in Millions	Jun. 30, 2020	Jun. 30, 2019
Restricted cash	$ 5.4	$ 0.2

DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Revlon, Inc. ("Revlon" and together with its subsidiaries, the "Company") conducts its business exclusively through its direct wholly-owned operating subsidiary, Revlon Consumer Products Corporation ("Products Corporation") and its subsidiaries. Revlon is an indirect majority-owned subsidiary of MacAndrews & Forbes Incorporated (together with certain of its affiliates other than the Company, "MacAndrews & Forbes"), a corporation beneficially owned by Ronald O. Perelman. Mr. Perelman is Chairman of Revlon's and Products Corporation's Board of Directors. The Company is a leading global beauty company with an iconic portfolio of brands that develops, manufactures, markets, distributes and sells an extensive array of color cosmetics; hair color, hair care and hair treatments; fragrances; skin care; beauty tools; men’s grooming products; anti-perspirant deodorants; and other beauty care products across a variety of distribution channels. The Company operates in four brand-centric reporting units that are aligned with its organizational structure based on four global brand teams: Revlon; Elizabeth Arden; Portfolio; and Fragrances, which represent the Company's four reporting segments. For further information, refer to Note 14, "Segment Data and Related Information." The accompanying Consolidated Financial Statements are unaudited. In management's opinion, all adjustments necessary for a fair presentation of the Company's financial information have been made. The Unaudited Consolidated Financial Statements include the Company's accounts after the elimination of all material intercompany balances and transactions. Certain prior year amounts have been reclassified to conform to the current year presentation. The preparation of the Company's Unaudited Consolidated Financial Statements in conformity with U.S. generally accepted accounting principles ("U.S. GAAP") requires management to make estimates and assumptions that affect amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the financial statements and reported amounts of revenues and expenses during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically and the effects of revisions are reflected in the Unaudited Consolidated Financial Statements in the period they are determined to be necessary. Significant estimates made in the accompanying Unaudited Consolidated Financial Statements include, but are not limited to: expected sales returns; certain assumptions related to the valuation of acquired intangible and long-lived assets and the recoverability of goodwill, intangible and long-lived assets; income taxes, including deferred tax valuation allowances and reserves for estimated tax liabilities; and certain estimates and assumptions used in the calculation of the net periodic benefit (income) costs and the projected benefit obligations for the Company’s pension and other post-retirement plans, including the expected long-term return on pension plan assets and the discount rate used to value the Company’s pension benefit obligations. The Unaudited Consolidated Financial Statements should be read in conjunction with the audited consolidated financial statements and related notes contained in Revlon's Annual Report on Form 10-K for the fiscal year ended December 31, 2019 (the "2019 Form 10-K"). The Company's results of operations and financial position for interim periods are not necessarily indicative of those to be expected for the full year. Recently Evaluated and/or Adopted Accounting Pronouncements In August 2018, the FASB issued Accounting Standard Update ("ASU") No. 2018-15, "Internal Use Software (Subtopic 350-40) - Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract," which requires a customer in a cloud computing hosting arrangement that is a service contract to follow the existing guidance in ASC 350-40 on internal-use software to determine which implementation costs are to be deferred and recognized as an asset and which costs are to be expensed as incurred. This guidance is effective for annual periods beginning after December 15, 2019, with early adoption permitted, and may be applied either retrospectively or prospectively to all software implementation costs incurred after adoption. The Company adopted ASU No. 2018-15 prospectively, beginning as of January 1, 2020. The Company completed its assessment and determined that this new guidance does not have a material impact on the Company’s results of operations, financial condition and/or financial statement disclosures. Recently Issued Accounting Pronouncements In March 2020, the FASB issued ASU 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting." The new guidance under ASU 2020-04 provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts and hedging relationships that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform. These amendments are effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. The Company is in the process of assessing the impact, if any, that ASU No. 2020-04 is expected to have on the Company’s results of operations, financial condition and/or financial statement disclosures. In December 2019, the FASB issued ASU No. 2019-12, "Income Taxes (Topic 740) - Simplifying the Accounting for Income Taxes," which removes certain exceptions for recognizing deferred taxes for investments, performing intra-period allocations and calculating income taxes in interim periods. This ASU also adds guidance to reduce complexity in certain areas, including recognizing deferred taxes for tax goodwill and allocating taxes to members of a consolidated group. This guidance is effective for annual periods beginning after December 15, 2020, with early adoption permitted, including adoption in any interim period. An entity that elects to early adopt the amendments in an interim period should reflect any adjustments as of the beginning of the annual period that includes that interim period. Additionally, an entity that elects early adoption must adopt all the amendments in the same period. The amendments in this ASU that are related to separate financial statements of legal entities that are not subject to tax should be applied on a retrospective basis for all periods presented. The amendments in this ASU that are related to changes in ownership of foreign equity method investments or foreign subsidiaries should be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. The amendments in this ASU that are related to franchise taxes that are partially based on income should be applied on either a retrospective basis for all periods presented or a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. All other amendments under this ASU should be applied on a prospective basis. After reviewing this ASU, the Company decided that it will adopt this guidance beginning as of January 1, 2021. The Company is in the process of assessing the impact, if any, that this ASU is expected to have on the Company’s results of operations, financial condition and/or financial statement disclosures. In August 2018, the FASB issued ASU No. 2018-14, "Compensation-Retirement Benefits-Defined Benefit Plans-General (Subtopic 715): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans.” This new guidance removes certain disclosures that are not considered cost beneficial, clarifies certain required disclosures and requires certain additional disclosures. This guidance is effective for annual periods beginning after December 15, 2020, with early adoption permitted. The Company will adopt this guidance (on a retrospective basis for certain new additional disclosures), beginning as of January 1, 2021. This new pronouncement only affects disclosure items and it is not expected to have a material impact on the Company’s results of operations, financial condition and/or financial statement disclosures. In June 2016, the FASB issued ASU No. 2016-13, "Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments," which was subsequently amended in November 2018 through ASU No. 2018-19, "Codification Improvements to Topic 326, Financial Instruments - Credit Losses." ASU No. 2016-13 will require entities to estimate lifetime expected credit losses for trade and other receivables, net investments in leases, financing receivables, debt securities and other instruments, which will result in earlier recognition of credit losses. Further, the new credit loss model will affect how entities in all industries estimate their allowance for losses for receivables that are current with respect to their payment terms. ASU No. 2018-19 further clarifies that receivables arising from operating leases are not within the scope of Topic 326. Instead, impairment from receivables of operating leases should be accounted for in accordance with Topic 842, Leases. In November 2019, the FASB issued ASU No. 2019-10, which, among other things, deferred the application of the new guidance on credit losses for smaller reporting companies ("SRC") to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. This guidance will be applied through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective (i.e., a modified-retrospective approach). Under the above-mentioned deferral, the Company expects to adopt ASU No. 2016-03, and the related ASU No. 2018-19 amendments, beginning as of January 1, 2023 and is in the process of assessing the impact, if any, that this new guidance is expected to have on the Company’s results of operations, financial condition and/or financial statement disclosures.

RESTRUCTURING CHARGES

6 Months Ended

Jun. 30, 2020

RESTRUCTURING CHARGES

Revlon 2020 Restructuring Program

Building upon its previously-announced 2018 Optimization Program, in March 2020 the Company announced that it is implementing a worldwide organizational restructuring (the “Revlon 2020 Restructuring Program”) designed to reduce the Company’s selling, general and administrative expenses, as well as cost of goods sold, improve the Company’s gross profit and Adjusted EBITDA and maximize productivity, cash flow and liquidity. The Revlon 2020 Restructuring Program includes rightsizing the organization and operating with more efficient workflows and processes. The leaner organizational structure is also expected to improve communication flow and cross-functional collaboration, leveraging the more efficient business processes.

As a result of the Revlon 2020 Restructuring Program, the Company expects to eliminate approximately 1,000 positions worldwide, including approximately 650 current employees and approximately 350 open positions of which approximately 700 were eliminated by June 30, 2020. In March 2020, the Company began informing certain employees that were affected by the Revlon 2020 Restructuring Program. While certain aspects of the Revlon 2020 Restructuring Program may be subject to consultations with employees, works councils, unions and/or governmental authorities, the Company currently expects to substantially complete the employee-related actions by the end of 2020 and the other consolidation and outsourcing actions during 2021 and 2022.

In connection with implementing the Revlon 2020 Restructuring Program, the Company expects to recognize during 2020 approximately $60 million to $70 million of total pre-tax restructuring and related charges (the “2020 Restructuring Charges”), consisting primarily of employee-related costs, such as severance, retention and other contractual termination benefits. In addition, the Company expects restructuring charges in the range of $75 million to $85 million to be charged and paid during 2021 and 2022. The Company expects that substantially all of these restructuring charges will be paid in cash, with approximately $55 million to $65 million of the total charges expected to be paid in 2020, approximately $40 million to $45 million expected to be paid in 2021, with the balance expected to be paid in 2022.

A summary of the 2020 Restructuring Charges incurred since its inception in March 2020 and through June 30, 2020 is presented in the following table:



	Restructuring Charges and Other, Net
	Employee Severance and Other Personnel Benefits		Other Costs		Total Restructuring Charges		Leases (a)		Other Related Charges(b)		Total Restructuring and Related Charges

Cumulative charges incurred through June 30, 2020	$	46.3	$	0.3	$	46.6	$	9.8	$	0.7	$	57.1

^(a) Lease-related charges are recorded within SG&A in the Company’s Unaudited Consolidated Statement of Operations and Comprehensive Loss. These lease-related charges include: (i) $3.5 million for accelerated recognition of rent expense related to certain abandoned leases; (ii) $3.0 million for the disposal of leasehold improvements and other equipment in connection with certain leases; (iii) $2.4 million of rent expense related to the Revlon 2020 Restructuring Program; and (iv) $0.9 million of disposal of leasehold improvements and other equipment in connection with the abandoned leases identified in clause (i) of this footnote (a).

^(b)Other related charges are recorded within SG&A in the Company’s Unaudited Consolidated Statement of Operations and Comprehensive Loss.

A summary of the 2020 Restructuring Charges incurred since its inception in March 2020 and through June 30, 2020 by reportable segment is presented in the following table:



	Cumulative charges incurred through June 30, 2020
Revlon	$	18.0
Elizabeth Arden	10.3
Portfolio	11.1
Fragrances	7.2
Total	$	46.6

2018 Optimization Restructuring Program

In November 2018, the Company announced that it was implementing the 2018 Optimization Restructuring Program (the "2018 Optimization Program") designed to streamline the Company’s operations, reporting structures and business processes, with the objective of maximizing productivity and improving profitability, cash flows and liquidity. The 2018 Optimization Program was substantially completed by December 31, 2019.

As of June 30, 2020, restructuring and related charges under the 2018 Optimization Program expected to be paid in cash are approximately $32 million of the total $39.5 million of recorded charges, of which $29.8 million were already paid through June 30, 2020, with any residual balance expected to be paid during the remainder of 2020.

A summary of the 2018 Optimization Restructuring Charges incurred since its inception in November 2018 and through June 30, 2020 is presented in the following table:



	Restructuring Charges and Other, Net
	Employee Severance and Other Personnel Benefits^(a)		Other Costs		Total Restructuring Charges		Inventory Adjustments^(b)		Other Related Charges^(c)		Total Restructuring and Related Charges
Charges incurred through December 31, 2019	$	20.3	$	0.3	$	20.6	$	4.9	$	14.0	$	39.5
Charges incurred during the six months ended June 30, 2020	(0.7)		—		(0.7)		—		0.7		—
Cumulative charges incurred through June 30, 2020	$	19.6	$	0.3	$	19.9	$	4.9	$	14.7	$	39.5

^(a) Includes reversal due to true-up of previously-accrued restructuring charges.

^(b) Inventory adjustments are recorded within cost of sales in the Company’s Unaudited Consolidated Statement of Operations and Comprehensive Loss.

^(c)Other related charges are recorded within SG&A in the Company’s Unaudited Consolidated Statement of Operations and Comprehensive Loss.

A summary of the 2018 Optimization Restructuring Charges incurred since its inception in November 2018 and through June 30, 2020 by reportable segment is presented in the following table:



	Charges incurred during the six months ended June 30, 2020		Cumulative charges incurred through June 30, 2020
Revlon	$	(0.4)	$	8.4
Elizabeth Arden	(0.1)		4.2
Portfolio	(0.1)		3.9
Fragrances	(0.1)		3.4
Total	$	(0.7)	$	19.9

Restructuring Reserve

The liability balance and related activity for each of the Company's restructuring programs are presented in the following table:



										Utilized, Net
			Liability Balance at January 1, 2020			Expense, Net			Foreign Currency Translation			Cash			Non-cash			Liability Balance at June 30, 2020
Revlon 2020 Restructuring Program:
Employee severance and other personnel benefits	$	—		$	46.3		$	—		$	(9.0)		$	—		$	37.3
Other	—			0.3			—			(0.3)			—			—
Total Revlon 2020 Restructuring Program	—			46.6			—			(9.3)			—			37.3

2018 Optimization Program:
Employee severance and other personnel benefits	5.7			(0.7)			—			(3.2)			—			1.8











Other immaterial actions:^(a)
Employee severance and other personnel benefits	4.3			(0.4)			—			(0.4)			—			3.5


Total restructuring reserve	$	10.0		$	45.5		$	—		$	(12.9)		$	—		$	42.6

^(a) The balance of other immaterial restructuring initiatives primarily consists of balances outstanding under the EA Integration Restructuring Program implemented by the Company in December 2016, which was completed by December 2018. The reversal of charges and payments made during the six months ended June 30, 2020 primarily related to other individually and collectively immaterial restructuring initiatives.

As of June 30, 2020 and 2019, all of the restructuring reserve balances were included within accrued expenses and other current liabilities in the Company's Consolidated Balance Sheets.

INVENTORIES

6 Months Ended

Jun. 30, 2020

Inventory Disclosure [Abstract]

INVENTORIES

As of June 30, 2020 and December 31, 2019, the Company's inventory balances consisted of the following:


	June 30,		December 31,
	2020		2019
Finished goods	$	384.9	$	326.5
Raw materials and supplies	109.8		110.4
Work-in-process	16.5		11.5
	$	511.2	$	448.4

LEASES AND PROPERTY, PLANT AND EQUIPMENT

6 Months Ended

Jun. 30, 2020

Leases [Abstract]

LEASES AND PROPERTY, PLANT AND EQUIPMENT

The Company leases facilities for executive offices, warehousing, research and development and sales operations and leases various types of equipment under operating and finance lease agreements. The majority of the Company’s real estate leases, in terms of total undiscounted payments, are located in the U.S.

At the effective date of January 1, 2019, the Company adopted ASU No. 2016-02 using a modified retrospective approach applying the standard’s transition provisions provided by such ASU. Refer to Note 1, "Description of Business and Summary of Significant Accounting Policies," in the 2019 Form 10-K for additional information regarding the Company's adoption of ASU No. 2016-02.

During the first and second quarter of 2020, as a result of COVID-19’s impact on the Company’s operations, the Company considered whether indicators of impairment existed for its Property, Plant and Equipment ("PP&E"), including its Right-of-Use ("ROU") assets consisting of the Company's leases as described above. In accordance with ASC Topic 360, "Property, Plant and Equipment," for purposes of recognition and measurement of an impairment loss, long-lived assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. An impairment loss is recognized only if the carrying amount of a long-lived asset and/or asset group is not recoverable and exceeds its fair value. The carrying amount of a long-lived asset and/or asset group is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the long-lived asset

and/or asset group and the impairment loss is measured as the amount by which the carrying amount of a long-lived asset and/or asset group exceeds its fair value. In performing such review, the Company considers several indicators of impairment, including, among other factors, the following: (i) whether there exists any significant adverse change in the extent or manner in which a long-lived asset and/or asset group is being used; (ii) whether there exists any projection or forecast demonstrating losses associated with the use of a long-lived asset and/or asset group; and (iii) whether there exists a current expectation that, more likely than not, a long-lived asset and/or asset group will be sold or otherwise disposed of significantly before the end of its previously-estimated useful life. Following these interim assessments, the Company concluded that the carrying amounts of its PP&E, including its lease ROU assets, were not impaired during the six months ended June 30, 2020.

The following table includes disclosure related to the ASC 842 lease standard for the periods presented, after application of the applicable practical expedients and short-term lease considerations:


	Six Months Ended
	June 30, 2020			June 30, 2019
Lease Cost:
Finance Lease Cost:
Amortization of ROU assets	$	0.2		$	0.1
Interest on lease liabilities	0.1			0.0
Operating Lease Cost	21.8			21.3
Total Lease Cost	$	22.1		$	21.4

Other Information:
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from finance leases	0.1			0.0
Operating cash flows from operating leases	19.2			21.0
Financing cash flows from finance leases	0.1			0.4

	June 30, 2020			December 31, 2019
ROU assets for finance leases	0.8			1.0
ROU assets for operating leases	88.4			91.4
Accumulated amortization on ROU assets for finance leases	0.5			0.3
Accumulated amortization on ROU assets for operating leases	29.7			23.2

Weighted-average remaining lease term - finance leases	2.4 years			2.8 years
Weighted-average remaining lease term - operating leases	5.8 years			6.2 years

Weighted-average discount rate - finance leases	15.0		%	15.6		%
Weighted-average discount rate - operating leases	15.7		%	15.8		%

Maturities of lease liabilities as of June 30, 2020 were as follows:


	Operating Leases		Finance Leases
July 2020 through December 2020	$	18.0	$	0.3
2021	33.6		0.5
2022	26.4		0.3
2023	21.9		0.0
2024	16.5		—
Thereafter	47.8		—
Total undiscounted cash flows	$	164.2	$	1.1

Present value:
Short-term lease liability	$	19.3	$	0.4
Long-term lease liability	85.5		0.4
Total lease liability	$	104.8	$	0.8
Difference between undiscounted cash flows and discounted cash flows	$	59.4	$	0.3

GOODWILL AND INTANGIBLE ASSETS, NET

6 Months Ended

Jun. 30, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL AND INTANGIBLE ASSETS, NET

Goodwill

In accordance with ASC Topic 350, “Intangibles – Goodwill and Other,” the Company performs its annual impairment test during the fourth quarter of each year. The Company also reviews goodwill for impairment whenever events or changes in circumstances indicate that the carrying value of its goodwill may not be recoverable. After the close of each interim quarter, management assesses whether there exists any indicators of impairment requiring the Company to perform an interim goodwill impairment analysis.

During the first quarter of 2020, as a result of COVID-19’s impact on the Company’s operations, the Company determined that indicators of potential impairment existed requiring the Company to perform an interim goodwill impairment analysis. These indicators included a deterioration in the general economic conditions, adverse developments in equity and credit markets, deterioration in some of the economic channels in which the Company's operates (especially in the mass retail channel), the recent trading values of the Company's capital stock and the corresponding decline in the Company’s market capitalization and the revision of the Company's internal forecasts as a result of COVID-19.

As a result, for the first quarter of 2020 the Company examined and performed quantitative interim goodwill impairment assessments for all its reporting units, namely: (i) Revlon; (ii) Elizabeth Arden Skin and Color; (iii) Elizabeth Arden Fragrances; (iv) Fragrances; (v) Mass Portfolio; and (vi) Professional Portfolio. In performing these assessments the Company used the simplified approach allowed under ASU No. 2017-04, "Simplifying the Test for Goodwill Impairment."

Based upon such assessments, the Company determined that it was more likely than not that the fair values of each of its Revlon, Elizabeth Arden Skin and Color and Fragrances reporting units exceeded their respective carrying amounts for the first quarter of 2020. As of March 31, 2020, prior to the recording of any impairment charges, the Revlon, Elizabeth Arden Skin and Color and Fragrances reporting units had goodwill balances of $264.7 million, $67.4 million and $120.8 million, respectively.

Additionally, based on its first quarter of 2020 quantitative interim assessment, the Company determined that indicators of impairment existed for the (i) Elizabeth Arden Fragrances; (ii) Mass Portfolio; and (iii) Professional Portfolio reporting units. Following the results of such assessments, the Company recorded non-cash impairment charges in the amount by which the carrying value of each reporting unit exceeded its respective fair value, limited to the amount of each reporting unit's goodwill. For the three months ended March 31, 2020, the Company recognized a total of $99.8 million of non-cash goodwill impairment charges consisting of: $54.3 million and $19.6 million for the Mass Portfolio and Professional Portfolio reporting units, respectively, within the Company's Portfolio segment and $25.9 million for the Elizabeth Arden Fragrances reporting unit within the Company's Elizabeth Arden segment. These impairment charges were included as a separate component of operating income within the "Impairment charges" caption on the face of the Company's Unaudited Consolidated Statement of Operations

and Comprehensive Loss for the six months ended June 30, 2020. Following the recognition of these non-cash goodwill impairment charges, as of March 31, 2020, the Elizabeth Arden Fragrances, Mass Portfolio and Professional Portfolio reporting units had approximately $23.5 million, nil and $97.2 million, respectively, in remaining goodwill.

Primarily as a result of COVID-19 still affecting multiple countries around the world, the Company considered whether newer and/or additional indicators of impairment existed during the second quarter of 2020 that would warrant another interim assessment of goodwill for impairment purposes. The Company concluded that additional indicators of impairment existed as of June 30, 2020, primarily in connection with further revisions to the Company's expected future cash flows as a result of COVID-19.

Based upon such assessments for its second quarter of 2020, the Company determined that it was more likely than not that the fair values of each of its Revlon, Elizabeth Arden Skin and Color and Fragrances reporting units exceeded their respective carrying amounts for the second quarter of 2020. As of June 30, 2020, prior to the recording of any impairment charges, the Revlon, Elizabeth Arden Skin and Color and Fragrances reporting units had goodwill balances of $264.9 million, $67.4 million and $120.8 million, respectively.

Additionally, based on its second quarter of 2020 quantitative interim assessment, the Company determined that indicators of impairment existed for the (i) Elizabeth Arden Fragrances; and (ii) Professional Portfolio reporting units. Following the results of such assessments, the Company recorded non-cash impairment charges in the amount by which the carrying value of each reporting unit exceeded its respective fair value, limited to the amount of each reporting unit's goodwill. For the three months ended June 30, 2020, the Company recognized a total of $11.2 million of non-cash goodwill impairment charges consisting of: $9.6 million for the Professional Portfolio reporting unit within the Company's Portfolio segment and $1.6 million for the Elizabeth Arden Fragrances reporting unit within the Company's Elizabeth Arden segment. These impairment charges were included as a separate component of operating income within the "Impairment charges" caption on the face of the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss for the three and six months ended June 30, 2020. Following the recognition of these non-cash goodwill impairment charges, as of June 30, 2020, the Elizabeth Arden Fragrances and Professional Portfolio reporting units had approximately $22.0 million and $87.6 million, respectively, in remaining goodwill.

The above-mentioned fair values for the two quarterly interim assessments were primarily determined using a weighted average market and income approach. The income approach requires several assumptions including those regarding future sales growth, EBITDA (earnings before interest, taxes, depreciation and amortization) margins, and capital expenditures, which are the basis for the information used in the discounted cash flow model. The weighted-average cost of capital used in the income approach for the two quarterly interim assessments ranged from 10.5% to 12.0%, with a perpetual growth rate of 2%. For the market approach, the Company considered the market comparable method based upon total enterprise value multiples of other comparable publicly-traded companies.

The key assumptions used to determine the estimated fair value of the reporting units for the two quarterly interim assessments included the expected success of the Company's future new product launches, the Company's achievement of its expansion plans, the Company's realization of its cost reduction initiatives and other efficiency efforts, as well as certain assumptions regarding COVID-19's expected impact on the Company. If such plans and assumptions do not materialize as anticipated, or if there are further challenges in the business environment in which the Company's reporting units operate, a resulting change in actual results from the Company's key assumptions could have a negative impact on the estimated fair values of the reporting units, which could require the Company to recognize additional impairment charges in future reporting periods.

The inputs and assumptions utilized in the two quarterly interim impairment analyses are classified as Level 3 inputs in the fair value hierarchy as defined in ASC Topic 820, “Fair Value Measurements.”

The following table presents the changes in goodwill by segment for the six months ended June 30, 2020:



	Revlon		Portfolio		Elizabeth Arden		Fragrances		Total




Balance at January 1, 2020	$	264.9	$	171.1	$	116.9	$	120.8	$	673.7
Foreign currency translation adjustment	—		—		—		—		—

Goodwill impairment charge	—		(83.5)		(27.5)		—		(111.0)
Balance at June 30, 2020	$	264.9	$	87.6	$	89.4	$	120.8	$	562.7

Cumulative goodwill impairment charges^(a)									$	(166.2)

^(a)Amount refers to cumulative goodwill impairment charges related to impairments recognized in 2015, 2017, 2018 and 2020; $11.2 million and $111.0 million of such impairment charges were recognized during the three and six months ended June 30, 2020, respectively.

In connection with recognizing these goodwill impairment charges for the three and six months ended June 30, 2020, the Company recognized a tax benefit of approximately nil and $8.3 million, respectively, during such periods.

Intangible Assets, Net

In accordance with ASC Topic 360, and in conjunction with the Company's performance of its interim impairment testing of goodwill for the first and second quarters of 2020, the Company reviewed its finite-lived intangible assets for impairment. In performing such review, the Company makes judgments about the recoverability of its purchased finite-lived intangible assets whenever events or changes in circumstances indicate that an impairment to its finite-lived intangible assets may exist. The Company also considers several indicators of impairment, including, among other factors, the following: (i) whether there exists any significant adverse change in the extent or manner in which a long-lived asset and/or asset group is being used; (ii) whether there exists any projection or forecast demonstrating losses associated with the use of a long-lived asset and/or asset group; and (iii) whether there exists a current expectation that, more likely than not, a long-lived asset and/or asset group will be sold or otherwise disposed of significantly before the end of its previously-estimated useful life. The carrying amount of a finite-lived intangible asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the finite-lived intangible asset and/or asset group and the impairment loss is measured as the amount by which the carrying amount of the finite-lived intangible asset exceeds its fair value.

In connection with the interim impairment assessment for the first and second quarters of 2020, the Company also reviewed indefinite-lived intangible assets, consisting of certain trade names, using March 31, 2020 and June 30, 2020 carrying values, respectively, similar to goodwill, in accordance with ASC Topic 350.

As a result of COVID-19’s impact on the Company’s operations and on the expected future cash flows of certain asset groups, in connection with the Company's first quarter of 2020 interim assessment of finite-lived and indefinite-lived intangible assets, as of March 31, 2020 the Company recognized $24.5 million of total non-cash impairment charges related to certain indefinite-lived intangible assets within the Company's Mass Portfolio, Elizabeth Arden Fragrances and Elizabeth Arden Skin and Color reporting units.

As a result of COVID-19’s continued and additional impact on the Company’s operations and on the expected future cash flows of certain asset groups, in connection with the Company's interim assessment of indefinite-lived intangible assets for the second quarter of 2020, as of June 30, 2020 the Company recognized $8.6 million of total non-cash impairment charges related to certain indefinite-lived intangible assets within the Company's Elizabeth Arden Fragrances and Elizabeth Arden Skin and Color reporting units.

The fair values of the Company's intangible assets for the two quarterly interim assessments were determined based on the undiscounted cash flows method for its finite-lived intangibles and based on the relief from royalty method for its indefinite-lived intangibles, respectively. The inputs and assumptions utilized in the impairment analyses are classified as Level 3 inputs in the fair value hierarchy as defined in ASC Topic 820, “Fair Value Measurements.” These impairment charges were included as a separate component of operating income within the "Impairment charges" caption on the face of the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss for the three and six months ended June 30, 2020. A summary of such impairment charges by segments is included in the following table:


	Three Months Ended
	June 30, 2020
	Revlon		Portfolio		Elizabeth Arden		Fragrances		Total

Indefinite-lived intangible assets	$	0.0	$	0.0	$	(8.6)	$	0.0	$	(8.6)
Total Intangibles Impairment	$	0.0	$	0.0	$	(8.6)	$	0.0	$	(8.6)


	Six Months Ended
	June 30, 2020
	Revlon		Portfolio		Elizabeth Arden		Fragrances		Total

Indefinite-lived intangible assets	$	—	$	(2.5)	$	(30.6)	$	—	$	(33.1)
Total Intangibles Impairment	$	—	$	(2.5)	$	(30.6)	$	—	$	(33.1)

In connection with recognizing these intangible assets impairment charges for the three and six months ended June 30, 2020, the Company recognized a tax benefit of approximately $1.8 million and $6.9 million, respectively, during such periods.

The following tables present details of the Company's total intangible assets as of June 30, 2020 and December 31, 2019:


	June 30, 2020
	Gross Carrying Amount		Accumulated Amortization		Impairment		Net Carrying Amount		Weighted-Average Useful Life (in Years)
Finite-lived intangible assets:
Trademarks and licenses	$	271.7	$	(119.3)	$	—	$	152.4	13
Customer relationships	248.0		(103.1)		—		144.9		11
Patents and internally-developed intellectual property	21.9		(12.9)		—		9.0		5
Distribution rights	31.0		(6.6)		—		24.4		14
Other	1.3		(1.3)		—		—		0
Total finite-lived intangible assets	$	573.9	$	(243.2)	$	—	$	330.7

Indefinite-lived intangible assets:
Trade names	$	144.0	N/A		$	(33.1)	$	110.9
Total indefinite-lived intangible assets	$	144.0	N/A		$	(33.1)	$	110.9

Total intangible assets	$	717.9	$	(243.2)	$	(33.1)	$	441.6

	December 31, 2019
	Gross Carrying Amount		Accumulated Amortization		Impairment		Net Carrying Amount		Weighted-Average Useful Life (in Years)
Finite-lived intangible assets:
Trademarks and licenses	$	271.2	$	(110.9)	$	—	$	160.3	13
Customer relationships	248.3		(96.5)		—		151.8		11
Patents and internally-developed intellectual property	21.5		(12.1)		—		9.4		5
Distribution rights	31.0		(5.6)		—		25.4		15
Other	1.3		(1.3)		—		—		0
Total finite-lived intangible assets	$	573.3	$	(226.4)	$	—	$	346.9

Indefinite-lived intangible assets:
Trade names	$	143.8	N/A		$	—	$	143.8
Total indefinite-lived intangible assets	$	143.8	N/A		$	—	$	143.8

Total intangible assets	$	717.1	$	(226.4)	$	—	$	490.7

Amortization expense for finite-lived intangible assets was $8.2 million and $8.8 million for the three months ended June 30, 2020 and 2019, respectively, and $16.7 million and $23.6 million for the six months ended June 30, 2020 and 2019, respectively. The variance with the previous comparable six-month period was attributable primarily to the accelerated amortization of the Pure Ice intangible assets during the quarter ended March 31, 2019 as a result of the revision of the brand’s intangible assets useful lives following the termination of a business relationship with the brand's principal customer.

The following table reflects the estimated future amortization expense for each period presented, a portion of which is subject to exchange rate fluctuations, for the Company's finite-lived intangible assets as of June 30, 2020:



	Estimated Amortization Expense
2020	$	17.3
2021	33.3
2022	32.4
2023	30.9
2024	27.5
Thereafter	189.3
Total	$	330.7

ACCRUED EXPENSES AND OTHER

6 Months Ended

Jun. 30, 2020

Payables and Accruals [Abstract]

ACCRUED EXPENSES AND OTHER

As of June 30, 2020 and December 31, 2019, the Company's accrued expenses and other current liabilities consisted of the following:


	June 30,		December 31,
	2020		2019
Sales returns and allowances	$	64.6	$	89.7
Advertising, marketing and promotional costs	69.2		82.8
Taxes ^(a)	46.9		54.3
Compensation and related benefits	31.3		42.1
Interest	34.8		34.0
Professional services and insurance	19.8		16.3
Short-term lease liability	19.7		14.5
Freight and distribution costs	7.4		13.2
Restructuring reserve	42.6		10.0
Software	3.1		4.0
Other ^(b)	39.1		54.0
Total	$	378.5	$	414.9

^(a) Accrued Taxes for Products Corporation as of June 30, 2020 and December 31, 2019 were $49.9 million and $57.6 million, respectively.

(b) Accrued Other as of December 31, 2019 includes approximately $2.3 million of severance to Mr. Fabian Garcia, the Company's former President and Chief Executive Officer, which was paid in 2020.

DEBT

6 Months Ended

Jun. 30, 2020

Debt Disclosure [Abstract]

DEBT

As of June 30, 2020 and December 31, 2019, the Company's debt balances consisted of the following:


	June 30,		December 31,
	2020		2019
2020 BrandCo Term Loan Facility due 2025, net of debt issuance costs (see (a) below)	1,582.5		$	—
2019 Term Loan Facility due 2023, net of discounts and debt issuance costs (see (b) below)	—		187.1
2018 Foreign Asset-Based Term Facility due 2021, net of discounts and debt issuance costs (see (c) below)	51.6		82.3
Amended 2016 Revolving Credit Facility due 2021, net of debt issuance costs (see (d) below)	247.2		269.9
2016 Term Loan Facility: 2016 Term Loan due 2023 and 2025, net of discounts and debt issuance costs (see (e) below)	911.8		1,713.6
5.75% Senior Notes due 2021, net of debt issuance costs (see (f) below)	387.2		498.1
6.25% Senior Notes due 2024, net of debt issuance costs (see (g) below)	443.5		442.8


Spanish Government Loan due 2025	0.3		0.4
Debt	$	3,624.1	$	3,194.2
Less current portion^(*)	(648.3)		(288.0)
Long-term debt	$	2,975.8	$	2,906.2

Short-term borrowings (see (h) below)	$	2.6	$	2.2

^(*) At June 30, 2020, the Company classified $648.3 million as its current portion of long-term debt, comprised primarily of $387.2 million of Products Corporation's 5.75% Senior Notes due February 15, 2021 (the "5.75% Senior Notes"), net of debt issuance costs, $247.2 million of net borrowings under the Amended 2016 Revolving Credit Facility, net of debt issuance costs, $9.6 million of amortization payments on the 2016 Term Loan Facility scheduled to be paid over the next four calendar quarters, and $4.2 million of amortization payments under the 2020 BrandCo Term Loan Facility due within one year. At December 31, 2019, the Company classified $288.0 million as its current portion of long-term debt, comprised primarily of $269.9 million of net borrowings under the Amended 2016 Revolving Credit Facility, net of debt issuance costs, and $18.0 million of amortization payments on the 2016 Term Loan Facility. See below in this Note 7, "Debt," and Note 19, "Subsequent Events," for details regarding the Company's recent debt-related transactions.

^(a)The aggregate principal amount outstanding under the 2020 BrandCo Term Loan Facility at June 30, 2020 was $1,720.4 million, including $809.8 million of principal rolled-up from the 2016 Term Loan Facility to the Roll-up BrandCo Facility and the Junior Roll-up BrandCo Facility. See further details below, within this Note 7, "Debt."

^(b) On May 7, 2020, in connection with closing the 2020 BrandCo Facilities, the Company fully repaid the 2019 Term Loan Facility pursuant to that Term Credit Agreement, dated as of August 6, 2019 (the “2019 Term Loan Facility”). See Note 9, "Long-Term Debt," to the Consolidated Financial Statements in the Company's 2019 Form 10-K for certain details regarding the 2019 Term Loan Facility, which prior to its repayment was scheduled to mature on the earliest of: (x) August 6, 2023; (y) the 180th day prior to the stated maturity of Products Corporation’s existing 2016 Term Loan Facility, if any loans under the 2016 Term Loan Facility remained outstanding and had not been replaced or refinanced by such date; and (z) the date of any springing maturity of the 2016 Term Loan Facility (i.e., the 91st day prior to the maturity of the 5.75% Senior Notes due February 15, 2021 if any 5.75% Senior Notes remained outstanding by such date and certain liquidity thresholds were not met). The lenders under the 2019 Term Loan Facility participated in the 2020 BrandCo Term Loan Facility and, as a result, the Company determined that the full repayment of the 2019 Term Loan Facility represented a debt modification under U.S. GAAP. Accordingly, the Company recorded approximately $33.5 million in connection with fees paid to the lenders for the prepayment of the 2019 Term Loan Facility, as well as approximately $10.3 million in other lenders' fees, which were capitalized as part of the total debt issuance costs for the 2020 BrandCo Term Loan Facility. See further details below, within this Note 7, "Debt."

^(c) The aggregate principal amount outstanding under the 2018 Foreign Asset-Based Term Facility at June 30, 2020 was U.S. Dollar equivalent $54.5 million. In connection with the amendment described below, the Company repaid €5 million of the original aggregate principal amount of €77 million. See Note 9, "Long-Term Debt," to the Consolidated Financial Statements in the Company's 2019 Form 10-K for certain details regarding the euro-denominated senior secured asset-based term loan facility that various foreign subsidiaries of Products Corporation entered into on July 9, 2018 and which is scheduled to mature on July 9, 2021, subject to a springing maturity on November 16, 2020 if any of the 5.75% Senior Notes remain outstanding on such date (the “2018 Foreign Asset-Based Term Facility”). In May, 2020 the Company entered into an amendment to the 2018 Foreign Asset Based Term Facility to, among other things, increase the margin applicable to the interest rate from EURIBOR (with a floor of 0.50%) plus a margin of 6.50% to EURIBOR (with a floor 0.50%) plus a margin of 7.00%. See further details below, within this Note 7, "Debt."

^(d) Total borrowings at face amount under Tranche A of the Amended 2016 Revolving Credit Facility at June 30, 2020 were $249.5 million (excluding $7.7 million of outstanding undrawn letters of credit). See Note 9, "Long-Term Debt," to the Consolidated Financial Statements in the Company's 2019 Form 10-K for certain details regarding Products Corporation's Amended 2016 Revolving Credit Facility. In April 2018, Products Corporation amended the Amended 2016 Revolving Credit Facility Agreement, as detailed below, to, among other things, add a new $41.5 million senior secured first in, last out "Tranche B," while the original $400 million tranche under such facility became a senior secured last in, first out "Tranche A." Tranche A matures on the earlier of: (x) September 7, 2021; and (y) the 91^st day prior to the maturity of Products Corporation’s 5.75% Senior Notes, if, on that date (and solely for so long as), (i) any of Products Corporation’s 5.75% Senior Notes remain outstanding and (ii) Products Corporation’s available liquidity does not exceed the aggregate principal amount of the then outstanding 5.75% Senior Notes by at least $200 million. On April 17, 2020, the maturity date of Tranche B was extended from April 17, 2020 to May 17, 2020 and was fully repaid on such extended maturity date.

^(e) The aggregate principal amount outstanding under the 2016 Term Loan Facility at June 30, 2020 was $924.8 million. See Note 9, "Long-Term Debt," to the Consolidated Financial Statements in the Company's 2019 Form 10-K for certain details regarding Products Corporation's 2016 Term Loan that was originally scheduled to mature on the earlier of: (x) September 7, 2023; and (y) the 91^st day prior to the maturity of Products Corporation’s 5.75% Senior Notes due 2021 if, on that date (and solely for so long as), (i) any of Products Corporation's 5.75% Senior Notes remain outstanding and (ii) Products

Corporation’s available liquidity does not exceed the aggregate principal amount of the then outstanding 5.75% Senior Notes by at least $200 million (the “Original Maturity Date”). On May 7, 2020, in connection with closing the 2020 BrandCo Facilities, the Company amended the 2016 Term Loan Facility to, among other things, extend the maturity of a portion of the 2016 Term Loan Facility to June 30, 2025, subject to certain springing maturities the “Extended Maturity Date”). See further details below within this Note 7, "Debt." As a result of such transaction, as of June 30, 2020, $894.0 million of the 2016 Term Loan is scheduled to mature on the Original Maturity Date and $30.8 million is scheduled to mature on the Extended Maturity Date.

^(f) The aggregate principal amount outstanding under the 5.75% Senior Notes at June 30, 2020 was $387.2 million. See Note 9, "Long-Term Debt," to the Consolidated Financial Statements in the Company's 2019 Form 10-K for certain details regarding Products Corporation's 5.75% Senior Notes that are scheduled to mature on February 15, 2021. During the three months ended June 30, 2020, the Company repurchased $112.8 million in aggregate principal face amount of the 5.75% Senior Notes, recording a net gain on extinguishment of debt of approximately $11.9 million, which is included in "(Gain) loss on early extinguishment of debt, net" on the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss for the three and six months ended June 30, 2020. See further details below within this Note 7, "Debt."

^(g) The aggregate principal amount outstanding under the 6.25% Senior Notes at June 30, 2020 was $450 million. See Note 9, "Long-Term Debt," to the Consolidated Financial Statements in the Company's 2019 Form 10-K for certain details regarding Products Corporation's 6.25% Senior Notes that are scheduled to mature on August 1, 2024 (the "6.25% Senior Notes").

^(h)There were no borrowings at June 30, 2020 under the 2019 Senior Line of Credit Facility between Products Corporation and MacAndrews & Forbes Group, LLC, a related party, discussed below.

Current Year Debt Transactions

Consummation of 2020 BrandCo Refinancing Transactions

On May 7, 2020 (the “BrandCo 2020 Facilities Closing Date”), the Company, entered into a term credit agreement (the “2020 BrandCo Credit Agreement”) with Jefferies Finance LLC, as administrative agent and collateral agent, and certain financial institutions (the “2020 Facilities Lenders”) that are lenders or the affiliates of lenders under Products Corporation’s Term Loan Credit Agreement, dated as of September 7, 2016 and amended on April 30, 2020 and as amended on the BrandCo 2020 Facilities Closing Date, as further described below (as amended to date, the “2016 Term Loan Facility”). Pursuant to the 2020 BrandCo Credit Agreement, the 2020 Facilities Lenders provided the Company with new and roll-up senior secured term loan facilities (the “2020 BrandCo Facilities” and, collectively, the "2020 BrandCo Term Loan Facility" and, together with the use of proceeds thereof and the Extension Amendment (as defined below), the “2020 Refinancing Transactions”).

Principal and Maturity: The 2020 BrandCo Facilities consist of: (i) a senior secured term loan facility in an aggregate principal amount outstanding on the BrandCo 2020 Facilities Closing Date of $815 million, plus the amount of certain fees and accrued interest that have been capitalized (the “2020 BrandCo Facility”); (ii) commitments in respect of a senior secured term loan facility in an aggregate principal amount of $950 million (the “Roll-up BrandCo Facility”); and (iii) a senior secured term loan facility in an aggregate principal amount outstanding on the BrandCo 2020 Facilities Closing Date of $3 million (the “Junior Roll-up BrandCo Facility”). Additionally, on May 28, 2020, Products Corporation borrowed from the 2020 Facilities Lenders an additional $65 million of term loans under the 2020 BrandCo Facility to repay in full the 2020 Incremental Facility (as defined below) under the 2016 Term Loan Facility, as a result of which the 2020 BrandCo Facility at June 30, 2020 had an aggregate principal amount outstanding of $910.6 million (including paid-in-kind closing fees of $29.1 million and paid-in-kind interest of $1.5 million that have been capitalized). Additionally, during the three months ended June 30, 2020, certain lenders under the 2016 Term Loan Facility due June 2023, representing $809.8 million in aggregate principal outstanding, rolled-up to the Roll-up BrandCo Facility and the Junior Roll-up BrandCo Facility due June 2025, as a result of which the Roll-up BrandCo Facility and the Junior Roll-up BrandCo Facility at June 30, 2020 have an aggregate principal amount outstanding of $809.8 million. The Company determined that the roll-up of such 2016 Term Loan Facility lenders into the Roll-up BrandCo Facility and the Junior Roll-up BrandCo Facility represented a debt modification under U.S. GAAP, as the cash flow effect between the amount that Products Corporation owed to the participating lenders under the old debt instrument (i.e., the 2016 Term Loan Facility) and the amount that Products Corporation owed to such lenders after the consummation of the roll-up into the new debt instrument (i.e., the Roll-up BrandCo Facility and the Junior Roll-up BrandCo Facility) on a present value basis was less than 10% and, thus, the debt instruments were not considered to be substantially different within the meaning of ASC 470, Debt, under U.S. GAAP.

The proceeds of the 2020 BrandCo Facility were used: (i) to repay in full approximately $200 million of indebtedness outstanding under Products Corporation’s 2019 Term Loan Facility; (ii) to repay in full and terminate commitments under the 2020 Incremental Facility; and (iii) to pay fees and expenses in connection with the 2020 BrandCo Facilities and the 2020 Refinancing Transactions. The Company will use the remaining net proceeds for general corporate purposes, including repurchasing, repaying or refinancing Products Corporation’s outstanding 5.75% Senior Notes. The proceeds of the Roll-up BrandCo Facility are available prior to the third anniversary of the BrandCo 2020 Facilities Closing Date to purchase at par an equivalent amount of any remaining term loans under the 2016 Term Loan Facility held by the lenders participating in the 2020 BrandCo Facility or their transferees. During the three months ended June 30, 2020, certain lenders under the 2016 Term Loan Facility due June 2023, representing $809.8 million in aggregate principal outstanding, rolled-up to the Roll-up BrandCo Facility and the Junior Roll-up BrandCo Facility due June 2025, as a result of which the Roll-up BrandCo Facility and the

Junior Roll-up BrandCo Facility at June 30, 2020 have an aggregate principal amount outstanding of $809.8 million, with a remaining capacity for the roll-up of loans under the 2016 Term Loan Facility of $143.2 million.

The 2020 BrandCo Facilities will mature on June 30, 2025, subject to a springing maturity 91 days prior to the August 1, 2024 maturity date of Products Corporation’s 6.25% Senior Notes if, on such date, $100 million or more in aggregate principal amount of the 6.25% Senior Notes remain outstanding.

The Company incurred approximately $116.7 million of new debt issuance costs in connection with closing the 2020 BrandCo Facility, which include paid-in kind amounts that are recorded as an adjustment to the carrying amount of the related liability and amortized to interest expense in accordance with the effective interest method over the term of the 2020 BrandCo Facilities.

Borrower, Guarantees and Security: Products Corporation is the borrower under the 2020 BrandCo Facilities and the 2020 BrandCo Facilities are guaranteed by certain of Products Corporation's indirect subsidiaries (the “BrandCos”) that hold certain intellectual property assets related to the Elizabeth Arden and American Crew brands, certain other Portfolio segment brands and certain owned Fragrance segment brands (the “Specified Brand Assets”). While the BrandCos do not guarantee the 2016 Term Loan Facility, all guarantors of the 2016 Term Loan Facility guarantee the 2020 BrandCo Facilities. All of the assets of the BrandCos (including all capital stock issued by the BrandCos) have been pledged to secure the 2020 BrandCo Facility on a first-priority basis, the Roll-up BrandCo Facility on a second-priority basis and the Junior Roll-up BrandCo Facility on a third-priority basis and while such assets do not secure the 2016 Term Loan Facility, the 2020 BrandCo Facilities are secured on a pari passu basis by the assets securing the 2016 Term Loan Facility.

Contribution and License Agreements: In connection with the pledge of the Specified Brand Assets, Products Corporation and certain of its subsidiaries contributed the Specified Brand Assets to the BrandCos. Products Corporation entered into license and royalty arrangements on arm’s length terms with the relevant BrandCos to provide for the continued use of the Specified Brand Assets by Products Corporation and its subsidiaries during the term of the 2020 BrandCo Facilities.

Interest and Fees: Loans under the 2020 BrandCo Facility bear interest at a rate equal to LIBOR (with a LIBOR floor of 1.50%) plus (x) 10.50% per annum, payable not less than quarterly in arrears in cash and (y) 2.00% per annum payable not less than quarterly in-kind by adding such amount to the principal amount of outstanding loans under the 2020 BrandCo Facility. Loans under the Roll-up BrandCo Facility and the Junior Roll-up BrandCo Facility bear interest at a rate equal to LIBOR (with a LIBOR floor of 0.75%) plus 3.50% per annum, payable not less than quarterly in arrears in cash.

Affirmative and Negative Covenants: The 2020 BrandCo Facilities contain certain affirmative and negative covenants that, among other things, limit Products Corporation’s and its restricted subsidiaries’ ability to: (i) incur additional debt; (ii) incur liens; (iii) sell, transfer or dispose of assets; (iv) make investments; (v) make dividends and distributions on, or repurchases of, equity; (vi) make prepayments of contractually subordinated, unsecured or junior lien debt; (vii) enter into certain transactions with their affiliates; (viii) enter into sale-leaseback transactions; (ix) change their lines of business; (x) restrict dividends from their subsidiaries or restrict liens; (xi) change their fiscal year; and (xii) modify the terms of certain debt. The 2020 BrandCo Facilities also restrict distributions and other payments from the BrandCos based on certain minimum thresholds of net sales with respect to the Specified Brand Assets. The 2020 BrandCo Facilities also contain certain customary representations, warranties and events of default, including a cross default provision making it an event of default under the 2020 BrandCo Credit Agreement if there is an event of default under Products Corporation’s existing 2016 Credit Agreements, the 2018 Foreign Asset-Based Term Agreement or the Senior Notes Indentures. The lenders under the 2020 BrandCo Credit Agreement may declare all outstanding loans under the 2020 BrandCo Facilities to be due and payable immediately upon an event of default. Under such circumstances, the lenders under the 2016 Credit Agreements, the 2018 Foreign Asset-Based Term Agreement, and the holders under the Senior Notes Indentures may also declare all outstanding amounts under such instruments to be due and payable immediately as a result of similar cross default or cross acceleration provisions, subject to certain exceptions and limitations described in the relevant instruments.

Prepayments: The 2020 BrandCo Facilities are subject to certain mandatory prepayments, including from the net proceeds from the issuance of certain additional debt and asset sale proceeds of certain non-ordinary course asset sales or other dispositions of property, subject to certain exceptions. The 2020 BrandCo Facilities may be repaid at any time, subject to customary prepayment premiums.

2016 Term Loan Facility Extension Amendment: Term loan lenders under the 2016 Term Loan Facility were offered the opportunity to participate at par in the 2020 BrandCo Facilities based on their holdings of term loans under the 2016 Term Loan Facility. Lenders participating in the 2020 BrandCo Facilities, as well as other consenting lenders representing, in the aggregate, a majority of the loans and commitments under the 2016 Term Loan Facility, consented to an amendment to the 2016 Term

Loan Facility (the “Extension Amendment”) that, among other things, made certain modifications to the covenants thereof and extended the maturity date of their term loans (“Extended Term Loans”) to June 30, 2025, subject to (i) the same September 7, 2023 springing maturity date of the non-extended term loans under the 2016 Term Loan Facility if, on such date, $75 million or more in aggregate principal amount of the non-extended term loans under the 2016 Term Loan Facility remains outstanding, and (ii) a springing maturity of 91 days prior to the August 1, 2024 maturity date of the 6.25% Senior Notes if, on such date, $100 million or more in aggregate principal amount of the 6.25% Senior Notes remains outstanding. The Extension Amendment became effective on the BrandCo 2020 Facilities Closing Date. As of June 30, 2020, approximately $30.8 million in aggregate principal amount of Extended Term Loans were outstanding after giving effect to the 2020 Refinancing Transactions. The Extended Term Loans bear interest at a rate of LIBOR (with a LIBOR floor of 0.75%) plus 3.50% per annum, payable not less than quarterly in arrears in cash, consistent with the interest rate applicable to the non-extended term loans. Approximately $17.0 million of accrued interest outstanding on the 2016 Term Loan Facility was paid on the BrandCo 2020 Facilities Closing Date. The aggregate principal amount of non-extended term loans under the 2016 Term Loan Facility as of June 30, 2020 was $894.0 million.

Repurchases of 5.75% Senior Notes due 2021

On May 7, 2020, the Company used a portion of the proceeds from the 2020 BrandCo Facility to repurchase and subsequently cancel $50 million in aggregate principal face amount of its 5.75% Senior Notes. Products Corporation also paid approximately $0.7 million of accrued interest outstanding on the 5.75% Senior Notes on May 7, 2020. After the BrandCo 2020 Facilities Closing Date, the Company repurchased and subsequently canceled in July 2020 a further $62.8 million in aggregate principal face amount of its 5.75% Senior Notes. Accordingly, as of June 30, 2020, the Company had repurchased and subsequently cancelled a total of approximately $112.8 million in aggregate principal face amount of its 5.75% Senior Notes, resulting in a net gain on extinguishment of debt of approximately $11.9 million, which was recorded within "(Gain) loss on early extinguishment of debt, net" on the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss for the three and six months ended June 30, 2020. See Note 19, "Subsequent Events," for more information regarding the Exchange Offer that the Company commenced in July 2020 with respect to the 5.75% Senior Notes.

Prepayment of the 2019 Term Loan Facility due 2023

On the BrandCo 2020 Facilities Closing Date, the Company used a portion of the proceeds from the 2020 BrandCo Facility to fully prepay the entire principal amount outstanding under its 2019 Term Loan Facility, totaling $200 million, plus approximately $1.3 million of accrued interest outstanding thereon, as well as approximately $33.5 million in prepayment premiums, $10.3 million in lenders' fees, $0.3 million in legal fees and approximately $2.0 million in other third party fees. As the lenders under the 2019 Term Loan Facility participated in the 2020 BrandCo Term Loan Facility, the Company determined that the full repayment of the 2019 Term Loan Facility represented a debt modification under U.S. GAAP as the cash flow effect between the old debt instrument (i.e., the 2019 Term Loan Facility) and the new debt instrument (i.e., the 2020 BrandCo Facility) on a present value basis was less than 10% and, thus, the debt instruments were not considered to be substantially different within the meaning of ASC 470, Debt, under U.S. GAAP. Accordingly, the $33.5 million of prepayment premiums, as well as the $10.3 million in other lenders' fees were capitalized as part of the aforementioned $116.7 million of total new debt issuance costs for the 2020 BrandCo Term Loan Facility, while the aforementioned $0.3 million of legal fees and $2.0 million in other third party fees were expensed as incurred in the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss for the three and six months ended June 30, 2020.

Amendment to the 2018 Foreign Asset-Based Term Facility

On May 4, 2020, the Company entered into an amendment to the 2018 Foreign Asset Based Term Facility, which had an original outstanding principal amount of €77 million. Such amendment provided for the following:

•increasing the interest rate on the loan from EURIBOR (with a floor 0.50%) plus a margin of 6.50% to EURIBOR (with a floor 0.50%) plus a margin of 7.00%;

•adding a springing maturity date of 91 days prior to the February 15, 2021 maturity of the 5.75% Senior Notes if any of the 5.75% Senior Notes remain outstanding on such date;

•requiring a mandatory prepayment of €5.0 million; and

•clarifying certain terms and waiving certain provisions in connection with the 2020 Refinancing Transactions.

Approximately $0.4 million of amendment fees paid to the lenders under 2018 Foreign Asset-Based Term Facility were capitalized and are amortized to interest expense, together with any unamortized debt issuance costs outstanding prior to the amendment. As of June 30, 2020, there was €48.5 million outstanding under the 2018 Foreign Asset-Based Term Facility, reflecting a repayment of €28.5 million made during the quarter ended June 30, 2020.

Incremental Revolving Credit Facility under the 2016 Term Loan Agreement

On April 30, 2020, Products Corporation entered into a Joinder Agreement (the “2020 Joinder Agreement”), with Revlon, certain of their subsidiaries and certain existing lenders (the “Incremental Lenders”) under Products Corporation’s 2016 Term Loan Agreement to provide for a $65 million incremental revolving credit facility (the “2020 Incremental Facility”). On the closing of the 2020 Incremental Facility, Products Corporation borrowed $63.5 million of revolving loans for working capital purposes and subsequently on May 11, 2020 Products Corporation also borrowed the additional $1.5 million of delayed funding. After the BrandCo 2020 Facilities Closing Date, Products Corporation borrowed the remaining $1.5 million of revolving loans for working capital purposes. The commitments in respect of the 2020 Incremental Facility would have terminated on September 7, 2021, subject to a springing maturity date of 91 days prior to the February 15, 2021 maturity date of Products Corporation's 5.75% Senior Notes if any such notes remain outstanding on such date, and certain liquidity requirements are not satisfied. Prior to its full repayment on May 28, 2020, amounts outstanding under the 2020 Incremental Facility bore interest at a rate of (x) LIBOR plus 16% or (y) an Alternate Base Rate plus 15%, at Products Corporation’s option. Except as to pricing, maturity and differences due to its revolving nature, the terms of the 2020 Incremental Facility were otherwise substantially consistent with the existing term loans under the 2016 Term Loan Facility. The 2020 Incremental Facility was repaid in full, and the commitments thereunder terminated, on May 28, 2020. Upon such repayment, approximately $2.9 million of upfront commitment fees that the Company incurred in connection with consummating the 2020 Incremental Facility were entirely expensed within "Miscellaneous, net" on the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss for the three and six months ended June 30, 2020.

Amendments to 2016 Revolving Credit Agreement

On May 7, 2020, in connection with consummating the 2020 Refinancing Transactions, the Company entered into Amendment No. 4 to Products Corporation’s Asset-Based Revolving Credit Agreement, dated as of September 7, 2016, as amended (the “2016 Revolving Credit Facility”). Amendment No. 4, among other things, made certain amendments and provided for certain waivers relating to the 2020 Refinancing Transactions under the 2016 Revolving Credit Facility. In exchange for such amendments and waivers, the interest rate margin applicable to loans under Tranche A of the 2016 Revolving Credit Facility increased by 0.75%. In connection with the amendments to Tranche B of the 2016 Revolving Credit Facility (which was fully repaid on its May 17, 2020 extended maturity date), the Company incurred approximately $1.1 million in lender's fees that upon its full repayment were entirely expensed within “Miscellaneous, net” on the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss as of June 30, 2020.

Previously, on April 17, 2020 (the “FILO Closing Date”), the Company entered into Amendment No. 3 to the 2016 Revolving Credit Facility (“Amendment No. 3”), pursuant to which, the maturity date applicable to $36.3 million of loans under the $41.5 million senior secured first in, last out Tranche B under the 2016 Revolving Credit Facility (the “FILO Tranche”) was extended from April 17, 2020 to May 17, 2020 (the “Extended Maturity Date”). The Company repaid the remaining approximately $5.2 million of FILO Tranche loans as of the FILO Closing Date. In addition, Amendment No. 3 increased the applicable interest margin for the FILO Tranche by 0.75%, subject to a LIBOR floor of 0.75%. The FILO Tranche was fully repaid on the Extended Maturity Date.

Covenants

Products Corporation was in compliance with all applicable covenants under the 2020 BrandCo Credit Agreement, 2016 Credit Agreements, the 2018 Foreign Asset-Based Term Agreement, the Amended 2019 Senior Line of Credit Agreement, as well as with all applicable covenants under its Senior Notes Indentures, in each case as of June 30, 2020. At June 30, 2020, the aggregate principal amounts outstanding and availability under Products Corporation’s various revolving credit facilities were as follows:



	Commitment		Borrowing Base		Aggregate principal amount outstanding at June 30, 2020		Availability at June 30, 2020 ^(a)
Amended 2016 Revolving Credit Facility	$	400.0	$	307.9	$	249.5	$	50.7


Amended 2019 Senior Line of Credit Facility	$	30.0	N/A		$	—	$	30.0

^(a) Availability as of June 30, 2020 is based upon the borrowing base then in effect under the Amended 2016 Revolving Credit Facility of $307.9 million, less $7.7 million of outstanding undrawn letters of credit and $249.5 million then drawn. As Products Corporation’s consolidated fixed charge coverage ratio was greater than 1.0 to 1.0 as of June 30, 2020, all of the $50.7 million of availability under the

Amended 2016 Revolving Credit Facility was available as of such date. Tranche B under the Amended 2016 Revolving Credit Facility was fully repaid in May 2020.

The Company’s foreign subsidiaries held $62.1 million out of the Company's total $338.5 million in cash and cash equivalents as of June 30, 2020. While the cash held by the Company’s foreign subsidiaries is primarily used to fund their operations, the Company regularly assesses its global cash needs and the available sources of cash to fund these needs, which regularly includes repatriating foreign-held cash to settle historical intercompany loans and other intercompany payables. The Company believes that it has and will have sufficient liquidity to meet its cash needs for at least the next 12 months based upon the cash generated by its operations, cash on hand (which as of June 30, 2020 included approximately $276.4 million of proceeds remaining from the 2020 Refinancing Transactions), availability under the Amended 2016 Revolving Credit Facility, the Amended 2019 Senior Line of Credit Facility, as well as other permissible borrowings, along with the option to further settle historical intercompany loans and payables with certain foreign subsidiaries. The Company also expects to generate additional liquidity from cost reductions resulting from the implementation of the Revlon 2020 Restructuring Program, which was initiated during the first quarter of 2020, the 2018 Optimization Program and cost reductions generated from other cost control initiatives, including, without limitation, new interim measures to reduce costs in response to COVID-19 (such as: (i) switching to a reduced work week and reducing executive and employee compensation in the range of 20% to 40%; (ii) furloughing approximately 40% of the Company’s U.S.-based employees and those in certain other locations; (iii) suspending the Company’s 2020 merit base salary increases, discretionary profit sharing contributions and matching contributions to the Company’s 401(k) plan; (iv) reducing Board and committee compensation by 50% and eliminating Board and committee meeting fees; and (v) suspending or terminating services and payments under consulting agreements with certain directors), as well as funds provided by selling certain assets (such as the Natural Honey and Floid brands that were sold in December 2019) in connection with the Company's ongoing Strategic Review. For information regarding certain risks related to the Company’s indebtedness, see Item 1A. “Risk Factors” in the Company's 2019 Form 10-K.

FAIR VALUE MEASUREMENTS

6 Months Ended

Jun. 30, 2020

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS

Assets and liabilities are required to be categorized into three levels of fair value based upon the assumptions used to value the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3, if applicable, generally would require significant management judgment. The three levels for categorizing the fair value measurement of assets and liabilities are as follows:

•Level 1: Fair valuing the asset or liability using observable inputs, such as quoted prices in active markets for identical assets or liabilities;

•Level 2: Fair valuing the asset or liability using inputs other than quoted prices that are observable for the applicable asset or liability, either directly or indirectly, such as quoted prices for similar (as opposed to identical) assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and

•Level 3: Fair valuing the asset or liability using unobservable inputs that reflect the Company’s own assumptions regarding the applicable asset or liability.

As of both June 30, 2020 and December 31, 2019, the Company did not have any financial assets and liabilities that were required to be measured at fair value.

As of June 30, 2020, the fair value and carrying value of the Company’s long-term debt, including the current portion of long-term debt, are categorized in the table below:


	June 30, 2020
	Fair Value
	Level 1		Level 2		Level 3		Total		Carrying Value
Liabilities:
Long-term debt, including current portion^(a)	$	—	$	2,250.2	$	—	$	2,250.2	$	3,624.1

As of December 31, 2019, the fair value and carrying value of the Company’s long-term debt, including the current portion of long-term debt, are categorized in the table below:


	December 31, 2019
	Fair Value
	Level 1		Level 2		Level 3		Total		Carrying Value
Liabilities:
Long-term debt, including current portion^(a)	$	—	$	2,522.2	$	—	$	2,522.2	$	3,194.2

^(a)The fair value of the Company's long-term debt, including the current portion of long-term debt, is based on quoted market prices for similar issuances and maturities.

The carrying amounts of the Company's cash and cash equivalents, trade receivables, notes receivable, accounts payable and short-term borrowings approximate their respective fair values.

PENSION AND POST-RETIREMENT BENEFITS

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

FINANCIAL INSTRUMENTS	6 Months Ended
FINANCIAL INSTRUMENTS	Jun. 30, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
FINANCIAL INSTRUMENTS	FINANCIAL INSTRUMENTS Letters of Credit Products Corporation maintains standby and trade letters of credit for various corporate purposes under which Products Corporation is obligated, of which $7.7 million and $11.4 million (including amounts available under credit agreements in effect at that time) were maintained as of June 30, 2020 and December 31, 2019, respectively. Included in these amounts are approximately $5.3 million and $8.3 million in standby letters of credit that primarily support Products Corporation’s workers compensation, general liability and automobile insurance programs, in each case as outstanding as of June 30, 2020 and December 31, 2019, respectively. The estimated liability under such programs is accrued by Products Corporation.

PENSION AND POST-RETIREMENT BENEFITS

6 Months Ended

Jun. 30, 2020

Retirement Benefits [Abstract]

Net Periodic Benefit Cost

The components of net periodic benefit costs for the Company's pension and the other post-retirement benefit plans for the three months ended June 30, 2020 and 2019, respectively, were as follows:



	Pension Plans						Other Post-Retirement Benefit Plans
	Three Months Ended June 30,
	2020		2019		2020		2019
Net periodic benefit costs:
Service cost	$	0.4	$	0.5	$	—	$	—
Interest cost	3.7		5.0		0.1		0.1
Expected return on plan assets	(5.6)		(6.0)		—		—
Amortization of actuarial loss	2.9		2.6		0.1		—

Total net periodic benefit costs prior to allocation	$	1.4	$	2.1	$	0.2	$	0.1
Portion allocated to Revlon Holdings	(0.1)		(0.1)		—		—
Total net periodic benefit costs	$	1.3	$	2.0	$	0.2	$	0.1

In the three months ended June 30, 2020, the Company recognized net periodic benefit cost of $1.5 million, compared to net periodic benefit cost of $2.1 million in the three months ended June 30, 2019, primarily due to lower interest costs partially offset by lower expected return on plan assets and higher amortization of actuarial loss.

The components of net periodic benefit costs for the Company's pension and the other post-retirement benefit plans for the six months ended June 30, 2020 and 2019, respectively, were as follows:


	Pension Plans						Other Post-Retirement Benefit Plans
	Six Months Ended June 30,
	2020		2019		2020		2019
Net periodic benefit costs:
Service cost	$	0.8	$	1.0	$	—	$	—
Interest cost	7.4		9.9		0.2		0.2
Expected return on plan assets	(11.4)		(12.0)		—		—
Amortization of actuarial loss	5.6		5.0		0.2		0.1

Total net periodic benefit costs prior to allocation	$	2.4	$	3.9	$	0.4	$	0.3
Portion allocated to Revlon Holdings	(0.1)		(0.1)		—		—
Total net periodic benefit costs	$	2.3	$	3.8	$	0.4	$	0.3

In the six months ended June 30, 2020, the Company recognized net periodic benefit cost of $2.7 million, compared to net periodic benefit cost of $4.1 million in the six months ended June 30, 2019, primarily due to lower interest costs partially offset by lower expected return on plan assets and higher amortization of actuarial loss.

Net periodic benefit costs are reflected in the Company's Unaudited Consolidated Financial Statements as follows for the periods presented:


	Three Months Ended June 30,						Six Months Ended June 30,
	2020		2019		2020		2019
Net periodic benefit costs:

Selling, general and administrative expense	$	0.4	$	0.4	$	0.8	$	0.9
Miscellaneous, net	1.1		1.7		1.9		3.2
Total net periodic benefit costs	$	1.5	$	2.1	$	2.7	$	4.1

The Company expects that it will have net periodic benefit cost of approximately $5.5 million for its pension and other post-retirement benefit plans for all of 2020, compared with net periodic benefit cost of $7.2 million in 2019.

Contributions:

The Company’s intent is to fund at least the minimum contributions required to meet applicable federal employee benefit laws and local laws, or to directly pay benefit payments where appropriate. During the three months ended June 30, 2020, $1.8 million and $0.1 million were contributed to the Company’s pension plans and other post-retirement benefit plans, respectively. During the six months ended June 30, 2020, $5.2 million and $0.3 million were contributed to the Company’s pension plans and other post-retirement benefit plans, respectively. During 2020, the Company expects to contribute approximately $19 million in the aggregate to its pension and other post-retirement benefit plans.

As a result of the CARES Act passed by the U.S. Congress in March 2020 to address the economic environment resulting from COVID-19, and in accordance with the Limited Relief for Pension Funding and Retirement Plan Distributions provision of such act, the Company expects to defer approximately $9.4 million of contributions that were otherwise scheduled to be paid to its two qualified pension plans during 2020. The first quarterly contributions for the two qualified plans were originally due by April 15, 2020. The Company had already made $1.6 million in contributions to its qualified pension plans during the first quarter of 2020, prior to adopting the aforementioned provision of the CARES Act. The deferral is in effect only for 2020 and under the CARES relief provisions the Company will be required to pay the contributions by no later than January 1, 2021, including interest at the plans’ 2020 effective interest rate ("EIR") from the original due date to the actual payment date.

Relevant aspects of the qualified defined benefit pension plans, non-qualified pension plans and other post-retirement benefit plans sponsored by Products Corporation are disclosed in Note 12, "Pension and Post-Retirement Benefits," to the Consolidated Financial Statements in the Company's 2019 Form 10-K.

The entire disclosure for retirement benefits.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 55
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section S99
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(i)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (o)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (p)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 70
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-URI http://asc.fasb.org/topic&trid=2235017

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 60
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(03)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (q)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(1)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iii)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (l)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(2)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Share-based Payment Arrangement [Abstract]

STOCK COMPENSATION PLAN

6 Months Ended

Jun. 30, 2020

STOCK COMPENSATION PLAN

Revlon maintains the Fourth Amended and Restated Revlon, Inc. Stock Plan (as amended, the "Stock Plan"), which provides for awards of stock options, stock appreciation rights, restricted or unrestricted stock and restricted stock units ("RSUs") to eligible employees and directors of Revlon and its affiliates, including Products Corporation. An aggregate of 6,565,000 shares were reserved for issuance as Awards under the Stock Plan, of which there remained approximately 1.1 million shares available for grant as of June 30, 2020. In July 2014, the Stock Plan was amended to renew the Stock Plan for a 7-year renewal term expiring on April 14, 2021. In September 2019 the Stock Plan was amended in connection with the 2019 TIP, described below, to: (1) allow the Compensation Committee to delegate to Revlon’s Chief Executive Officer the authority to grant RSUs to the Company’s employees, other than its officers who are subject to Section 16 of the Securities Exchange Act of 1934, as amended (i.e., the Company’s Chief Executive Officer, Chief Financial Officer and Chief Accounting Officer & Controller); (2) allow for accelerated vesting of equity awards upon a termination without cause; (3) change the minimum vesting period for specified equity awards from 3 years to 2 years; and (4) to increase by 250,000 shares the number of shares of Revlon common stock that are not subject to the Stock Plan’s minimum vesting requirements.

Revlon 2019 Transaction Incentive Program

In August 2019, it was disclosed that MacAndrews & Forbes and Revlon determined to explore strategic transactions involving Revlon and third parties (the "Strategic Review"). In light of this, the Compensation Committee of Revlon’s Board of Directors approved a Revlon 2019 Transaction Incentive Program (the “2019 TIP”) that enables the Company to award cash-based and RSU-based retention grants and transaction bonus awards, as well as providing for the accelerated vesting of time-based RSUs and restricted shares following a termination without cause or due to death or disability.

Each Tier 1 participant’s 2019 TIP award is payable two-thirds in cash and one-third in RSUs vesting in 50% tranches on each of December 31, 2020 and December 31, 2021, while Tier 2 awards are payable 100% in cash in one lump-sum on December 31, 2020, in each case subject to certain earlier vesting for a change of control or termination of employment without cause, as described below. As of September 5, 2019, the Company approved a total of 206,812 time-based RSUs under Tier 1 of the 2019 TIP, which are scheduled to vest in equivalent amounts on each of December 31, 2020 and December 31, 2021, subject to continued employment (the “2019 TIP RSUs”). As of June 30, 2020, a total of 153,739 time-based RSUs under Tier 1 of the 2019 TIP had been granted and are outstanding. The Company’s President and Chief Executive Officer declined an award under the retention program and will receive a transaction bonus only if the Company completes a transaction.

The 2019 TIP RSUs vest in full upon an involuntary termination, other than if due to cause; provided that if a change of control occurs or a brand or business segment is sold and (i) the impacted grantee accepts an offer of employment from the buyer, then: (A) if the buyer assumes the 2019 TIP RSUs, the grantee will continue to vest in the assumed awards (with the grantee having the continued right to accelerated vesting upon an involuntary termination, other than if due to cause); and (B) if the buyer does not assume the 2019 TIP RSUs, the grantee’s 2019 TIP RSUs will vest upon closing the change of control; and (ii) the impacted grantee declines an offer of employment from the buyer for substantially comparable total compensation and benefits, the grantee will forfeit their unvested 2019 TIP RSUs (collectively, the “Special Vesting Rules”).

The 2019 TIP also provides for the following cash-based awards payable to certain employees, subject to continued employment through the respective vesting dates: (i) Tier 1 - $6.8 million payable in two equal installments as of December 31, 2020 and December 31, 2021; and (ii) Tier 2 - $2.5 million payable in one installment as of December 31, 2020. Such cash-based awards follow the Special Vesting Rules following a termination without cause or due to death or disability. During 2019 and through June 30, 2020, the Company granted $4.9 million and $2.4 million cash-based awards, net of forfeitures, under Tier 1 and Tier 2 of the 2019 TIP, respectively, which are being amortized over the period from the grant dates to December 31, 2021 and December 31, 2020, respectively. The total amount amortized for these cash-based awards since the program's inception and through June 30, 2020 is approximately $3.8 million, of which $1.1 million and $2.6 million were recorded during the three and six months ended June 30, 2020, respectively, within "Acquisition, integration and divestiture costs" in the Company's Unaudited Consolidated Statements of Operations and Comprehensive Loss.

Long-Term Incentive Program

The Company's LTIP RSUs consist of time-based RSUs and performance-based RSUs. Time-based RSUs are generally scheduled to vest ratably over a 3-year service period, while performance-based RSUs are scheduled to vest based on the achievement of certain Company performance metrics and cliff-vest at the completion of a 3-year performance period.

The fair value of the LTIP and TIP RSUs is determined based on the NYSE closing share price on the grant date.

In connection with the announcement of the 2019 TIP, in August 2019 the Company also approved applying the Special Vesting Rules to outstanding, pre-existing LTIP RSUs, except that accelerated vesting in the case of termination of employment

without cause will apply only to any tranche of outstanding, pre-existing LTIP RSUs scheduled to vest in the 12-month period following termination, with any future tranches being forfeited. Prior to the approval of these Special Vesting Rules, while the outstanding, pre-existing LTIP RSUs would generally have accelerated vesting upon a change of control, they did not feature accelerated vesting for termination and, in such cases, they were entirely forfeited upon termination.

During the first quarter of 2020, the Company granted approximately 1.3 million time-based and performance-based RSU awards under the Stock Plan (the "2020 LTIP RSUs"). During the second quarter of 2020, there were no grants under the 2020 LTIP RSUs. See the roll-forward table in the following sections of this Note 11 for activity related to the six months ended June 30, 2020.

Acceleration of Vesting

Under the aforementioned provisions for acceleration of vesting, as of June 30, 2020 and since the time these provisions became effective in September 2019, 30,781 LTIP RSUs and 22,798 2019 TIP Tier 1 RSUs were vested on an accelerated basis due to involuntary terminations, resulting in accelerated amortization of approximately $1.0 million. In addition, for the three and six months ended June 30, 2020 and under the same accelerated vesting provisions, the Company also recorded approximately $0.1 million and $0.8 million of accelerated amortization in connection with the cash portion of the 2019 TIP Tier 1 and Tier 2 awards that were vested on an accelerated basis due to involuntary terminations. See the roll-forward table in the following sections of this Note 11 for activity related to the six months ended June 30, 2020.

During the six months ended June 30, 2020, the activity related to time-based and performance-based RSUs previously granted to eligible employees and the grant date fair value per share related to these RSUs were as follows under the LTIP and 2019 TIP programs, respectively:


	Time-Based LTIP			Performance-Based LTIP
	RSUs (000's)	Weighted-Average Grant Date Fair Value per RSU	RSUs (000's)		Weighted-Average Grant Date Fair Value per RSU
Outstanding as of December 31, 2019
2019 TIP RSUs ^(b)	200.6	16.44	n/a		—
LTIP RSUs:
2019	425.6	22.55	425.6		22.55
2018	241.9	19.00	364.7		19.00
2017 ^(a)	54.0	19.70	110.9		19.70
Total LTIP RSUs	721.5		901.2
Total LTIP and TIP RSUs Outstanding as of December 31, 2019	922.1		901.2
Granted
2019 TIP RSUs Granted ^(b)	11.7	10.24	n/a		—
LTIP RSUs:
2020	648.4	14.96	648.4		14.96
2019	—	—	—		—
2018	—	—	—		—
2017 ^(a)	—	—	—		—
Total LTIP RSUs Granted	648.4		648.4
Vested
2019 TIP RSUs Vested ^(b)(c)	(22.8)	16.44	n/a		—
LTIP RSUs:
2019^(c)	(131.0)	22.55	—		—
2018^(c)	(105.6)	19.31	—		—
2017 ^(a)(c)	(53.4)	19.70	(14.2)		19.70
Total LTIP RSUs Vested	(290.0)		(14.2)
Forfeited/Canceled
2019 TIP RSUs Forfeited/Canceled ^(b)	(35.8)	16.44	n/a		—
LTIP RSUs:
2019	(79.8)	22.55	(102.5)		22.55
2018	(49.0)	17.56	(101.4)		17.87
2017 ^(a)	(0.6)	19.70	(96.7)		19.70
Total LTIP RSUs Forfeited/Canceled	(129.4)		(300.6)
Outstanding as of June 30, 2020
2019 TIP RSUs	153.7	15.97	n/a		—
LTIP RSUs:
2020	648.4	14.96	648.4		14.96
2019	214.8	22.55	323.1		22.55
2018	87.3	19.44	263.3		19.44
2017 ^(a)	—	—	—		—
Total LTIP RSUs	950.5		1,234.8
Total LTIP and TIP RSUs Outstanding as of June 30, 2020	1,104.2		1,234.8

^(a)The 2017 time-based and performance-based LTIP RSUs were recognized over a 2-year service and performance period (i.e., 2018 and 2019).

^(b) The 2019 TIP provides for RSU awards that are only time-based.

^(c) Includes acceleration of vesting upon involuntary terminations for the six months ended June 30, 2020 of 25,321 RSUs under the 2019, 2018 and 2017 LTIPs and of 22,798 RSUs under the 2019 TIP Tier I awards.

Time-Based LTIP and TIP RSUs

The Company recognized $2.1 million and $3.8 million of net compensation expense related to the time-based LTIP and TIP RSUs for the three and six months ended June 30, 2020, respectively. As of June 30, 2020, the Company had $15.5 million of total deferred compensation expense related to non-vested, time-based LTIP and TIP RSUs. The cost is recognized over the vesting period of the awards, as described above.

Performance-based LTIP RSUs

The Company recognized $1.5 million and $1.2 million of net adjustments to compensation expense related to the performance-based LTIP RSUs for the three and six months ended June 30, 2020, respectively. The amount of net compensation expense recognized during 2020 was affected by adjustments to the awards' expected achievement rates made primarily as a result of the ongoing adverse impact of COVID-19 on the Company's results of operations. As of June 30, 2020, the Company had $21.9 million of total deferred compensation expense related to non-vested, performance-based LTIP RSUs. The cost is recognized over the service period of the awards, as described above.

INCOME TAXES	6 Months Ended
INCOME TAXES	Jun. 30, 2020
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES The Company's provision for income taxes represents federal, foreign, state and local income taxes. The Company’s tax provision changes quarterly based on various factors including, but not limited to, the geographical level and mix of earnings; enacted tax legislation; foreign, state and local income taxes; tax audit settlements; and the interaction of various global tax strategies. For the three and six months ended June 30, 2020, the Company concluded that the use of the cut-off tax rate method was more appropriate than the annual effective tax rate method, because the annual effective tax rate method would not be reliable due to its sensitivity to minimal changes in forecasted annual pre-tax earnings. The Company recorded a benefit from income taxes of $9.9 million (Products Corporation - benefit from income taxes of $9.6 million) for the three months ended June 30, 2020 and a benefit from income taxes of $1.2 million (Products Corporation - benefit from income taxes of $0.9 million) for the three months ended June 30, 2019, respectively. The $8.7 million increase (Products Corporation - $8.7 million) in the benefit from income taxes in the three months ended June 30, 2020 compared to the three months ended June 30, 2019, was primarily due to: (i) the increased loss from continuing operations before income taxes on which the tax benefit is recognized; (ii) the mix and level of earnings; and (iii) a reduction in the U.S. tax on the Company's foreign earnings, offset by an increase in tax expense related to uncertain tax positions and by the net change in valuation allowances recorded related to increased net losses in certain state jurisdictions. The Company recorded a benefit from income taxes of $47.1 million (Products Corporation - benefit from income taxes of $46.5 million) for the six months ended June 30, 2020 and a benefit from income taxes of $1.1 million (Products Corporation - benefit from income taxes of $0.6 million) for the six months ended June 30, 2019, respectively. The $46.0 million increase (Products Corporation - $45.9 million) in the benefit from income taxes in the six months ended June 30, 2020 compared to the six months ended June 30, 2019, was primarily due to: (i) the increased loss from continuing operations before income taxes on which the tax benefit is recognized; (ii) the mix and level of earnings; and (iii) a reduction in the U.S. tax on the Company's foreign earnings, net of the impact of non-deductible impairment charges, partially offset by the net change in valuation allowances recorded related to the limitation on the deductibility of interest. The Company's effective tax rate for the three and six months ended June 30, 2020 was lower than the federal statutory rate of 21% primarily due to the impact of non-deductible impairment charges and the valuation allowance related to the limitation on the deductibility of interest, partially offset by the impact of the "Coronavirus Aid, Relief and Economic Security Act" (the "CARES Act"), signed into law on March 27, 2020 by President Trump, which resulted in a partial release of a valuation allowance on the Company's 2019 federal tax attributes associated with the limitation on the deductibility of interest. The Company's effective tax rate for the three and six months ended June 30, 2019 was lower than the federal statutory rate of 21%, primarily due to the valuation allowance related to the limitation on the deductibility of interest and the U.S. tax on the Company's foreign earnings. The CARES Act, among other things, includes provisions providing for refundable payroll tax credits, the deferral of employer social security tax payments, acceleration of alternative minimum tax credit refunds and the increase of the net interest deduction limitation from 30% to 50%. The Company continues to examine the impact that the CARES Act may have on its results of operations, financial condition and/or financial statement disclosures. The Company expects that its tax provision and effective tax rate in any individual quarter and year-to-date period will vary and may not be indicative of the Company's tax provision and effective tax rate for the full year. In assessing the recoverability of its deferred tax assets, the Company continually evaluates the available positive and negative evidence to assess the amount of deferred tax assets for which it is more likely than not to realize a benefit. For any deferred tax asset in excess of the amount for which it is more likely than not that the Company will realize a benefit, the Company establishes a valuation allowance. A valuation allowance is a non-cash charge, and it in no way limits the Company's ability to utilize its deferred tax assets, including its ability to utilize tax loss and credit carryforward amounts. As of June 30, 2020, the Company concluded that, based on its evaluation of objectively verifiable evidence, it does not require a valuation allowance on its federal deferred tax assets, other than those associated with the limitation on the deductibility of interest. The Company does have a valuation allowance on deferred tax assets associated with its activity in certain U.S. states and foreign jurisdictions. These conclusions regarding the establishment of valuation allowances on the Company's deferred tax assets as of the end of the second quarter of 2020 are consistent with the Company's conclusions on such matters as compared to prior quarters. The key assumptions used to determine positive and negative evidence included the Company’s cumulative taxable loss for the past three years, future reversals of existing taxable temporary differences, the Company's cost reduction initiatives and other efficiency efforts, as well as certain assumptions regarding COVID-19's expected impact on the Company. Potential negative evidence, including, among other things, any further worsening of the economies in the jurisdictions in which the Company operates and any future reduced profitability in such jurisdictions could result in additional valuation allowances which would reduce the Company's future deferred tax assets. In such event, the Company's tax expense would likely materially increase in the period the valuation allowance is recognized and adversely impact the Company's results of operations and statement of financial condition in such period. The Company will continue to monitor the circumstances that would require it to establish an additional valuation allowance on its deferred tax assets. Accordingly, depending on future evidence that may become available, the Company's assessments regarding its valuation allowance position may change. For further information, see Note 14, "Income Taxes," to the Consolidated Financial Statements in the Company's 2019 Form 10-K and Item 1A. “Risk Factors-Uncertainties in the interpretation and application of the U.S. income tax provisions could have a material impact on the Company's financial condition, results of operations and/or cash flows” in the Company's 2019 Form 10-K.

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References + Details

ACCUMULATED OTHER COMPREHENSIVE LOSS

6 Months Ended

Jun. 30, 2020

ACCUMULATED OTHER COMPREHENSIVE LOSS

A roll-forward of the Company's accumulated other comprehensive loss as of June 30, 2020 is as follows:


	Foreign Currency Translation		Actuarial (Loss) Gain on Post-retirement Benefits		Other		Accumulated Other Comprehensive Loss







Balance at January 1, 2020	$	(27.3)	$	(219.8)	$	(0.3)	$	(247.4)
Foreign currency translation adjustment	5.1		—		—		5.1
Amortization of pension related costs, net of tax of $1.2 million^(a)	—		6.5		—		6.5




Other comprehensive (loss) gain	$	5.1	$	6.5	$	—	$	11.6
Balance at June 30, 2020	$	(22.2)	$	(213.3)	$	(0.3)	$	(235.8)

^(a)Amounts represent the change in accumulated other comprehensive loss as a result of the amortization of actuarial losses (gains) arising during each year related to the Company’s pension and other post-retirement plans. See Note 10, "Pension and Post-retirement Benefits," for further information on the Company’s pension and other post-retirement plans.

For the three and six months ended June 30, 2020 and 2019, the Company did not have any activity related to financial instruments.

SEGMENT DATA AND RELATED INFORMATION

6 Months Ended

Jun. 30, 2020

Segment Reporting [Abstract]

SEGMENT DATA AND RELATED INFORMATION

Operating Segments

Operating segments include components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker (the Company's "Chief Executive Officer") in deciding how to allocate resources and in assessing the Company's performance. As a result of the similarities in the procurement,

manufacturing and distribution processes for the Company’s products, much of the information provided in the Unaudited Consolidated Financial Statements and provided in the segment table below is similar to, or the same as, that reviewed on a regular basis by the Company's Chief Executive Officer.

As of June 30, 2020, the Company’s operations are organized into the following reportable segments:

•Revlon - The Revlon segment is comprised of the Company's flagship Revlon brands. Revlon segment products are primarily marketed, distributed and sold in the mass retail channel, large volume retailers, chain drug and food stores, chemist shops, hypermarkets, general merchandise stores, e-commerce sites, television shopping, department stores, professional hair and nail salons, one-stop shopping beauty retailers and specialty cosmetic stores in the U.S. and internationally under brands such as Revlon in color cosmetics; Revlon ColorSilk and Revlon Professional in hair color; and Revlon in beauty tools.

•Elizabeth Arden - The Elizabeth Arden segment is comprised of the Company's Elizabeth Arden branded products. The Elizabeth Arden segment markets, distributes and sells fragrances, skin care and color cosmetics primarily to prestige retailers, department and specialty stores, perfumeries, boutiques, e-commerce sites, the mass retail channel, travel retailers and distributors, as well as direct sales to consumers via its Elizabeth Arden branded retail stores and elizabetharden.com e-commerce website, in the U.S. and internationally, under brands such as Elizabeth Arden Ceramide, Prevage, Eight Hour, SUPERSTART, Visible Difference and Skin Illuminating in the Elizabeth Arden skin care brands; and Elizabeth Arden White Tea, Elizabeth Arden Red Door, Elizabeth Arden 5th Avenue and Elizabeth Arden Green Tea in Elizabeth Arden fragrances.

•Portfolio - The Company’s Portfolio segment markets, distributes and sells a comprehensive line of premium, specialty and mass products primarily to the mass retail channel, hair and nail salons and professional salon distributors in the U.S. and internationally and large volume retailers, specialty and department stores under brands such as Almay and SinfulColors in color cosmetics; American Crew in men's grooming products (which are also sold direct-to-consumer on its americancrew.com website); CND in nail polishes, gel nail color and nail enhancements; Cutex nail care products; and Mitchum in anti-perspirant deodorants. The Portfolio segment also includes a multi-cultural hair care line consisting of Creme of Nature hair care products, which are sold in both professional salons and in large volume retailers and other retailers, primarily in the U.S.; and a hair color line under the Llongueras brand (licensed from a third party) that is sold in the mass retail channel, large volume retailers and other retailers, primarily in Spain.

•Fragrances - The Fragrances segment includes the development, marketing and distribution of certain owned and licensed fragrances as well as the distribution of prestige fragrance brands owned by third parties. These products are typically sold to retailers in the U.S. and internationally, including prestige retailers, specialty stores, e-commerce sites, the mass retail channel, travel retailers and other international retailers. The owned and licensed fragrances include brands such as: (i) Juicy Couture (which are also sold direct-to-consumer on its juicycouturebeauty.com website), John Varvatos and AllSaints in prestige fragrances; (ii) Britney Spears, Elizabeth Taylor, Christina Aguilera, Jennifer Aniston and Mariah Carey in celebrity fragrances; and (iii) Curve, Giorgio Beverly Hills, Ed Hardy, Charlie, Lucky Brand, ‹PS› (logo of former Paul Sebastian brand), Alfred Sung, Halston, Geoffrey Beene and White Diamonds in mass fragrances.

The Company's management evaluates segment profit for each of the Company's reportable segments. The Company allocates corporate expenses to each reportable segment to arrive at segment profit, and these expenses are included in the internal measure of segment operating performance. The Company defines segment profit as income from continuing operations before interest, taxes, depreciation, amortization, stock-based compensation expense, gains/losses on foreign currency fluctuations, gains/losses on the early extinguishment of debt and miscellaneous expenses. Segment profit also excludes the impact of certain items that are not directly attributable to the reportable segments' underlying operating performance. Such items are shown below in the table reconciling segment profit to consolidated income from continuing operations before income taxes. The Company does not have any material inter-segment sales.

The accounting policies for each of the reportable segments are the same as those described in Note 1, "Description of Business and Summary of Significant Accounting Policies." The Company's assets and liabilities are managed centrally and are reported internally in the same manner as the Unaudited Consolidated Financial Statements; thus, no additional information regarding assets and liabilities of the Company’s reportable segments is produced for the Company's Chief Executive Officer or included in these Unaudited Consolidated Financial Statements.

The following table is a comparative summary of the Company’s net sales and segment profit for Revlon and Products Corporation by reportable segment for the periods presented.

Revlon, Inc.




	Three Months Ended June 30,						Six Months Ended June 30,
	2020		2019		2020		2019
Segment Net Sales:
Revlon	$	135.0	$	251.5	$	316.8	$	498.8
Elizabeth Arden	80.9		117.4		176.1		228.8
Portfolio	88.5		118.7		198.5		235.9
Fragrances	43.2		82.6		109.2		159.9
Total	$	347.6	$	570.2	$	800.6	$	1,123.4

Segment Profit:
Revlon	$	12.3	$	25.6	$	27.9	$	51.2
Elizabeth Arden	10.8		2.7		15.0		4.6
Portfolio	14.5		6.1		21.7		10.6
Fragrances	7.8		12.6		9.2		19.4
Total	$	45.4	$	47.0	$	73.8	$	85.8

Reconciliation:
Total Segment Profit	$	45.4	$	47.0	$	73.8	$	85.8
Less:

Depreciation and amortization	36.4		38.7		73.2		85.7
Non-cash stock compensation expense	1.1		3.4		3.5		3.8
Non-Operating items:
Restructuring and related charges	22.3		9.9		56.7		22.0
Acquisition, integration and divestiture costs	1.2		—		3.3		0.6
(Gain) loss on divested assets	(0.2)		—		0.6		—
Financial control remediation and sustainability actions and related charges	5.7		4.4		7.8		6.4
Excessive coupon redemptions	—		—		4.2		—
COVID-19 charges	17.9		—		25.4		—



Impairment charges	19.8		—		144.1		—



Operating loss	(58.8)		(9.4)		(245.0)		(32.7)
Less:
Interest Expense	60.9		47.8		109.3		95.5

Amortization of debt issuance costs	6.0		3.5		10.0		6.7

(Gain) loss on early extinguishment of debt, net	(11.9)		—		(11.9)		—
Foreign currency losses, net	2.3		1.2		18.9		1.4
Miscellaneous, net	20.6		4.6		16.5		5.9
Loss from continuing operations before income taxes	$	(136.7)	$	(66.5)	$	(387.8)	$	(142.2)

Products Corporation



	Three Months Ended June 30,						Six Months Ended June 30,
	2019		2018		2020		2019
Segment Net Sales:
Revlon	$	135.0	$	251.5	$	316.8	$	498.8
Elizabeth Arden	80.9		117.4		176.1		228.8
Portfolio	88.5		118.7		198.5		235.9
Fragrances	43.2		82.6		109.2		159.9
Total	$	347.6	$	570.2	$	800.6	$	1,123.4

Segment Profit:
Revlon	$	13.0	$	26.3	$	29.4	$	52.7
Elizabeth Arden	11.3		3.0		15.9		5.2
Portfolio	15.0		6.4		22.7		11.3
Fragrances	8.0		12.8		9.7		19.9
Total	$	47.3	$	48.5	$	77.7	$	89.1

Reconciliation:
Total Segment Profit	$	47.3	$	48.5	$	77.7	$	89.1
Less:

Depreciation and amortization	36.4		38.7		73.2		85.7
Non-cash stock compensation expense	1.1		3.4		3.5		3.8
Non-Operating items:
Restructuring and related charges	22.3		9.9		56.7		22.0
Acquisition, integration and divestiture costs	1.2		—		3.3		0.6
(Gain) loss on divested assets	(0.2)		—		0.6		—
Financial control remediation and sustainability actions and related charges	5.7		4.4		7.8		6.4


Excessive coupon redemptions	—		—		4.2		—
COVID-19 charges	17.9		—		25.4		—
Impairment charge	19.8		—		144.1		—

Operating income (loss)	(56.9)		(7.9)		(241.1)		(29.4)
Less:
Interest Expense	60.9		47.8		109.3		95.5

Amortization of debt issuance costs	6.0		3.5		10.0		6.7

(Gain) loss on early extinguishment of debt, net	(11.9)		—		(11.9)		—
Foreign currency losses, net	2.3		1.2		18.9		1.4
Miscellaneous, net	20.6		4.6		16.5		5.9
Loss from continuing operations before income taxes	$	(134.8)	$	(65.0)	$	(383.9)	$	(138.9)

As of June 30, 2020, the Company had operations established in approximately 25 countries outside of the U.S. and its products are sold throughout the world. Generally, net sales by geographic area are presented by attributing revenues from external customers on the basis of where the products are sold.

The following tables present the Company's segment net sales by geography and total net sales by classes of similar products for the periods presented:


	Three Months Ended June 30, 2020																			Six Months Ended June 30, 2020
		Revlon		Elizabeth Arden		Portfolio		Fragrances		Total		Revlon		Elizabeth Arden		Portfolio		Fragrances			Total
Geographic Area⁽¹⁾:
Net Sales
North America		$	80.1	$	15.0	$	52.1	$	29.7	$	176.9	$	179.2	$	36.4	$	122.9	$	71.9		$	410.4
EMEA*		26.5		13.7		30.2		9.3		79.7		63.8		39.6		60.8		25.6			189.8
Asia		6.8		49.1		0.7		2.0		58.6		21.5		92.2		1.2		5.4			120.3
Latin America*		10.0		0.2		3.4		0.3		13.9		24.0		1.0		8.3		1.1			34.4
Pacific*		11.6		2.9		2.1		1.9		18.5		28.3		6.9		5.3		5.2			45.7
		$	135.0	$	80.9	$	88.5	$	43.2	$	347.6	$	316.8	$	176.1	$	198.5	$	109.2		$	800.6


	Three Months Ended June 30, 2019																			Six Months Ended June 30, 2019
		Revlon		Elizabeth Arden		Portfolio		Fragrances		Total		Revlon		Elizabeth Arden		Portfolio		Fragrances			Total
Geographic Area⁽¹⁾:
Net Sales
North America		$	134.7	$	26.2	$	73.0	$	52.6	$	286.5	267.9		54.4		143.1		99.8			$	565.2
EMEA*		51.5		30.6		34.8		21.9		138.8		105.2		58.5		72.6		42.1			278.4
Asia		24.4		53.9		1.4		4.1		83.8		48.3		101.6		2.2		8.8			160.9
Latin America*		21.7		2.2		6.5		1.8		32.2		37.4		5.0		11.7		4.0			58.1
Pacific*		19.2		4.5		3.0		2.2		28.9		40.0		9.3		6.3		5.2			60.8
		$	251.5	$	117.4	$	118.7	$	82.6	$	570.2	$	498.8	$	228.8	$	235.9	$	159.9		$	1,123.4

(1) During the first quarter of 2020, the Company changed the presentation of its Travel Retail business, which previously was included in its EMEA Region, as it is currently presented within each geographic area in accordance with the location of the retail customer. Travel Retail net sales represented approximately 1.8% and 5.3% of the Company's total net sales for the second quarter of 2020 and 2019, respectively, and 2.3% and 5.0% of the Company's total net sales for the six months ended June 30, 2020 and 2019, respectively. Prior year amounts have been updated to reflect the current year presentation.

* The EMEA region includes Europe, the Middle East and Africa; the Latin America region includes Mexico, Central America and South America; and the Pacific region includes Australia and New Zealand.



	Three Months Ended June 30,											Six Months Ended June 30,
	2020					2019				2020			2019
Classes of similar products:
Net sales:
Color cosmetics	$	70.6	20%	$	193.5	34%	$	200.6	25%	$	396.3	35%
Fragrance	64.0		18%	117.1		21%	158.9		20%	227.4		20%
Hair care	105.4		30%	129.8		23%	222.1		28%	258.5		23%
Beauty care	45.4		13%	48.0		8%	91.5		11%	89.1		8%
Skin care	62.2		19%	81.8		14%	127.5		16%	152.1		14%
	$	347.6		$	570.2		$	800.6		$	1,123.4

The following table presents the Company's long-lived assets by geographic area as of June 30, 2020 and December 31, 2019:


	June 30, 2020							December 31, 2019
Long-lived assets, net:
United States	$	1,224.8	82%	$	1,414.0			83%
International	262.4		18%	280.1				17%
	$	1,487.2				$	1,694.1

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI http://asc.fasb.org/topic&trid=2134510

Earnings Per Share, Basic and Diluted [Abstract]

REVLON, INC. BASIC AND DILUTED EARNINGS (LOSS) PER COMMON SHARE

6 Months Ended

Jun. 30, 2020

REVLON, INC. BASIC AND DILUTED EARNINGS (LOSS) PER COMMON SHARE

Shares used in calculating Revlon's basic loss per share are computed using the weighted-average number of Revlon's shares of Class A Common Stock outstanding during each period. Shares used in diluted loss per share include the dilutive effect of unvested restricted stock, LTIP RSUs and TIP RSUs under the Company’s Stock Plan using the treasury stock method. For the respective periods ended June 30, 2020 and 2019, Revlon's diluted loss per share equals basic loss per share, as the assumed vesting of restricted stock, LTIP RSUs and TIP RSUs would have an anti-dilutive effect. As of June 30, 2020 and 2019, there were no outstanding stock options under the Company's Stock Plan. See Note 11, "Stock Compensation Plan," for information on the LTIP and TIP RSUs.

Following are the components of Revlon's basic and diluted loss per common share for the periods presented:


	Three months ended June 30,						Six months ended June 30,
	2020		2019		2020		2019
Numerator:
Loss from continuing operations, net of taxes	$	(126.8)	$	(65.3)	$	(340.7)	$	(141.1)
Income from discontinued operations, net of taxes	—		1.6		—		2.3
Net loss	$	(126.8)	$	(63.7)	$	(340.7)	$	(138.8)
Denominator:
Weighted-average common shares outstanding – Basic	53,471,004		53,126,700		53,319,228		53,020,633
Effect of dilutive restricted stock and RSUs	—		—		—		—
Weighted-average common shares outstanding – Diluted	53,471,004		53,126,700		53,319,228		53,020,633
Basic and Diluted (loss) earnings per common share:
Continuing operations	$	(2.37)	$	(1.23)	$	(6.39)	$	(2.66)
Discontinued operations	—		0.03		—		0.04
Net loss per common share	$	(2.37)	$	(1.20)	$	(6.39)	$	(2.62)





Unvested restricted stock and RSUs under the Stock Plan^(a)	—		304,608		56,058		445,525

^(a)These are outstanding common stock equivalents that were not included in the computation of Revlon's diluted earnings per common share because their inclusion would have had an anti-dilutive effect.

CONTINGENCIES	6 Months Ended
CONTINGENCIES	Jun. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
CONTINGENCIES	CONTINGENCIES The Company is involved in various routine legal proceedings incidental to the ordinary course of its business. The Company believes that the outcome of all pending legal proceedings in the aggregate is not reasonably likely to have a material adverse effect on the Company’s business, prospects, results of operations, financial condition and/or cash flows. However, in light of the uncertainties involved in legal proceedings generally, the ultimate outcome of a particular matter could be material to the Company’s operating results for a particular period depending on, among other things, the size of the loss or the nature of the liability imposed and the level of the Company’s income for that particular period.

RELATED PARTY TRANSACTIONS	6 Months Ended
RELATED PARTY TRANSACTIONS	Jun. 30, 2020
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	RELATED PARTY TRANSACTIONS Reimbursement Agreements Revlon, Products Corporation and MacAndrews & Forbes have entered into reimbursement agreements (the "Reimbursement Agreements") pursuant to which: (i) MacAndrews & Forbes is obligated to provide (directly or through its affiliates) certain professional and administrative services, including, without limitation, employees, to the Company, and to purchase services from third-party providers, such as insurance, legal, accounting and air transportation services, on behalf of the Company, to the extent requested by Products Corporation; and (ii) Products Corporation is obligated to provide certain professional and administrative services, including, without limitation, employees, to MacAndrews & Forbes and to purchase services from third-party providers, such as insurance, legal and accounting services, on behalf of MacAndrews & Forbes, to the extent requested by MacAndrews & Forbes, provided that in each case the performance of such services does not cause an unreasonable burden to MacAndrews & Forbes or Products Corporation, as the case may be. The Company reimburses MacAndrews & Forbes for the allocable costs of the services that MacAndrews & Forbes purchases for or provides to the Company and for the reasonable out-of-pocket expenses that MacAndrews & Forbes incurs in connection with the provision of such services. MacAndrews & Forbes reimburses Products Corporation for the allocable costs of the services that Products Corporation purchases for or provides to MacAndrews & Forbes and for the reasonable out-of-pocket expenses incurred by Products Corporation in connection with the purchase or provision of such services. Each of the Company, on the one hand, and MacAndrews & Forbes, on the other, has agreed to indemnify the other party for losses arising out of the services provided by it under the Reimbursement Agreements, other than losses resulting from its willful misconduct or gross negligence. The Reimbursement Agreements may be terminated by either party on 90 days' notice. The Company does not intend to request services under the Reimbursement Agreements unless their costs would be at least as favorable to the Company as could be obtained from unaffiliated third parties. The Company participates in MacAndrews & Forbes' directors and officers liability insurance program (the "D&O Insurance Program"), as well as its other insurance coverages, such as property damage, business interruption, liability and other coverages, which cover the Company, as well as MacAndrews & Forbes and its subsidiaries. The limits of coverage for certain of the policies are available on an aggregate basis for losses to any or all of the participating companies and their respective directors and officers. The Company reimburses MacAndrews & Forbes from time-to-time for their allocable portion of the premiums for such coverage or the Company pays the insurers directly, which premiums the Company believes are more favorable than the premiums that the Company would pay were it to secure stand-alone coverage. Any amounts paid by the Company directly to MacAndrews & Forbes in respect of premiums are included in the amounts paid under the Reimbursement Agreements. To ensure the availability of directors and officers liability insurance coverage through January 2023, the Company and MacAndrews & Forbes agreed to collectively make payments under MacAndrews & Forbes’ D&O Insurance Program. In furtherance of such arrangement, on July 28, 2020, the Company made a payment of approximately $3.86 million to MacAndrews & Forbes under the Reimbursement Agreements. The Company expects to make a further payment of approximately $1.4 million in July 2021 in respect of its participation in the D&O Insurance Program. The net activity related to services purchased under the Reimbursement Agreements during the six months ended June 30, 2020 and 2019 was $0.3 million income and $0.3 million expense, respectively. As of June 30, 2020 and December 31, 2019, a payable balance of $16,000 and $0.2 million, respectively, to MacAndrews & Forbes were included in the Company's Unaudited Consolidated Balance Sheet for transactions subject to the Reimbursement Agreements. Amended 2019 Senior Line of Credit Facility See Note 9, "Debt," in the Company's 2019 Form 10-K regarding the Amended 2019 Senior Line of Credit Agreement between Products Corporation and MacAndrews & Forbes Group, LLC. Other During the six months ended June 30, 2020 and 2019, the Company engaged several companies in which MacAndrews & Forbes had a controlling interest to provide the Company with various ordinary course business services. These services included processing approximately $14.2 million and $11.0 million of coupon redemptions for the Company's retail customers for the six months ended June 30, 2020 and 2019, respectively, for which the Company incurred fees of approximately $0.4 million and $0.2 million for the six months ended June 30, 2020 and 2019, respectively, and other similar advertising, coupon redemption and raw material supply services, for which the Company had net payables aggregating to approximately $0.3 million and $0.4 million for the six months ended June 30, 2020 and 2019, respectively. As of June 30, 2020 and December 31, 2019, a payable balance of approximately $4.3 million and $5.5 million, respectively, were included in the Company's Consolidated Balance Sheet for the aforementioned coupon redemption services. The Company believes that its engagement of each of these affiliates was on arm's length terms, taking into account each firm's expertise in its respective field, and that the fees paid or received were at least as favorable as those available from unaffiliated parties. In April 2020, in connection with the organizational measures taken by the Company in response to COVID-19, the Company and Ms. Debbie Perelman, the Company’s President and Chief Executive Officer and a member of Revlon’s and Products Corporation’s Boards of Directors, agreed in writing that, effective on or about April 11, 2020, Ms. Perelman’s base salary would be reduced by 40% to $675,000, less all applicable withholdings and deductions, during the span of COVID-19. The Chairman of the Compensation Committee has the authority to reinstate Ms. Perelman’s base salary in effect immediately prior to such amendment at any time he deems appropriate, in his sole discretion, exercised reasonably. In July 2020, the Chairman of the Compensation Committee, acting pursuant to his delegated authority, partially reinstated Ms. Perelman’s base salary to the same 25% reduction as is currently applicable to the other members of the Company’s Executive Leadership Team. Also in connection with such COVID-19 measures, in March 2020, the Company agreed in writing with each of Ms. Mitra Hormozi and Mr. E. Scott Beattie that, effective April 1, 2020, their provision of advisory services to the Company was suspended, and payment of their consulting fees was also suspended. In connection with Ms. Hormozi’s resignation from the Board in July 2020, the Company and Ms. Hormozi terminated her Consulting Agreement, dated as of November 7, 2019, as amended, which Consulting Agreement had previously been suspended as part of the organizational cost-reduction measures taken by the Company in response to the ongoing COVID-19 pandemic. The Company’s CEO may reinstate Mr. Beattie’s advisory services and payment of his consulting fees at the appropriate time, in her sole discretion, exercised reasonably. As previously disclosed in the Company’s 2019 Form 10-K, prior to this suspension of services and payments, in March 2020, the Company and Mr. Beattie entered into an Amended and Restated Consulting Agreement (the “2020 Consulting Agreement”), pursuant to which he was scheduled to serve as Senior Advisor to the Company’s CEO for an additional year, subject to automatic 1-year renewals, unless either party elects not to renew, and subject to certain standard termination rights, in consideration for which, the Company would pay Mr. Beattie a fee of $250,000 per year, supplemental to the Board’s compensation program for non-employee directors. The foregoing description of the 2020 Consulting Agreement is qualified in its entirety by reference to the full text of such agreement, a copy of which was filed with the SEC on March 12, 2020 together with the Company’s 2019 Form 10-K.

PRODUCTS CORPORATION AND SUBSIDIARIES GUARANTOR FINANCIAL INFORMATION

6 Months Ended

Jun. 30, 2020

Condensed Financial Information Disclosure [Abstract]

PRODUCTS CORPORATION AND SUBSIDIARIES GUARANTOR FINANCIAL INFORMATION

Products Corporation's 5.75% Senior Notes and 6.25% Senior Notes are fully and unconditionally guaranteed on a senior basis by certain of Products Corporation’s direct and indirect wholly-owned domestic subsidiaries (the "5.75% Senior Notes Guarantors" and the "6.25% Senior Notes Guarantors," respectively, and together the "Guarantor Subsidiaries").

The following Condensed Consolidating Financial Statements present the financial information as of June 30, 2020 and December 31, 2019, and for each of the three and six months June 30, 2020 and 2019 for (i) Products Corporation on a stand-alone basis; (ii) the Guarantor Subsidiaries on a stand-alone basis; (iii) the subsidiaries of Products Corporation that do not guarantee Products Corporation's 5.75% Senior Notes and 6.25% Senior Notes (the "Non-Guarantor Subsidiaries") on a stand-alone basis; and (iv) Products Corporation, the Guarantor Subsidiaries and the Non-Guarantor Subsidiaries on a consolidated basis. The Condensed Consolidating Financial Statements are presented on the equity method, under which the investments in subsidiaries are recorded at cost and adjusted to the applicable share of the subsidiary's cumulative results of operations, capital contributions, distributions and other equity changes. The principal elimination entries eliminate investments in subsidiaries and intercompany balances and transactions.


Products Corporation and Subsidiaries Condensed Consolidating Balance Sheets
As of June 30, 2020
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated

ASSETS
Cash and cash equivalents	$	271.9	$	5.9	$	60.7	$	—	$	338.5
Trade receivables, less allowances for doubtful accounts	73.5		59.4		155.4		—		288.3
Inventories	145.9		175.9		189.4		—		511.2
Prepaid expenses and other	224.8		38.1		44.9		—		307.8
Intercompany receivables	3,173.6		3,134.9		508.9		(6,817.4)		—
Investment in subsidiaries	1,574.2		14.8		—		(1,589.0)		—
Property, plant and equipment, net	189.0		73.8		102.7		—		365.5
Deferred income taxes	235.6		(53.6)		29.1		—		211.1
Goodwill	48.9		264.0		249.8		—		562.7
Intangible assets, net	(20.9)		333.8		128.7		—		441.6
Other assets	72.0		13.6		31.8		—		117.4
Total assets	$	5,988.5	$	4,060.6	$	1,501.4	$	(8,406.4)	$	3,144.1
LIABILITIES AND STOCKHOLDER’S DEFICIENCY
Short-term borrowings	$	—	$	—	$	2.6	$	—	$	2.6
Current portion of long-term debt	648.2		—		0.1		—		648.3
Accounts payable	107.6		47.6		69.4		—		224.6
Accrued expenses and other	257.7		(35.0)		158.9		—		381.6
Intercompany payables	3,317.2		2,954.4		545.7		(6,817.3)		—
Long-term debt	2,922.8		—		53.0		—		2,975.8
Other long-term liabilities	173.1		111.4		38.4		—		322.9
Total liabilities	7,426.6		3,078.4		868.1		(6,817.3)		4,555.8
Stockholder’s (deficiency) equity	(1,438.1)		982.2		633.3		(1,589.1)		(1,411.7)
Total liabilities and stockholder’s (deficiency) equity	$	5,988.5	$	4,060.6	$	1,501.4	$	(8,406.4)	$	3,144.1


Products Corporation and Subsidiaries Condensed Consolidating Balance Sheets
As of December 31, 2019
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated

ASSETS
Cash and cash equivalents	$	0.8	$	6.4	$	97.1	$	—	$	104.3
Trade receivables, less allowances for doubtful accounts	95.5		92.3		235.6		—		423.4
Inventories	131.0		151.5		165.9		—		448.4
Prepaid expenses and other	219.7		26.4		46.5		—		292.6
Intercompany receivables	2,857.7		2,854.6		452.7		(6,165.0)		—
Investment in subsidiaries	1,598.3		30.7		—		(1,629.0)		—
Property, plant and equipment, net	208.7		89.5		110.4		—		408.6
Deferred income taxes	165.0		(37.8)		30.9		—		158.1
Goodwill	159.9		264.0		249.8		—		673.7
Intangible assets, net	13.0		346.9		130.8		—		490.7
Other assets	67.8		16.2		37.1		—		121.1
Total assets	$	5,517.4	$	3,840.7	$	1,556.8	$	(7,794.0)	$	3,120.9
LIABILITIES AND STOCKHOLDER’S DEFICIENCY
Short-term borrowings	$	—	$	—	$	2.2	$	—	$	2.2
Current portion of long-term debt	287.9		—		0.1		—		288.0
Accounts payable	108.4		39.9		103.5		—		251.8
Accrued expenses and other	124.1		70.0		224.1		—		418.2
Intercompany payables	3,030.3		2,668.7		466.0		(6,165.0)		—
Long-term debt	2,822.2		—		84.0		—		2,906.2
Other long-term liabilities	220.4		118.2		5.3		—		343.9
Total liabilities	6,593.3		2,896.8		885.2		(6,165.0)		4,210.3
Stockholder’s (deficiency) equity	(1,075.9)		943.9		671.6		(1,629.0)		(1,089.4)
Total liabilities and stockholder’s deficiency	$	5,517.4	$	3,840.7	$	1,556.8	$	(7,794.0)	$	3,120.9



Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
Three Months Ended June 30, 2020
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
Net Sales	$	93.8	$	78.2	$	175.6	$	—	$	347.6
Cost of sales	54.4		43.5		70.7		—		168.6
Gross profit	39.4		34.7		104.9		—		179.0
Selling, general and administrative expenses	58.8		45.2		90.4		—		194.4
Acquisition and integration costs	2.0		(0.5)		(0.3)		—		1.2
Restructuring charges and other, net	17.1		3.0		0.6		—		20.7
Impairment charges	19.8		—		—		—		19.8
Gain on divested assets	(0.2)		—		—		—		(0.2)
Operating (loss) income	(58.1)		(13.0)		14.2		—		(56.9)
Other (income) expense:
Intercompany interest, net	(0.3)		0.6		(0.3)		—		—
Interest expense	59.2		—		1.7		—		60.9
Amortization of debt issuance costs	6.0		—		—		—		6.0
(Gain) loss on early extinguishment of debt, net	(11.9)		—		—		—		(11.9)
Foreign currency losses (gains), net	6.2		0.5		(4.4)		—		2.3
Miscellaneous, net	24.9		(6.9)		2.6		—		20.6
Other expense (income), net	84.1		(5.8)		(0.4)		—		77.9
(Loss) income from continuing operations before income taxes	(142.2)		(7.2)		14.6		—		(134.8)
(Benefit from) provision for income taxes	(35.8)		21.6		4.6		—		(9.6)
(Loss) income from continuing operations, net of taxes	(106.4)		(28.8)		10.0		—		(125.2)

Equity in income (loss) of subsidiaries	4.7		(6.9)		—		2.2		—
Net (loss) income	$	(101.7)	$	(35.7)	$	10.0	$	2.2	$	(125.2)
Other comprehensive income (loss)	14.3		7.9		11.2		(19.1)		14.3
Total comprehensive (loss) income	$	(87.4)	$	(27.8)	$	21.2	$	(16.9)	$	(110.9)



Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
Three Months Ended June 30, 2019
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
Net Sales	$	155.5	$	124.8	$	290.3	$	(0.4)	$	570.2
Cost of sales	72.2		64.1		108.0		(0.4)		243.9
Gross profit	83.3		60.7		182.3		—		326.3
Selling, general and administrative expenses	109.3		81.5		140.2		—		331.0

Restructuring charges and other, net	0.8		0.8		1.6		—		3.2
Operating (loss) income	(26.8)		(21.6)		40.5		—		(7.9)
Other (income) expense:
Intercompany interest, net	(1.1)		0.7		0.4		—		—
Interest expense	46.1		—		1.7		—		47.8
Amortization of debt issuance costs	3.5		—		—		—		3.5

Foreign currency losses, net	1.8		0.3		(0.9)		—		1.2
Miscellaneous, net	(10.1)		(12.7)		27.4		—		4.6
Other expense (income), net	40.2		(11.7)		28.6		—		57.1
(Loss) income from continuing operations before income taxes	(67.0)		(9.9)		11.9		—		(65.0)
(Benefit from) provision for income taxes	(3.6)		(0.1)		2.8		—		(0.9)
Loss (income) from continuing operations, net of taxes	(63.4)		(9.8)		9.1		—		(64.1)
Income from discontinued operations, net of taxes	—		—		1.6		—		1.6
Equity in income (loss) of subsidiaries	1.1		6.3		—		(7.4)		—
Net (loss) income	$	(62.3)	$	(3.5)	$	10.7	$	(7.4)	$	(62.5)
Other comprehensive income (loss)	5.3		(1.1)		(0.5)		1.6		5.3
Total comprehensive (loss) income	$	(57.0)	$	(4.6)	$	10.2	$	(5.8)	$	(57.2)



Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
Six Months Ended June 30, 2020
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
Net Sales	$	210.2	$	190.7	$	399.8	$	(0.1)	$	800.6
Cost of sales	112.9		97.9		155.7		(0.1)		366.4
Gross profit	97.3		92.8		244.1		—		434.2
Selling, general and administrative expenses	163.2		116.1		202.5		—		481.8
Acquisition, integration and divestiture costs	3.2		—		0.1		—		3.3
Restructuring charges and other, net	40.7		4.3		0.5		—		45.5
Impairment charges	144.1		—		—		—		144.1
Loss on divested assets	0.6		—		—		—		0.6
Operating (loss) income	(254.5)		(27.6)		41.0		—		(241.1)
Other (income) expense:
Intercompany interest, net	(3.0)		1.1		1.9		—		—
Interest expense	105.7		—		3.6		—		109.3
Amortization of debt issuance costs	10.0		—		—		—		10.0
(Gain) loss on early extinguishment of debt, net	(11.9)		—		—		—		(11.9)
Foreign currency losses, net	0.6		2.4		15.9		—		18.9
Miscellaneous, net	0.9		(16.1)		31.7		—		16.5
Other expense (income), net	102.3		(12.6)		53.1		—		142.8
Loss from continuing operations before income taxes	(356.8)		(15.0)		(12.1)		—		(383.9)
Benefit from for income taxes	(52.1)		1.4		4.2		—		(46.5)
Loss from continuing operations, net of taxes	(304.7)		(16.4)		(16.3)		—		(337.4)

Equity in (loss) income of subsidiaries	(29.3)		(26.9)		—		56.2		—
Net (loss) income	$	(334.0)	$	(43.3)	$	(16.3)	$	56.2	$	(337.4)
Other comprehensive (loss) income	11.6		14.4		2.4		(16.8)		11.6
Total comprehensive (loss) income	$	(322.4)	$	(28.9)	$	(13.9)	$	39.4	$	(325.8)


Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
Six Months Ended June 30, 2019
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
Net Sales	$	311.0	$	254.1	$	561.5	$	(3.2)	$	1,123.4
Cost of sales	140.2		129.2		215.5		(3.2)		481.7
Gross profit	170.8		124.9		346.0		—		641.7
Selling, general and administrative expenses	239.0		156.6		266.2		—		661.8
Acquisition, integration and divestiture costs	0.5		0.1		—		—		0.6
Restructuring charges and other, net	2.4		2.9		3.4		—		8.7


Operating (loss) income	(71.1)		(34.7)		76.4		—		(29.4)
Other (income) expenses:
Intercompany interest, net	(2.4)		1.4		1.0		—		—
Interest expense	92.0		—		3.5		—		95.5
Amortization of debt issuance costs	6.7		—		—		—		6.7

Foreign currency losses, net	0.3		0.3		0.8		—		1.4
Miscellaneous, net	(18.0)		(26.2)		50.1		—		5.9
Other expense (income), net	78.6		(24.5)		55.4		—		109.5
(Loss) income from continuing operations before income taxes	(149.7)		(10.2)		21.0		—		(138.9)
(Benefit from) provision for income taxes	(5.4)		0.4		4.4		—		(0.6)
(Loss) income from continuing operations, net of taxes	(144.3)		(10.6)		16.6		—		(138.3)
Income from discontinued operations, net of taxes	—		—		2.3		—		2.3
Equity in income (loss) of subsidiaries	8.5		11.7		—		(20.2)		—
Net (loss) income	$	(135.8)	$	1.1	$	18.9	$	(20.2)	$	(136.0)
Other comprehensive income (loss)	6.2		(1.2)		0.1		1.1		6.2
Total comprehensive (loss) income	$	(129.6)	$	(0.1)	$	19.0	$	(19.1)	$	(129.8)


Products Corporation and Subsidiaries Condensed Consolidating Statements of Cash Flows
Six Months Ended June 30, 2020
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES:
Net cash (used in) provided by operating activities	$	(148.3)	$	14.6	$	(30.5)	$	—	$	(164.2)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash (used in) provided by investing activities	(2.7)		—		—		—		(2.7)



CASH FLOWS FROM FINANCING ACTIVITIES:
Net decrease in short-term borrowings and overdraft	(1.3)		(6.2)		0.5		—		(7.0)
Borrowings under the 2020 BrandCo Facilities	880.0		—		—		—		880.0
Repurchases of the 5.75% Senior Notes	(99.6)		—		—		—		(99.6)
Net borrowings under the Amended 2016 Revolving Credit Facility	(22.9)		—		—		—		(22.9)


Repayment of the 2019 Term Loan Facility	(200.0)		—		—		—		(200.0)
Repayments under the 2018 Foreign Asset-Based Term Loan	(31.4)				—		—		(31.4)
Repayments under the 2016 Term Loan Facility	(6.9)		—		—		—		(6.9)
Payment of financing costs	(101.2)		—		—		—		(101.2)
Tax withholdings related to net share settlements of restricted stock and RSUs	(1.6)		—		—		—		(1.6)
Other financing activities	(1.0)		—		—		—		(1.0)
Net cash provided by (used in) financing activities	414.1		(6.2)		0.5		—		408.4
Effect of exchange rate changes on cash, cash equivalents and restricted cash	—		(9.0)		6.9		—		(2.1)
Net increase (decrease) in cash, cash equivalents and restricted cash	263.1		(0.6)		(23.1)		—		239.4
Cash, cash equivalents and restricted cash at beginning of period	$	1.0	$	6.4	$	97.2	$	—	$	104.5
Cash, cash equivalents and restricted cash at end of period	$	264.1	$	5.8	$	74.1	$	—	$	343.9


Products Corporation and Subsidiaries Condensed Consolidating Statements of Cash Flows
Six Months Ended June 30, 2019
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES:
Net cash (used in) provided by operating activities	$	(36.8)	$	4.8	$	(9.2)	$	—	$	(41.2)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash used in investing activities	(6.3)		(1.2)		(4.7)		—		(12.2)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net decrease in short-term borrowings and overdraft	(9.7)		(6.6)		(2.5)		—		(18.8)
Repayments under the 2016 Term Loan Facility	(9.0)		—		—		—		(9.0)

Net borrowings under the Amended 2016 Revolving Credit Facility	59.9		—		—		—		59.9

Payments of financing costs	(0.8)		—		(0.6)		—		(1.4)
Tax withholdings related to net share settlements of restricted stock and RSUs	(1.6)		—		—		—		(1.6)
Other financing activities	(0.4)		—		(0.1)		—		(0.5)
Net cash provided by financing activities	38.4		(6.6)		(3.2)		—		28.6
Effect of exchange rate changes on cash, cash equivalents and restricted cash	—		0.1		0.4		—		0.5
Net decrease in cash, cash equivalents and restricted cash	(4.7)		(2.9)		(16.7)		—		(24.3)
Cash, cash equivalents and restricted cash at beginning of period	$	7.2	$	6.6	$	73.7	$	—	87.5
Cash, cash equivalents and restricted cash at end of period	$	2.5	$	3.7	$	57.0	$	—	$	63.2

SUBSEQUENT EVENTS	6 Months Ended
SUBSEQUENT EVENTS	Jun. 30, 2020
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	SUBSEQUENT EVENTS On July 27, 2020, Products Corporation commenced an offer to exchange (the “Exchange Offer”) any and all of its $387.2 million aggregate principal amount of outstanding 5.75% Senior Notes due 2021 (the “Existing Notes”) for a combination of 5.75% Senior Notes due February 15, 2024 (the “New Notes”) and an Early Tender/Consent Fee, payable in cash, upon the terms and conditions set forth in the confidential Offering Memorandum and Consent Solicitation Statement (the “Offering Memorandum”) dated July 27, 2020. The New Notes will be senior unsecured notes with terms substantially the same as those of the Existing Notes, with certain adjustments specified in the Offering Memorandum. Concurrently with the Exchange Offer, the Company is soliciting consents (the “Consent Solicitation”) to eliminate substantially all of the restrictive covenants and certain events of default with respect to the Existing Notes. Unless earlier terminated or extended, the Exchange Offer will expire at 11:59 p.m. E.D.T. on August 21, 2020. For each $1,000 principal amount of Existing Notes tendered into the Exchange Offer and Consent Solicitation prior to the early tender deadline of 5:00 p.m. E.D.T. on August 7, 2020, holders of Existing Notes will receive $750 principal amount of New Notes and $50 of cash as an early tender/consent fee. Holders who tender their Existing Notes after the early tender deadline will receive only $750 principal amount of New Notes for each $1,000 principal amount of Existing Notes tendered. The Exchange Offer and Consent Solicitation are subject to the following conditions precedent: (i) the valid tender without valid withdrawal of not less than 95% of the aggregate outstanding principal amount of Existing Notes (and the provision of the related Consents for such tendered Existing Notes); (ii) the receipt of all necessary consents from the lenders under the Company’s term and revolving credit agreements required in order to consummate the Exchange Offer and Consent Solicitation; (iii) the receipt of requisite consents in the Consent Solicitation; and (iv) various other customary conditions precedent. The conditions precedent are for the sole benefit of the Company and may be amended or waived, in whole or in part, at any time, in the sole and absolute discretion of the Company, subject to applicable law.

DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	The preparation of the Company's Unaudited Consolidated Financial Statements in conformity with U.S. generally accepted accounting principles ("U.S. GAAP") requires management to make estimates and assumptions that affect amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the financial statements and reported amounts of revenues and expenses during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically and the effects of revisions are reflected in the Unaudited Consolidated Financial Statements in the period they are determined to be necessary. Significant estimates made in the accompanying Unaudited Consolidated Financial Statements include, but are not limited to: expected sales returns; certain assumptions related to the valuation of acquired intangible and long-lived assets and the recoverability of goodwill, intangible and long-lived assets; income taxes, including deferred tax valuation allowances and reserves for estimated tax liabilities; and certain estimates and assumptions used in the calculation of the net periodic benefit (income) costs and the projected benefit obligations for the Company’s pension and other post-retirement plans, including the expected long-term return on pension plan assets and the discount rate used to value the Company’s pension benefit obligations. The Unaudited Consolidated Financial Statements should be read in conjunction with the audited consolidated financial statements and related notes contained in Revlon's Annual Report on Form 10-K for the fiscal year ended December 31, 2019 (the "2019 Form 10-K").The Company's results of operations and financial position for interim periods are not necessarily indicative of those to be expected for the full year.
Recently Evaluated and/or Adopted and Recently Issued Accounting Pronouncements	Recently Evaluated and/or Adopted Accounting Pronouncements In August 2018, the FASB issued Accounting Standard Update ("ASU") No. 2018-15, "Internal Use Software (Subtopic 350-40) - Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract," which requires a customer in a cloud computing hosting arrangement that is a service contract to follow the existing guidance in ASC 350-40 on internal-use software to determine which implementation costs are to be deferred and recognized as an asset and which costs are to be expensed as incurred. This guidance is effective for annual periods beginning after December 15, 2019, with early adoption permitted, and may be applied either retrospectively or prospectively to all software implementation costs incurred after adoption. The Company adopted ASU No. 2018-15 prospectively, beginning as of January 1, 2020. The Company completed its assessment and determined that this new guidance does not have a material impact on the Company’s results of operations, financial condition and/or financial statement disclosures. Recently Issued Accounting Pronouncements In March 2020, the FASB issued ASU 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting." The new guidance under ASU 2020-04 provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts and hedging relationships that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform. These amendments are effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. The Company is in the process of assessing the impact, if any, that ASU No. 2020-04 is expected to have on the Company’s results of operations, financial condition and/or financial statement disclosures. In December 2019, the FASB issued ASU No. 2019-12, "Income Taxes (Topic 740) - Simplifying the Accounting for Income Taxes," which removes certain exceptions for recognizing deferred taxes for investments, performing intra-period allocations and calculating income taxes in interim periods. This ASU also adds guidance to reduce complexity in certain areas, including recognizing deferred taxes for tax goodwill and allocating taxes to members of a consolidated group. This guidance is effective for annual periods beginning after December 15, 2020, with early adoption permitted, including adoption in any interim period. An entity that elects to early adopt the amendments in an interim period should reflect any adjustments as of the beginning of the annual period that includes that interim period. Additionally, an entity that elects early adoption must adopt all the amendments in the same period. The amendments in this ASU that are related to separate financial statements of legal entities that are not subject to tax should be applied on a retrospective basis for all periods presented. The amendments in this ASU that are related to changes in ownership of foreign equity method investments or foreign subsidiaries should be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. The amendments in this ASU that are related to franchise taxes that are partially based on income should be applied on either a retrospective basis for all periods presented or a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. All other amendments under this ASU should be applied on a prospective basis. After reviewing this ASU, the Company decided that it will adopt this guidance beginning as of January 1, 2021. The Company is in the process of assessing the impact, if any, that this ASU is expected to have on the Company’s results of operations, financial condition and/or financial statement disclosures. In August 2018, the FASB issued ASU No. 2018-14, "Compensation-Retirement Benefits-Defined Benefit Plans-General (Subtopic 715): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans.” This new guidance removes certain disclosures that are not considered cost beneficial, clarifies certain required disclosures and requires certain additional disclosures. This guidance is effective for annual periods beginning after December 15, 2020, with early adoption permitted. The Company will adopt this guidance (on a retrospective basis for certain new additional disclosures), beginning as of January 1, 2021. This new pronouncement only affects disclosure items and it is not expected to have a material impact on the Company’s results of operations, financial condition and/or financial statement disclosures. In June 2016, the FASB issued ASU No. 2016-13, "Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments," which was subsequently amended in November 2018 through ASU No. 2018-19, "Codification Improvements to Topic 326, Financial Instruments - Credit Losses." ASU No. 2016-13 will require entities to estimate lifetime expected credit losses for trade and other receivables, net investments in leases, financing receivables, debt securities and other instruments, which will result in earlier recognition of credit losses. Further, the new credit loss model will affect how entities in all industries estimate their allowance for losses for receivables that are current with respect to their payment terms. ASU No. 2018-19 further clarifies that receivables arising from operating leases are not within the scope of Topic 326. Instead, impairment from receivables of operating leases should be accounted for in accordance with Topic 842, Leases. In November 2019, the FASB issued ASU No. 2019-10, which, among other things, deferred the application of the new guidance on credit losses for smaller reporting companies ("SRC") to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. This guidance will be applied through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective (i.e., a modified-retrospective approach). Under the above-mentioned deferral, the Company expects to adopt ASU No. 2016-03, and the related ASU No. 2018-19 amendments, beginning as of January 1, 2023 and is in the process of assessing the impact, if any, that this new guidance is expected to have on the Company’s results of operations, financial condition and/or financial statement disclosures.

RESTRUCTURING CHARGES (Tables)

6 Months Ended

Jun. 30, 2020

Restructuring and Related Activities [Abstract]

Schedule of Restructuring and Related Charges

A summary of the 2020 Restructuring Charges incurred since its inception in March 2020 and through June 30, 2020 is presented in the following table:



	Restructuring Charges and Other, Net
	Employee Severance and Other Personnel Benefits		Other Costs		Total Restructuring Charges		Leases (a)		Other Related Charges(b)		Total Restructuring and Related Charges

Cumulative charges incurred through June 30, 2020	$	46.3	$	0.3	$	46.6	$	9.8	$	0.7	$	57.1

^(b)Other related charges are recorded within SG&A in the Company’s Unaudited Consolidated Statement of Operations and Comprehensive Loss.

A summary of the 2020 Restructuring Charges incurred since its inception in March 2020 and through June 30, 2020 by reportable segment is presented in the following table:



	Cumulative charges incurred through June 30, 2020
Revlon	$	18.0
Elizabeth Arden	10.3
Portfolio	11.1
Fragrances	7.2
Total	$	46.6

A summary of the 2018 Optimization Restructuring Charges incurred since its inception in November 2018 and through June 30, 2020 is presented in the following table:



	Restructuring Charges and Other, Net
	Employee Severance and Other Personnel Benefits^(a)		Other Costs		Total Restructuring Charges		Inventory Adjustments^(b)		Other Related Charges^(c)		Total Restructuring and Related Charges
Charges incurred through December 31, 2019	$	20.3	$	0.3	$	20.6	$	4.9	$	14.0	$	39.5
Charges incurred during the six months ended June 30, 2020	(0.7)		—		(0.7)		—		0.7		—
Cumulative charges incurred through June 30, 2020	$	19.6	$	0.3	$	19.9	$	4.9	$	14.7	$	39.5

^(a) Includes reversal due to true-up of previously-accrued restructuring charges.

^(b) Inventory adjustments are recorded within cost of sales in the Company’s Unaudited Consolidated Statement of Operations and Comprehensive Loss.

^(c)Other related charges are recorded within SG&A in the Company’s Unaudited Consolidated Statement of Operations and Comprehensive Loss.

A summary of the 2018 Optimization Restructuring Charges incurred since its inception in November 2018 and through June 30, 2020 by reportable segment is presented in the following table:



	Charges incurred during the six months ended June 30, 2020		Cumulative charges incurred through June 30, 2020
Revlon	$	(0.4)	$	8.4
Elizabeth Arden	(0.1)		4.2
Portfolio	(0.1)		3.9
Fragrances	(0.1)		3.4
Total	$	(0.7)	$	19.9

Schedule of Liability Balance and Activity of Restructuring Programs

The liability balance and related activity for each of the Company's restructuring programs are presented in the following table:



										Utilized, Net
			Liability Balance at January 1, 2020			Expense, Net			Foreign Currency Translation			Cash			Non-cash			Liability Balance at June 30, 2020
Revlon 2020 Restructuring Program:
Employee severance and other personnel benefits	$	—		$	46.3		$	—		$	(9.0)		$	—		$	37.3
Other	—			0.3			—			(0.3)			—			—
Total Revlon 2020 Restructuring Program	—			46.6			—			(9.3)			—			37.3

2018 Optimization Program:
Employee severance and other personnel benefits	5.7			(0.7)			—			(3.2)			—			1.8











Other immaterial actions:^(a)
Employee severance and other personnel benefits	4.3			(0.4)			—			(0.4)			—			3.5


Total restructuring reserve	$	10.0		$	45.5		$	—		$	(12.9)		$	—		$	42.6

INVENTORIES (Tables)

6 Months Ended

Jun. 30, 2020

Inventory Disclosure [Abstract]

Components of Inventories

As of June 30, 2020 and December 31, 2019, the Company's inventory balances consisted of the following:


	June 30,		December 31,
	2020		2019
Finished goods	$	384.9	$	326.5
Raw materials and supplies	109.8		110.4
Work-in-process	16.5		11.5
	$	511.2	$	448.4

LEASES AND PROPERTY, PLANT AND EQUIPMENT (Tables)

6 Months Ended

Jun. 30, 2020

Leases [Abstract]

Schedule of Lease Cost

The following table includes disclosure related to the ASC 842 lease standard for the periods presented, after application of the applicable practical expedients and short-term lease considerations:


	Six Months Ended
	June 30, 2020			June 30, 2019
Lease Cost:
Finance Lease Cost:
Amortization of ROU assets	$	0.2		$	0.1
Interest on lease liabilities	0.1			0.0
Operating Lease Cost	21.8			21.3
Total Lease Cost	$	22.1		$	21.4

Other Information:
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from finance leases	0.1			0.0
Operating cash flows from operating leases	19.2			21.0
Financing cash flows from finance leases	0.1			0.4

	June 30, 2020			December 31, 2019
ROU assets for finance leases	0.8			1.0
ROU assets for operating leases	88.4			91.4
Accumulated amortization on ROU assets for finance leases	0.5			0.3
Accumulated amortization on ROU assets for operating leases	29.7			23.2

Weighted-average remaining lease term - finance leases	2.4 years			2.8 years
Weighted-average remaining lease term - operating leases	5.8 years			6.2 years

Weighted-average discount rate - finance leases	15.0		%	15.6		%
Weighted-average discount rate - operating leases	15.7		%	15.8		%

Schedule of Finance Lease Maturities

Maturities of lease liabilities as of June 30, 2020 were as follows:


	Operating Leases		Finance Leases
July 2020 through December 2020	$	18.0	$	0.3
2021	33.6		0.5
2022	26.4		0.3
2023	21.9		0.0
2024	16.5		—
Thereafter	47.8		—
Total undiscounted cash flows	$	164.2	$	1.1

Present value:
Short-term lease liability	$	19.3	$	0.4
Long-term lease liability	85.5		0.4
Total lease liability	$	104.8	$	0.8
Difference between undiscounted cash flows and discounted cash flows	$	59.4	$	0.3

Schedule of Operating Lease Maturities

Maturities of lease liabilities as of June 30, 2020 were as follows:


	Operating Leases		Finance Leases
July 2020 through December 2020	$	18.0	$	0.3
2021	33.6		0.5
2022	26.4		0.3
2023	21.9		0.0
2024	16.5		—
Thereafter	47.8		—
Total undiscounted cash flows	$	164.2	$	1.1

Present value:
Short-term lease liability	$	19.3	$	0.4
Long-term lease liability	85.5		0.4
Total lease liability	$	104.8	$	0.8
Difference between undiscounted cash flows and discounted cash flows	$	59.4	$	0.3

GOODWILL AND INTANGIBLE ASSETS, NET (Tables)

6 Months Ended

Jun. 30, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Changes in Goodwill by Segment

The following table presents the changes in goodwill by segment for the six months ended June 30, 2020:



	Revlon		Portfolio		Elizabeth Arden		Fragrances		Total




Balance at January 1, 2020	$	264.9	$	171.1	$	116.9	$	120.8	$	673.7
Foreign currency translation adjustment	—		—		—		—		—

Goodwill impairment charge	—		(83.5)		(27.5)		—		(111.0)
Balance at June 30, 2020	$	264.9	$	87.6	$	89.4	$	120.8	$	562.7

Cumulative goodwill impairment charges^(a)									$	(166.2)

Schedule of Impaired Intangible Assets

A summary of such impairment charges by segments is included in the following table:


	Three Months Ended
	June 30, 2020
	Revlon		Portfolio		Elizabeth Arden		Fragrances		Total

Indefinite-lived intangible assets	$	0.0	$	0.0	$	(8.6)	$	0.0	$	(8.6)
Total Intangibles Impairment	$	0.0	$	0.0	$	(8.6)	$	0.0	$	(8.6)


	Six Months Ended
	June 30, 2020
	Revlon		Portfolio		Elizabeth Arden		Fragrances		Total

Indefinite-lived intangible assets	$	—	$	(2.5)	$	(30.6)	$	—	$	(33.1)
Total Intangibles Impairment	$	—	$	(2.5)	$	(30.6)	$	—	$	(33.1)

Summary of Finite-Lived Intangible Assets

The following tables present details of the Company's total intangible assets as of June 30, 2020 and December 31, 2019:


	June 30, 2020
	Gross Carrying Amount		Accumulated Amortization		Impairment		Net Carrying Amount		Weighted-Average Useful Life (in Years)
Finite-lived intangible assets:
Trademarks and licenses	$	271.7	$	(119.3)	$	—	$	152.4	13
Customer relationships	248.0		(103.1)		—		144.9		11
Patents and internally-developed intellectual property	21.9		(12.9)		—		9.0		5
Distribution rights	31.0		(6.6)		—		24.4		14
Other	1.3		(1.3)		—		—		0
Total finite-lived intangible assets	$	573.9	$	(243.2)	$	—	$	330.7

Indefinite-lived intangible assets:
Trade names	$	144.0	N/A		$	(33.1)	$	110.9
Total indefinite-lived intangible assets	$	144.0	N/A		$	(33.1)	$	110.9

Total intangible assets	$	717.9	$	(243.2)	$	(33.1)	$	441.6

	December 31, 2019
	Gross Carrying Amount		Accumulated Amortization		Impairment		Net Carrying Amount		Weighted-Average Useful Life (in Years)
Finite-lived intangible assets:
Trademarks and licenses	$	271.2	$	(110.9)	$	—	$	160.3	13
Customer relationships	248.3		(96.5)		—		151.8		11
Patents and internally-developed intellectual property	21.5		(12.1)		—		9.4		5
Distribution rights	31.0		(5.6)		—		25.4		15
Other	1.3		(1.3)		—		—		0
Total finite-lived intangible assets	$	573.3	$	(226.4)	$	—	$	346.9

Indefinite-lived intangible assets:
Trade names	$	143.8	N/A		$	—	$	143.8
Total indefinite-lived intangible assets	$	143.8	N/A		$	—	$	143.8

Total intangible assets	$	717.1	$	(226.4)	$	—	$	490.7

Summary of Indefinite-Lived Intangible Assets

The following tables present details of the Company's total intangible assets as of June 30, 2020 and December 31, 2019:


	June 30, 2020
	Gross Carrying Amount		Accumulated Amortization		Impairment		Net Carrying Amount		Weighted-Average Useful Life (in Years)
Finite-lived intangible assets:
Trademarks and licenses	$	271.7	$	(119.3)	$	—	$	152.4	13
Customer relationships	248.0		(103.1)		—		144.9		11
Patents and internally-developed intellectual property	21.9		(12.9)		—		9.0		5
Distribution rights	31.0		(6.6)		—		24.4		14
Other	1.3		(1.3)		—		—		0
Total finite-lived intangible assets	$	573.9	$	(243.2)	$	—	$	330.7

Indefinite-lived intangible assets:
Trade names	$	144.0	N/A		$	(33.1)	$	110.9
Total indefinite-lived intangible assets	$	144.0	N/A		$	(33.1)	$	110.9

Total intangible assets	$	717.9	$	(243.2)	$	(33.1)	$	441.6

	December 31, 2019
	Gross Carrying Amount		Accumulated Amortization		Impairment		Net Carrying Amount		Weighted-Average Useful Life (in Years)
Finite-lived intangible assets:
Trademarks and licenses	$	271.2	$	(110.9)	$	—	$	160.3	13
Customer relationships	248.3		(96.5)		—		151.8		11
Patents and internally-developed intellectual property	21.5		(12.1)		—		9.4		5
Distribution rights	31.0		(5.6)		—		25.4		15
Other	1.3		(1.3)		—		—		0
Total finite-lived intangible assets	$	573.3	$	(226.4)	$	—	$	346.9

Indefinite-lived intangible assets:
Trade names	$	143.8	N/A		$	—	$	143.8
Total indefinite-lived intangible assets	$	143.8	N/A		$	—	$	143.8

Total intangible assets	$	717.1	$	(226.4)	$	—	$	490.7

Estimated Future Amortization Expense



	Estimated Amortization Expense
2020	$	17.3
2021	33.3
2022	32.4
2023	30.9
2024	27.5
Thereafter	189.3
Total	$	330.7

ACCRUED EXPENSES AND OTHER (Tables)

6 Months Ended

Jun. 30, 2020

Payables and Accruals [Abstract]

Components of Accrued Expenses and Other

As of June 30, 2020 and December 31, 2019, the Company's accrued expenses and other current liabilities consisted of the following:


	June 30,		December 31,
	2020		2019
Sales returns and allowances	$	64.6	$	89.7
Advertising, marketing and promotional costs	69.2		82.8
Taxes ^(a)	46.9		54.3
Compensation and related benefits	31.3		42.1
Interest	34.8		34.0
Professional services and insurance	19.8		16.3
Short-term lease liability	19.7		14.5
Freight and distribution costs	7.4		13.2
Restructuring reserve	42.6		10.0
Software	3.1		4.0
Other ^(b)	39.1		54.0
Total	$	378.5	$	414.9

^(a) Accrued Taxes for Products Corporation as of June 30, 2020 and December 31, 2019 were $49.9 million and $57.6 million, respectively.

(b) Accrued Other as of December 31, 2019 includes approximately $2.3 million of severance to Mr. Fabian Garcia, the Company's former President and Chief Executive Officer, which was paid in 2020.

DEBT (Tables)

6 Months Ended

Jun. 30, 2020

Debt Disclosure [Abstract]

Schedule of Components of Long-Term Debt

As of June 30, 2020 and December 31, 2019, the Company's debt balances consisted of the following:


	June 30,		December 31,
	2020		2019
2020 BrandCo Term Loan Facility due 2025, net of debt issuance costs (see (a) below)	1,582.5		$	—
2019 Term Loan Facility due 2023, net of discounts and debt issuance costs (see (b) below)	—		187.1
2018 Foreign Asset-Based Term Facility due 2021, net of discounts and debt issuance costs (see (c) below)	51.6		82.3
Amended 2016 Revolving Credit Facility due 2021, net of debt issuance costs (see (d) below)	247.2		269.9
2016 Term Loan Facility: 2016 Term Loan due 2023 and 2025, net of discounts and debt issuance costs (see (e) below)	911.8		1,713.6
5.75% Senior Notes due 2021, net of debt issuance costs (see (f) below)	387.2		498.1
6.25% Senior Notes due 2024, net of debt issuance costs (see (g) below)	443.5		442.8


Spanish Government Loan due 2025	0.3		0.4
Debt	$	3,624.1	$	3,194.2
Less current portion^(*)	(648.3)		(288.0)
Long-term debt	$	2,975.8	$	2,906.2

Short-term borrowings (see (h) below)	$	2.6	$	2.2

^(h)There were no borrowings at June 30, 2020 under the 2019 Senior Line of Credit Facility between Products Corporation and MacAndrews & Forbes Group, LLC, a related party, discussed below.

Schedule of Line of Credit Facilities

At June 30, 2020, the aggregate principal amounts outstanding and availability under Products Corporation’s various revolving credit facilities were as follows:



	Commitment		Borrowing Base		Aggregate principal amount outstanding at June 30, 2020		Availability at June 30, 2020 ^(a)
Amended 2016 Revolving Credit Facility	$	400.0	$	307.9	$	249.5	$	50.7


Amended 2019 Senior Line of Credit Facility	$	30.0	N/A		$	—	$	30.0

Amended 2016 Revolving Credit Facility was available as of such date. Tranche B under the Amended 2016 Revolving Credit Facility was fully repaid in May 2020.

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

Fair Value Disclosure of Asset and Liability Not Measured at Fair Value

FAIR VALUE MEASUREMENTS (Tables)

6 Months Ended

Jun. 30, 2020

Fair Value Disclosures [Abstract]

As of June 30, 2020, the fair value and carrying value of the Company’s long-term debt, including the current portion of long-term debt, are categorized in the table below:


	June 30, 2020
	Fair Value
	Level 1		Level 2		Level 3		Total		Carrying Value
Liabilities:
Long-term debt, including current portion^(a)	$	—	$	2,250.2	$	—	$	2,250.2	$	3,624.1

As of December 31, 2019, the fair value and carrying value of the Company’s long-term debt, including the current portion of long-term debt, are categorized in the table below:


	December 31, 2019
	Fair Value
	Level 1		Level 2		Level 3		Total		Carrying Value
Liabilities:
Long-term debt, including current portion^(a)	$	—	$	2,522.2	$	—	$	2,522.2	$	3,194.2

^(a)The fair value of the Company's long-term debt, including the current portion of long-term debt, is based on quoted market prices for similar issuances and maturities.

PENSION AND POST-RETIREMENT BENEFITS (Tables)

6 Months Ended

Jun. 30, 2020

Retirement Benefits [Abstract]

Schedule of Components of Net Periodic Benefit Costs

The components of net periodic benefit costs for the Company's pension and the other post-retirement benefit plans for the three months ended June 30, 2020 and 2019, respectively, were as follows:



	Pension Plans						Other Post-Retirement Benefit Plans
	Three Months Ended June 30,
	2020		2019		2020		2019
Net periodic benefit costs:
Service cost	$	0.4	$	0.5	$	—	$	—
Interest cost	3.7		5.0		0.1		0.1
Expected return on plan assets	(5.6)		(6.0)		—		—
Amortization of actuarial loss	2.9		2.6		0.1		—

Total net periodic benefit costs prior to allocation	$	1.4	$	2.1	$	0.2	$	0.1
Portion allocated to Revlon Holdings	(0.1)		(0.1)		—		—
Total net periodic benefit costs	$	1.3	$	2.0	$	0.2	$	0.1

The components of net periodic benefit costs for the Company's pension and the other post-retirement benefit plans for the six months ended June 30, 2020 and 2019, respectively, were as follows:


	Pension Plans						Other Post-Retirement Benefit Plans
	Six Months Ended June 30,
	2020		2019		2020		2019
Net periodic benefit costs:
Service cost	$	0.8	$	1.0	$	—	$	—
Interest cost	7.4		9.9		0.2		0.2
Expected return on plan assets	(11.4)		(12.0)		—		—
Amortization of actuarial loss	5.6		5.0		0.2		0.1

Total net periodic benefit costs prior to allocation	$	2.4	$	3.9	$	0.4	$	0.3
Portion allocated to Revlon Holdings	(0.1)		(0.1)		—		—
Total net periodic benefit costs	$	2.3	$	3.8	$	0.4	$	0.3

Schedule of Classification of Net Periodic Benefit Costs

Net periodic benefit costs are reflected in the Company's Unaudited Consolidated Financial Statements as follows for the periods presented:


	Three Months Ended June 30,						Six Months Ended June 30,
	2020		2019		2020		2019
Net periodic benefit costs:

Selling, general and administrative expense	$	0.4	$	0.4	$	0.8	$	0.9
Miscellaneous, net	1.1		1.7		1.9		3.2
Total net periodic benefit costs	$	1.5	$	2.1	$	2.7	$	4.1

STOCK COMPENSATION PLAN (Tables)

6 Months Ended

Jun. 30, 2020

Share-based Payment Arrangement [Abstract]

Restricted stock units award activity


	Time-Based LTIP			Performance-Based LTIP
	RSUs (000's)	Weighted-Average Grant Date Fair Value per RSU	RSUs (000's)		Weighted-Average Grant Date Fair Value per RSU
Outstanding as of December 31, 2019
2019 TIP RSUs ^(b)	200.6	16.44	n/a		—
LTIP RSUs:
2019	425.6	22.55	425.6		22.55
2018	241.9	19.00	364.7		19.00
2017 ^(a)	54.0	19.70	110.9		19.70
Total LTIP RSUs	721.5		901.2
Total LTIP and TIP RSUs Outstanding as of December 31, 2019	922.1		901.2
Granted
2019 TIP RSUs Granted ^(b)	11.7	10.24	n/a		—
LTIP RSUs:
2020	648.4	14.96	648.4		14.96
2019	—	—	—		—
2018	—	—	—		—
2017 ^(a)	—	—	—		—
Total LTIP RSUs Granted	648.4		648.4
Vested
2019 TIP RSUs Vested ^(b)(c)	(22.8)	16.44	n/a		—
LTIP RSUs:
2019^(c)	(131.0)	22.55	—		—
2018^(c)	(105.6)	19.31	—		—
2017 ^(a)(c)	(53.4)	19.70	(14.2)		19.70
Total LTIP RSUs Vested	(290.0)		(14.2)
Forfeited/Canceled
2019 TIP RSUs Forfeited/Canceled ^(b)	(35.8)	16.44	n/a		—
LTIP RSUs:
2019	(79.8)	22.55	(102.5)		22.55
2018	(49.0)	17.56	(101.4)		17.87
2017 ^(a)	(0.6)	19.70	(96.7)		19.70
Total LTIP RSUs Forfeited/Canceled	(129.4)		(300.6)
Outstanding as of June 30, 2020
2019 TIP RSUs	153.7	15.97	n/a		—
LTIP RSUs:
2020	648.4	14.96	648.4		14.96
2019	214.8	22.55	323.1		22.55
2018	87.3	19.44	263.3		19.44
2017 ^(a)	—	—	—		—
Total LTIP RSUs	950.5		1,234.8
Total LTIP and TIP RSUs Outstanding as of June 30, 2020	1,104.2		1,234.8

^(a)The 2017 time-based and performance-based LTIP RSUs were recognized over a 2-year service and performance period (i.e., 2018 and 2019).

^(b) The 2019 TIP provides for RSU awards that are only time-based.

ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)

6 Months Ended

Jun. 30, 2020

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Components of Accumulated Other Comprehensive Loss

A roll-forward of the Company's accumulated other comprehensive loss as of June 30, 2020 is as follows:


	Foreign Currency Translation		Actuarial (Loss) Gain on Post-retirement Benefits		Other		Accumulated Other Comprehensive Loss







Balance at January 1, 2020	$	(27.3)	$	(219.8)	$	(0.3)	$	(247.4)
Foreign currency translation adjustment	5.1		—		—		5.1
Amortization of pension related costs, net of tax of $1.2 million^(a)	—		6.5		—		6.5




Other comprehensive (loss) gain	$	5.1	$	6.5	$	—	$	11.6
Balance at June 30, 2020	$	(22.2)	$	(213.3)	$	(0.3)	$	(235.8)

SEGMENT DATA AND RELATED INFORMATION (Tables)

6 Months Ended

Jun. 30, 2020

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

The following table is a comparative summary of the Company’s net sales and segment profit for Revlon and Products Corporation by reportable segment for the periods presented.

Revlon, Inc.




	Three Months Ended June 30,						Six Months Ended June 30,
	2020		2019		2020		2019
Segment Net Sales:
Revlon	$	135.0	$	251.5	$	316.8	$	498.8
Elizabeth Arden	80.9		117.4		176.1		228.8
Portfolio	88.5		118.7		198.5		235.9
Fragrances	43.2		82.6		109.2		159.9
Total	$	347.6	$	570.2	$	800.6	$	1,123.4

Segment Profit:
Revlon	$	12.3	$	25.6	$	27.9	$	51.2
Elizabeth Arden	10.8		2.7		15.0		4.6
Portfolio	14.5		6.1		21.7		10.6
Fragrances	7.8		12.6		9.2		19.4
Total	$	45.4	$	47.0	$	73.8	$	85.8

Reconciliation:
Total Segment Profit	$	45.4	$	47.0	$	73.8	$	85.8
Less:

Depreciation and amortization	36.4		38.7		73.2		85.7
Non-cash stock compensation expense	1.1		3.4		3.5		3.8
Non-Operating items:
Restructuring and related charges	22.3		9.9		56.7		22.0
Acquisition, integration and divestiture costs	1.2		—		3.3		0.6
(Gain) loss on divested assets	(0.2)		—		0.6		—
Financial control remediation and sustainability actions and related charges	5.7		4.4		7.8		6.4
Excessive coupon redemptions	—		—		4.2		—
COVID-19 charges	17.9		—		25.4		—



Impairment charges	19.8		—		144.1		—



Operating loss	(58.8)		(9.4)		(245.0)		(32.7)
Less:
Interest Expense	60.9		47.8		109.3		95.5

Amortization of debt issuance costs	6.0		3.5		10.0		6.7

(Gain) loss on early extinguishment of debt, net	(11.9)		—		(11.9)		—
Foreign currency losses, net	2.3		1.2		18.9		1.4
Miscellaneous, net	20.6		4.6		16.5		5.9
Loss from continuing operations before income taxes	$	(136.7)	$	(66.5)	$	(387.8)	$	(142.2)

Products Corporation



	Three Months Ended June 30,						Six Months Ended June 30,
	2019		2018		2020		2019
Segment Net Sales:
Revlon	$	135.0	$	251.5	$	316.8	$	498.8
Elizabeth Arden	80.9		117.4		176.1		228.8
Portfolio	88.5		118.7		198.5		235.9
Fragrances	43.2		82.6		109.2		159.9
Total	$	347.6	$	570.2	$	800.6	$	1,123.4

Segment Profit:
Revlon	$	13.0	$	26.3	$	29.4	$	52.7
Elizabeth Arden	11.3		3.0		15.9		5.2
Portfolio	15.0		6.4		22.7		11.3
Fragrances	8.0		12.8		9.7		19.9
Total	$	47.3	$	48.5	$	77.7	$	89.1

Reconciliation:
Total Segment Profit	$	47.3	$	48.5	$	77.7	$	89.1
Less:

Depreciation and amortization	36.4		38.7		73.2		85.7
Non-cash stock compensation expense	1.1		3.4		3.5		3.8
Non-Operating items:
Restructuring and related charges	22.3		9.9		56.7		22.0
Acquisition, integration and divestiture costs	1.2		—		3.3		0.6
(Gain) loss on divested assets	(0.2)		—		0.6		—
Financial control remediation and sustainability actions and related charges	5.7		4.4		7.8		6.4


Excessive coupon redemptions	—		—		4.2		—
COVID-19 charges	17.9		—		25.4		—
Impairment charge	19.8		—		144.1		—

Operating income (loss)	(56.9)		(7.9)		(241.1)		(29.4)
Less:
Interest Expense	60.9		47.8		109.3		95.5

Amortization of debt issuance costs	6.0		3.5		10.0		6.7

(Gain) loss on early extinguishment of debt, net	(11.9)		—		(11.9)		—
Foreign currency losses, net	2.3		1.2		18.9		1.4
Miscellaneous, net	20.6		4.6		16.5		5.9
Loss from continuing operations before income taxes	$	(134.8)	$	(65.0)	$	(383.9)	$	(138.9)

Schedule of Net Sales and Long-Lived Assets by Geographic Area

The following tables present the Company's segment net sales by geography and total net sales by classes of similar products for the periods presented:


	Three Months Ended June 30, 2020																			Six Months Ended June 30, 2020
		Revlon		Elizabeth Arden		Portfolio		Fragrances		Total		Revlon		Elizabeth Arden		Portfolio		Fragrances			Total
Geographic Area⁽¹⁾:
Net Sales
North America		$	80.1	$	15.0	$	52.1	$	29.7	$	176.9	$	179.2	$	36.4	$	122.9	$	71.9		$	410.4
EMEA*		26.5		13.7		30.2		9.3		79.7		63.8		39.6		60.8		25.6			189.8
Asia		6.8		49.1		0.7		2.0		58.6		21.5		92.2		1.2		5.4			120.3
Latin America*		10.0		0.2		3.4		0.3		13.9		24.0		1.0		8.3		1.1			34.4
Pacific*		11.6		2.9		2.1		1.9		18.5		28.3		6.9		5.3		5.2			45.7
		$	135.0	$	80.9	$	88.5	$	43.2	$	347.6	$	316.8	$	176.1	$	198.5	$	109.2		$	800.6


	Three Months Ended June 30, 2019																			Six Months Ended June 30, 2019
		Revlon		Elizabeth Arden		Portfolio		Fragrances		Total		Revlon		Elizabeth Arden		Portfolio		Fragrances			Total
Geographic Area⁽¹⁾:
Net Sales
North America		$	134.7	$	26.2	$	73.0	$	52.6	$	286.5	267.9		54.4		143.1		99.8			$	565.2
EMEA*		51.5		30.6		34.8		21.9		138.8		105.2		58.5		72.6		42.1			278.4
Asia		24.4		53.9		1.4		4.1		83.8		48.3		101.6		2.2		8.8			160.9
Latin America*		21.7		2.2		6.5		1.8		32.2		37.4		5.0		11.7		4.0			58.1
Pacific*		19.2		4.5		3.0		2.2		28.9		40.0		9.3		6.3		5.2			60.8
		$	251.5	$	117.4	$	118.7	$	82.6	$	570.2	$	498.8	$	228.8	$	235.9	$	159.9		$	1,123.4

* The EMEA region includes Europe, the Middle East and Africa; the Latin America region includes Mexico, Central America and South America; and the Pacific region includes Australia and New Zealand.

The following table presents the Company's long-lived assets by geographic area as of June 30, 2020 and December 31, 2019:


	June 30, 2020							December 31, 2019
Long-lived assets, net:
United States	$	1,224.8	82%	$	1,414.0			83%
International	262.4		18%	280.1				17%
	$	1,487.2				$	1,694.1

Schedule of Net Sales by Classes of Similar Products



	Three Months Ended June 30,											Six Months Ended June 30,
	2020					2019				2020			2019
Classes of similar products:
Net sales:
Color cosmetics	$	70.6	20%	$	193.5	34%	$	200.6	25%	$	396.3	35%
Fragrance	64.0		18%	117.1		21%	158.9		20%	227.4		20%
Hair care	105.4		30%	129.8		23%	222.1		28%	258.5		23%
Beauty care	45.4		13%	48.0		8%	91.5		11%	89.1		8%
Skin care	62.2		19%	81.8		14%	127.5		16%	152.1		14%
	$	347.6		$	570.2		$	800.6		$	1,123.4

REVLON, INC. BASIC AND DILUTED EARNINGS (LOSS) PER COMMON SHARE (Tables)

6 Months Ended

Jun. 30, 2020

Earnings Per Share, Basic and Diluted [Abstract]

Components of Basic and Diluted Loss Per Share

Following are the components of Revlon's basic and diluted loss per common share for the periods presented:


	Three months ended June 30,						Six months ended June 30,
	2020		2019		2020		2019
Numerator:
Loss from continuing operations, net of taxes	$	(126.8)	$	(65.3)	$	(340.7)	$	(141.1)
Income from discontinued operations, net of taxes	—		1.6		—		2.3
Net loss	$	(126.8)	$	(63.7)	$	(340.7)	$	(138.8)
Denominator:
Weighted-average common shares outstanding – Basic	53,471,004		53,126,700		53,319,228		53,020,633
Effect of dilutive restricted stock and RSUs	—		—		—		—
Weighted-average common shares outstanding – Diluted	53,471,004		53,126,700		53,319,228		53,020,633
Basic and Diluted (loss) earnings per common share:
Continuing operations	$	(2.37)	$	(1.23)	$	(6.39)	$	(2.66)
Discontinued operations	—		0.03		—		0.04
Net loss per common share	$	(2.37)	$	(1.20)	$	(6.39)	$	(2.62)





Unvested restricted stock and RSUs under the Stock Plan^(a)	—		304,608		56,058		445,525

PRODUCTS CORPORATION AND SUBSIDIARIES GUARANTOR FINANCIAL INFORMATION (Tables)

6 Months Ended

Jun. 30, 2020

Condensed Financial Information Disclosure [Abstract]

Condensed Balance Sheet


Products Corporation and Subsidiaries Condensed Consolidating Balance Sheets
As of June 30, 2020
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated

ASSETS
Cash and cash equivalents	$	271.9	$	5.9	$	60.7	$	—	$	338.5
Trade receivables, less allowances for doubtful accounts	73.5		59.4		155.4		—		288.3
Inventories	145.9		175.9		189.4		—		511.2
Prepaid expenses and other	224.8		38.1		44.9		—		307.8
Intercompany receivables	3,173.6		3,134.9		508.9		(6,817.4)		—
Investment in subsidiaries	1,574.2		14.8		—		(1,589.0)		—
Property, plant and equipment, net	189.0		73.8		102.7		—		365.5
Deferred income taxes	235.6		(53.6)		29.1		—		211.1
Goodwill	48.9		264.0		249.8		—		562.7
Intangible assets, net	(20.9)		333.8		128.7		—		441.6
Other assets	72.0		13.6		31.8		—		117.4
Total assets	$	5,988.5	$	4,060.6	$	1,501.4	$	(8,406.4)	$	3,144.1
LIABILITIES AND STOCKHOLDER’S DEFICIENCY
Short-term borrowings	$	—	$	—	$	2.6	$	—	$	2.6
Current portion of long-term debt	648.2		—		0.1		—		648.3
Accounts payable	107.6		47.6		69.4		—		224.6
Accrued expenses and other	257.7		(35.0)		158.9		—		381.6
Intercompany payables	3,317.2		2,954.4		545.7		(6,817.3)		—
Long-term debt	2,922.8		—		53.0		—		2,975.8
Other long-term liabilities	173.1		111.4		38.4		—		322.9
Total liabilities	7,426.6		3,078.4		868.1		(6,817.3)		4,555.8
Stockholder’s (deficiency) equity	(1,438.1)		982.2		633.3		(1,589.1)		(1,411.7)
Total liabilities and stockholder’s (deficiency) equity	$	5,988.5	$	4,060.6	$	1,501.4	$	(8,406.4)	$	3,144.1


Products Corporation and Subsidiaries Condensed Consolidating Balance Sheets
As of December 31, 2019
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated

ASSETS
Cash and cash equivalents	$	0.8	$	6.4	$	97.1	$	—	$	104.3
Trade receivables, less allowances for doubtful accounts	95.5		92.3		235.6		—		423.4
Inventories	131.0		151.5		165.9		—		448.4
Prepaid expenses and other	219.7		26.4		46.5		—		292.6
Intercompany receivables	2,857.7		2,854.6		452.7		(6,165.0)		—
Investment in subsidiaries	1,598.3		30.7		—		(1,629.0)		—
Property, plant and equipment, net	208.7		89.5		110.4		—		408.6
Deferred income taxes	165.0		(37.8)		30.9		—		158.1
Goodwill	159.9		264.0		249.8		—		673.7
Intangible assets, net	13.0		346.9		130.8		—		490.7
Other assets	67.8		16.2		37.1		—		121.1
Total assets	$	5,517.4	$	3,840.7	$	1,556.8	$	(7,794.0)	$	3,120.9
LIABILITIES AND STOCKHOLDER’S DEFICIENCY
Short-term borrowings	$	—	$	—	$	2.2	$	—	$	2.2
Current portion of long-term debt	287.9		—		0.1		—		288.0
Accounts payable	108.4		39.9		103.5		—		251.8
Accrued expenses and other	124.1		70.0		224.1		—		418.2
Intercompany payables	3,030.3		2,668.7		466.0		(6,165.0)		—
Long-term debt	2,822.2		—		84.0		—		2,906.2
Other long-term liabilities	220.4		118.2		5.3		—		343.9
Total liabilities	6,593.3		2,896.8		885.2		(6,165.0)		4,210.3
Stockholder’s (deficiency) equity	(1,075.9)		943.9		671.6		(1,629.0)		(1,089.4)
Total liabilities and stockholder’s deficiency	$	5,517.4	$	3,840.7	$	1,556.8	$	(7,794.0)	$	3,120.9

Condensed Income Statement and Statement of Comprehensive Income



Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
Three Months Ended June 30, 2020
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
Net Sales	$	93.8	$	78.2	$	175.6	$	—	$	347.6
Cost of sales	54.4		43.5		70.7		—		168.6
Gross profit	39.4		34.7		104.9		—		179.0
Selling, general and administrative expenses	58.8		45.2		90.4		—		194.4
Acquisition and integration costs	2.0		(0.5)		(0.3)		—		1.2
Restructuring charges and other, net	17.1		3.0		0.6		—		20.7
Impairment charges	19.8		—		—		—		19.8
Gain on divested assets	(0.2)		—		—		—		(0.2)
Operating (loss) income	(58.1)		(13.0)		14.2		—		(56.9)
Other (income) expense:
Intercompany interest, net	(0.3)		0.6		(0.3)		—		—
Interest expense	59.2		—		1.7		—		60.9
Amortization of debt issuance costs	6.0		—		—		—		6.0
(Gain) loss on early extinguishment of debt, net	(11.9)		—		—		—		(11.9)
Foreign currency losses (gains), net	6.2		0.5		(4.4)		—		2.3
Miscellaneous, net	24.9		(6.9)		2.6		—		20.6
Other expense (income), net	84.1		(5.8)		(0.4)		—		77.9
(Loss) income from continuing operations before income taxes	(142.2)		(7.2)		14.6		—		(134.8)
(Benefit from) provision for income taxes	(35.8)		21.6		4.6		—		(9.6)
(Loss) income from continuing operations, net of taxes	(106.4)		(28.8)		10.0		—		(125.2)

Equity in income (loss) of subsidiaries	4.7		(6.9)		—		2.2		—
Net (loss) income	$	(101.7)	$	(35.7)	$	10.0	$	2.2	$	(125.2)
Other comprehensive income (loss)	14.3		7.9		11.2		(19.1)		14.3
Total comprehensive (loss) income	$	(87.4)	$	(27.8)	$	21.2	$	(16.9)	$	(110.9)



Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
Three Months Ended June 30, 2019
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
Net Sales	$	155.5	$	124.8	$	290.3	$	(0.4)	$	570.2
Cost of sales	72.2		64.1		108.0		(0.4)		243.9
Gross profit	83.3		60.7		182.3		—		326.3
Selling, general and administrative expenses	109.3		81.5		140.2		—		331.0

Restructuring charges and other, net	0.8		0.8		1.6		—		3.2
Operating (loss) income	(26.8)		(21.6)		40.5		—		(7.9)
Other (income) expense:
Intercompany interest, net	(1.1)		0.7		0.4		—		—
Interest expense	46.1		—		1.7		—		47.8
Amortization of debt issuance costs	3.5		—		—		—		3.5

Foreign currency losses, net	1.8		0.3		(0.9)		—		1.2
Miscellaneous, net	(10.1)		(12.7)		27.4		—		4.6
Other expense (income), net	40.2		(11.7)		28.6		—		57.1
(Loss) income from continuing operations before income taxes	(67.0)		(9.9)		11.9		—		(65.0)
(Benefit from) provision for income taxes	(3.6)		(0.1)		2.8		—		(0.9)
Loss (income) from continuing operations, net of taxes	(63.4)		(9.8)		9.1		—		(64.1)
Income from discontinued operations, net of taxes	—		—		1.6		—		1.6
Equity in income (loss) of subsidiaries	1.1		6.3		—		(7.4)		—
Net (loss) income	$	(62.3)	$	(3.5)	$	10.7	$	(7.4)	$	(62.5)
Other comprehensive income (loss)	5.3		(1.1)		(0.5)		1.6		5.3
Total comprehensive (loss) income	$	(57.0)	$	(4.6)	$	10.2	$	(5.8)	$	(57.2)



Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
Six Months Ended June 30, 2020
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
Net Sales	$	210.2	$	190.7	$	399.8	$	(0.1)	$	800.6
Cost of sales	112.9		97.9		155.7		(0.1)		366.4
Gross profit	97.3		92.8		244.1		—		434.2
Selling, general and administrative expenses	163.2		116.1		202.5		—		481.8
Acquisition, integration and divestiture costs	3.2		—		0.1		—		3.3
Restructuring charges and other, net	40.7		4.3		0.5		—		45.5
Impairment charges	144.1		—		—		—		144.1
Loss on divested assets	0.6		—		—		—		0.6
Operating (loss) income	(254.5)		(27.6)		41.0		—		(241.1)
Other (income) expense:
Intercompany interest, net	(3.0)		1.1		1.9		—		—
Interest expense	105.7		—		3.6		—		109.3
Amortization of debt issuance costs	10.0		—		—		—		10.0
(Gain) loss on early extinguishment of debt, net	(11.9)		—		—		—		(11.9)
Foreign currency losses, net	0.6		2.4		15.9		—		18.9
Miscellaneous, net	0.9		(16.1)		31.7		—		16.5
Other expense (income), net	102.3		(12.6)		53.1		—		142.8
Loss from continuing operations before income taxes	(356.8)		(15.0)		(12.1)		—		(383.9)
Benefit from for income taxes	(52.1)		1.4		4.2		—		(46.5)
Loss from continuing operations, net of taxes	(304.7)		(16.4)		(16.3)		—		(337.4)

Equity in (loss) income of subsidiaries	(29.3)		(26.9)		—		56.2		—
Net (loss) income	$	(334.0)	$	(43.3)	$	(16.3)	$	56.2	$	(337.4)
Other comprehensive (loss) income	11.6		14.4		2.4		(16.8)		11.6
Total comprehensive (loss) income	$	(322.4)	$	(28.9)	$	(13.9)	$	39.4	$	(325.8)


Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
Six Months Ended June 30, 2019
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
Net Sales	$	311.0	$	254.1	$	561.5	$	(3.2)	$	1,123.4
Cost of sales	140.2		129.2		215.5		(3.2)		481.7
Gross profit	170.8		124.9		346.0		—		641.7
Selling, general and administrative expenses	239.0		156.6		266.2		—		661.8
Acquisition, integration and divestiture costs	0.5		0.1		—		—		0.6
Restructuring charges and other, net	2.4		2.9		3.4		—		8.7


Operating (loss) income	(71.1)		(34.7)		76.4		—		(29.4)
Other (income) expenses:
Intercompany interest, net	(2.4)		1.4		1.0		—		—
Interest expense	92.0		—		3.5		—		95.5
Amortization of debt issuance costs	6.7		—		—		—		6.7

Foreign currency losses, net	0.3		0.3		0.8		—		1.4
Miscellaneous, net	(18.0)		(26.2)		50.1		—		5.9
Other expense (income), net	78.6		(24.5)		55.4		—		109.5
(Loss) income from continuing operations before income taxes	(149.7)		(10.2)		21.0		—		(138.9)
(Benefit from) provision for income taxes	(5.4)		0.4		4.4		—		(0.6)
(Loss) income from continuing operations, net of taxes	(144.3)		(10.6)		16.6		—		(138.3)
Income from discontinued operations, net of taxes	—		—		2.3		—		2.3
Equity in income (loss) of subsidiaries	8.5		11.7		—		(20.2)		—
Net (loss) income	$	(135.8)	$	1.1	$	18.9	$	(20.2)	$	(136.0)
Other comprehensive income (loss)	6.2		(1.2)		0.1		1.1		6.2
Total comprehensive (loss) income	$	(129.6)	$	(0.1)	$	19.0	$	(19.1)	$	(129.8)

Condensed Cash Flow Statement


Products Corporation and Subsidiaries Condensed Consolidating Statements of Cash Flows
Six Months Ended June 30, 2020
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES:
Net cash (used in) provided by operating activities	$	(148.3)	$	14.6	$	(30.5)	$	—	$	(164.2)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash (used in) provided by investing activities	(2.7)		—		—		—		(2.7)



CASH FLOWS FROM FINANCING ACTIVITIES:
Net decrease in short-term borrowings and overdraft	(1.3)		(6.2)		0.5		—		(7.0)
Borrowings under the 2020 BrandCo Facilities	880.0		—		—		—		880.0
Repurchases of the 5.75% Senior Notes	(99.6)		—		—		—		(99.6)
Net borrowings under the Amended 2016 Revolving Credit Facility	(22.9)		—		—		—		(22.9)


Repayment of the 2019 Term Loan Facility	(200.0)		—		—		—		(200.0)
Repayments under the 2018 Foreign Asset-Based Term Loan	(31.4)				—		—		(31.4)
Repayments under the 2016 Term Loan Facility	(6.9)		—		—		—		(6.9)
Payment of financing costs	(101.2)		—		—		—		(101.2)
Tax withholdings related to net share settlements of restricted stock and RSUs	(1.6)		—		—		—		(1.6)
Other financing activities	(1.0)		—		—		—		(1.0)
Net cash provided by (used in) financing activities	414.1		(6.2)		0.5		—		408.4
Effect of exchange rate changes on cash, cash equivalents and restricted cash	—		(9.0)		6.9		—		(2.1)
Net increase (decrease) in cash, cash equivalents and restricted cash	263.1		(0.6)		(23.1)		—		239.4
Cash, cash equivalents and restricted cash at beginning of period	$	1.0	$	6.4	$	97.2	$	—	$	104.5
Cash, cash equivalents and restricted cash at end of period	$	264.1	$	5.8	$	74.1	$	—	$	343.9


Products Corporation and Subsidiaries Condensed Consolidating Statements of Cash Flows
Six Months Ended June 30, 2019
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES:
Net cash (used in) provided by operating activities	$	(36.8)	$	4.8	$	(9.2)	$	—	$	(41.2)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash used in investing activities	(6.3)		(1.2)		(4.7)		—		(12.2)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net decrease in short-term borrowings and overdraft	(9.7)		(6.6)		(2.5)		—		(18.8)
Repayments under the 2016 Term Loan Facility	(9.0)		—		—		—		(9.0)

Net borrowings under the Amended 2016 Revolving Credit Facility	59.9		—		—		—		59.9

Payments of financing costs	(0.8)		—		(0.6)		—		(1.4)
Tax withholdings related to net share settlements of restricted stock and RSUs	(1.6)		—		—		—		(1.6)
Other financing activities	(0.4)		—		(0.1)		—		(0.5)
Net cash provided by financing activities	38.4		(6.6)		(3.2)		—		28.6
Effect of exchange rate changes on cash, cash equivalents and restricted cash	—		0.1		0.4		—		0.5
Net decrease in cash, cash equivalents and restricted cash	(4.7)		(2.9)		(16.7)		—		(24.3)
Cash, cash equivalents and restricted cash at beginning of period	$	7.2	$	6.6	$	73.7	$	—	87.5
Cash, cash equivalents and restricted cash at end of period	$	2.5	$	3.7	$	57.0	$	—	$	63.2

DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)	6 Months Ended
	Jun. 30, 2020 reporting_unit segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of reporting units \| reporting_unit	4
Number of reporting segments \| segment	4

RESTRUCTURING CHARGES - Narrative (Details) $ in Millions	1 Months Ended	6 Months Ended	12 Months Ended		20 Months Ended	24 Months Ended	26 Months Ended
RESTRUCTURING CHARGES - Narrative (Details) $ in Millions	Mar. 31, 2020 job_position	Jun. 30, 2020 USD ($) job_position	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)	Jun. 30, 2020 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)
Restructuring Cost and Reserve [Line Items]
Restructuring and related charges		$ 45.5
Payments for restructuring		$ 12.9
Revlon 2020 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Expected number of positions eliminated \| job_position	1,000
Expected number of current employee positions to be eliminated \| job_position	650
Number of open positions eliminated \| job_position	350
Number of positions eliminated \| job_position		700
Restructuring costs recognized to date		$ 57.1			$ 57.1
Revlon 2020 Restructuring Plan \| Minimum \| Scenario, Forecast \| Employee Severance, Retention and Other Contractual Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring and related charges				$ 60.0		$ 75.0
Payments for restructuring			$ 40.0	55.0
Revlon 2020 Restructuring Plan \| Maximum \| Scenario, Forecast \| Employee Severance, Retention and Other Contractual Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring and related charges				70.0		$ 85.0
Payments for restructuring			$ 45.0	$ 65.0
2018 Optimization Restructuring Program
Restructuring Cost and Reserve [Line Items]
Restructuring and related charges		0.0
Payments for restructuring					29.8
Restructuring costs recognized to date		$ 39.5			$ 39.5			$ 39.5
2018 Optimization Restructuring Program \| Scenario, Forecast
Restructuring Cost and Reserve [Line Items]
Payments for restructuring							$ 32.0

RESTRUCTURING CHARGES - Restructuring and Related Charges Activity (Details) $ in Millions	6 Months Ended
	Jun. 30, 2020 USD ($)
Restructuring Reserve [Roll Forward]
Charges incurred during period	$ 45.5
Revlon 2020 Restructuring Plan
Restructuring Reserve [Roll Forward]
Charges incurred through end of period	57.1
Revlon 2020 Restructuring Plan \| Employee Severance and Other Personnel Benefits
Restructuring Reserve [Roll Forward]
Charges incurred during period	46.3
Charges incurred through end of period	46.3
Revlon 2020 Restructuring Plan \| Other Costs
Restructuring Reserve [Roll Forward]
Charges incurred during period	0.3
Charges incurred through end of period	0.3
Revlon 2020 Restructuring Plan \| Total Restructuring Charges
Restructuring Reserve [Roll Forward]
Charges incurred during period	46.6
Charges incurred through end of period	46.6
Revlon 2020 Restructuring Plan \| Leases
Restructuring Reserve [Roll Forward]
Charges incurred through end of period	9.8
Revlon 2020 Restructuring Plan \| Other Related Charges
Restructuring Reserve [Roll Forward]
Charges incurred through end of period	0.7
Revlon 2020 Restructuring Plan \| Accelerated Rent Expense, Abandoned Leases
Restructuring Reserve [Roll Forward]
Charges incurred through end of period	3.5
Revlon 2020 Restructuring Plan \| Disposal of Leasehold Improvements and Other Equipment
Restructuring Reserve [Roll Forward]
Charges incurred through end of period	3.0
Revlon 2020 Restructuring Plan \| Restructuring Related Rent Expense
Restructuring Reserve [Roll Forward]
Charges incurred through end of period	2.4
Revlon 2020 Restructuring Plan \| Disposal of Leasehold Improvements and Other Equipment, Abandoned Leases
Restructuring Reserve [Roll Forward]
Charges incurred through end of period	0.9
2018 Optimization Restructuring Program
Restructuring Reserve [Roll Forward]
Charges incurred through beginning of period	39.5
Charges incurred during period	0.0
Charges incurred through end of period	39.5
2018 Optimization Restructuring Program \| Employee Severance and Other Personnel Benefits
Restructuring Reserve [Roll Forward]
Charges incurred through beginning of period	20.3
Charges incurred during period	(0.7)
Charges incurred through end of period	19.6
2018 Optimization Restructuring Program \| Other Costs
Restructuring Reserve [Roll Forward]
Charges incurred through beginning of period	0.3
Charges incurred during period	0.0
Charges incurred through end of period	0.3
2018 Optimization Restructuring Program \| Total Restructuring Charges
Restructuring Reserve [Roll Forward]
Charges incurred through beginning of period	20.6
Charges incurred during period	(0.7)
Charges incurred through end of period	19.9
2018 Optimization Restructuring Program \| Inventory Adjustments
Restructuring Reserve [Roll Forward]
Charges incurred through beginning of period	4.9
Charges incurred during period	0.0
Charges incurred through end of period	4.9
2018 Optimization Restructuring Program \| Other Related Charges
Restructuring Reserve [Roll Forward]
Charges incurred through beginning of period	14.0
Charges incurred during period	0.7
Charges incurred through end of period	$ 14.7

RESTRUCTURING CHARGES - Restructuring and Related Charges by Segment (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2020	Dec. 31, 2019
Restructuring Cost and Reserve [Line Items]
Restructuring and related charges	$ 45.5
Revlon 2020 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Cumulative charges incurred	57.1
2018 Optimization Restructuring Program
Restructuring Cost and Reserve [Line Items]
Restructuring and related charges	0.0
Cumulative charges incurred	39.5	$ 39.5
Operating segments \| Revlon 2020 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Cumulative charges incurred	46.6
Operating segments \| 2018 Optimization Restructuring Program
Restructuring Cost and Reserve [Line Items]
Restructuring and related charges	(0.7)
Cumulative charges incurred	19.9
Operating segments \| Revlon \| Revlon 2020 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Cumulative charges incurred	18.0
Operating segments \| Revlon \| 2018 Optimization Restructuring Program
Restructuring Cost and Reserve [Line Items]
Restructuring and related charges	(0.4)
Cumulative charges incurred	8.4
Operating segments \| Elizabeth Arden \| Revlon 2020 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Cumulative charges incurred	10.3
Operating segments \| Elizabeth Arden \| 2018 Optimization Restructuring Program
Restructuring Cost and Reserve [Line Items]
Restructuring and related charges	(0.1)
Cumulative charges incurred	4.2
Operating segments \| Portfolio \| Revlon 2020 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Cumulative charges incurred	11.1
Operating segments \| Portfolio \| 2018 Optimization Restructuring Program
Restructuring Cost and Reserve [Line Items]
Restructuring and related charges	(0.1)
Cumulative charges incurred	3.9
Operating segments \| Fragrance \| Revlon 2020 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Cumulative charges incurred	7.2
Operating segments \| Fragrance \| 2018 Optimization Restructuring Program
Restructuring Cost and Reserve [Line Items]
Restructuring and related charges	(0.1)
Cumulative charges incurred	$ 3.4

RESTRUCTURING CHARGES - Restructuring Reserve (Details) - USD ($) $ in Millions	6 Months Ended	20 Months Ended
	Jun. 30, 2020	Jun. 30, 2020
Restructuring Reserve [Roll Forward]
Liability Balance at period start	$ 10.0
Expense, Net	45.5
Foreign Currency Translation	0.0
Cash utilized, net	(12.9)
Non-cash utilized, net	0.0
Liability Balance at period end	42.6	$ 42.6
Revlon 2020 Restructuring Plan \| Employee severance and other personnel benefits
Restructuring Reserve [Roll Forward]
Liability Balance at period start	0.0
Expense, Net	46.3
Foreign Currency Translation	0.0
Cash utilized, net	(9.0)
Non-cash utilized, net	0.0
Liability Balance at period end	37.3	37.3
Revlon 2020 Restructuring Plan \| Other Costs
Restructuring Reserve [Roll Forward]
Liability Balance at period start	0.0
Expense, Net	0.3
Foreign Currency Translation	0.0
Cash utilized, net	(0.3)
Non-cash utilized, net	0.0
Liability Balance at period end	0.0	0.0
Revlon 2020 Restructuring Plan \| Total Restructuring Charges
Restructuring Reserve [Roll Forward]
Liability Balance at period start	0.0
Expense, Net	46.6
Foreign Currency Translation	0.0
Cash utilized, net	(9.3)
Non-cash utilized, net	0.0
Liability Balance at period end	37.3	37.3
2018 Optimization Restructuring Program
Restructuring Reserve [Roll Forward]
Expense, Net	0.0
Cash utilized, net		(29.8)
2018 Optimization Restructuring Program \| Employee severance and other personnel benefits
Restructuring Reserve [Roll Forward]
Liability Balance at period start	5.7
Expense, Net	(0.7)
Foreign Currency Translation	0.0
Cash utilized, net	(3.2)
Non-cash utilized, net	0.0
Liability Balance at period end	1.8	1.8
2018 Optimization Restructuring Program \| Other Costs
Restructuring Reserve [Roll Forward]
Expense, Net	0.0
2018 Optimization Restructuring Program \| Total Restructuring Charges
Restructuring Reserve [Roll Forward]
Expense, Net	(0.7)
Other immaterial actions \| Employee severance and other personnel benefits
Restructuring Reserve [Roll Forward]
Liability Balance at period start	4.3
Expense, Net	(0.4)
Foreign Currency Translation	0.0
Cash utilized, net	(0.4)
Non-cash utilized, net	0.0
Liability Balance at period end	$ 3.5	$ 3.5

INVENTORIES (Details) - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Inventory Disclosure [Abstract]
Finished goods	$ 384.9	$ 326.5
Raw materials and supplies	109.8	110.4
Work-in-process	16.5	11.5
Inventories	$ 511.2	$ 448.4

LEASES AND PROPERTY, PLANT AND EQUIPMENT - Lease Cost and Other Information (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Finance Lease Cost:
Amortization of ROU assets	$ 0.2	$ 0.1
Interest on lease liabilities	0.1	0.0
Operating Lease Cost	21.8	21.3
Total Lease Cost	22.1	21.4
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from finance leases	0.1	0.0
Operating cash flows from operating leases	19.2	21.0
Financing cash flows from finance leases	0.1	0.4
ROU assets for finance leases	0.8	1.0
ROU assets for operating leases	88.4	$ 91.4
Accumulated amortization on ROU assets for finance leases	0.5		$ 0.3
Accumulated amortization on ROU assets for operating leases	$ 29.7		$ 23.2
Weighted-average remaining lease term - finance leases	2 years 4 months 24 days		2 years 9 months 18 days
Weighted-average remaining lease term - operating leases	5 years 9 months 18 days		6 years 2 months 12 days
Weighted-average discount rate - finance leases	15.00%		15.60%
Weighted-average discount rate - operating leases	15.70%		15.80%

LEASES AND PROPERTY, PLANT AND EQUIPMENT - Maturities of Lease Liabilities (Details) $ in Millions	Jun. 30, 2020 USD ($)
Operating Leases
July 2020 through December 2020	$ 18.0
2021	33.6
2022	26.4
2023	21.9
2024	16.5
Thereafter	47.8
Total undiscounted cash flows	164.2
Short-term lease liability	19.3
Long-term lease liability	85.5
Total lease liability	104.8
Difference between undiscounted cash flows and discounted cash flows	59.4
Finance Leases
July 2020 through December 2020	0.3
2021	0.5
2022	0.3
2023	0.0
2024	0.0
Thereafter	0.0
Total undiscounted cash flows	1.1
Short-term lease liability	0.4
Long-term lease liability	0.4
Total lease liability	0.8
Difference between undiscounted cash flows and discounted cash flows	$ 0.3

GOODWILL AND INTANGIBLE ASSETS, NET - Narrative (Details) - USD ($)	3 Months Ended			6 Months Ended		12 Months Ended
	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Goodwill [Line Items]
Goodwill	$ 562,700,000			$ 562,700,000		$ 673,700,000
Goodwill impairment charge		$ 99,800,000
Tax benefit due to nondeductible impairment losses	9,600,000		$ 900,000	46,500,000	$ 600,000
Indefinite-lived intangible assets impairment				33,100,000		0
Amortization expense	$ 8,200,000		$ 8,800,000	$ 16,700,000	$ 23,600,000
Weighted-average cost of capital \| Minimum
Goodwill [Line Items]
Goodwill measurement input	10.50%			10.50%
Weighted-average cost of capital \| Maximum
Goodwill [Line Items]
Goodwill measurement input	12.00%			12.00%
Perpetual growth rate
Goodwill [Line Items]
Goodwill measurement input	2.00%			2.00%
Goodwill
Goodwill [Line Items]
Tax benefit due to nondeductible impairment losses	$ 0			$ 8,300,000
Intangible assets
Goodwill [Line Items]
Tax benefit due to nondeductible impairment losses	1,800,000			6,900,000
Operating segments
Goodwill [Line Items]
Goodwill	562,700,000			562,700,000		673,700,000
Goodwill impairment charge	11,200,000			111,000,000.0
Indefinite-lived intangible assets impairment	8,600,000			33,100,000
Portfolio \| Operating segments
Goodwill [Line Items]
Goodwill	87,600,000			87,600,000		$ 171,100,000
Goodwill impairment charge				83,500,000
Indefinite-lived intangible assets impairment	(0.0)			2,500,000
Revlon Reporting Unit
Goodwill [Line Items]
Goodwill		264,700,000
Elizabeth Arden Skin and Color Reporting Unit
Goodwill [Line Items]
Goodwill	67,400,000	67,400,000		67,400,000
Fragrances Reporting Unit
Goodwill [Line Items]
Goodwill	120,800,000	120,800,000		120,800,000
Mass Portfolio Reporting Unit \| Portfolio
Goodwill [Line Items]
Goodwill		0
Goodwill impairment charge		54,300,000
Professional Portfolio Reporting Unit \| Portfolio
Goodwill [Line Items]
Goodwill		97,200,000
Goodwill impairment charge	9,600,000	19,600,000
Elizabeth Arden Fragrances Reporting Unit \| Elizabeth Arden
Goodwill [Line Items]
Goodwill	22,000,000.0	23,500,000		$ 22,000,000.0
Goodwill impairment charge	1,600,000	25,900,000
Mass Portfolio, Elizabeth Arden Fragrances and Elizabeth Arden Skin and Color Reporting Units \| COVID-19
Goodwill [Line Items]
Indefinite-lived intangible assets impairment		$ 24,500,000
Elizabeth Arden Fragrances and Elizabeth Arden Skin And Color Reporting Units \| COVID-19
Goodwill [Line Items]
Indefinite-lived intangible assets impairment	$ 8,600,000

GOODWILL AND INTANGIBLE ASSETS, NET - Changes in Goodwill by Segment (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2020
Goodwill [Roll Forward]
Beginning Balance		$ 673.7	$ 673.7
Goodwill impairment charge		(99.8)
Ending Balance	$ 562.7		562.7
Operating segments
Goodwill [Roll Forward]
Beginning Balance		673.7	673.7
Foreign currency translation adjustment			0.0
Goodwill impairment charge	(11.2)		(111.0)
Ending Balance	562.7		562.7
Cumulative goodwill impairment charges	(166.2)		(166.2)
Operating segments \| Revlon
Goodwill [Roll Forward]
Beginning Balance		264.9	264.9
Foreign currency translation adjustment			0.0
Goodwill impairment charge			0.0
Ending Balance	264.9		264.9
Operating segments \| Portfolio
Goodwill [Roll Forward]
Beginning Balance		171.1	171.1
Foreign currency translation adjustment			0.0
Goodwill impairment charge			(83.5)
Ending Balance	87.6		87.6
Operating segments \| Elizabeth Arden
Goodwill [Roll Forward]
Beginning Balance		116.9	116.9
Foreign currency translation adjustment			0.0
Goodwill impairment charge			(27.5)
Ending Balance	89.4		89.4
Operating segments \| Fragrance
Goodwill [Roll Forward]
Beginning Balance		$ 120.8	120.8
Foreign currency translation adjustment			0.0
Goodwill impairment charge			0.0
Ending Balance	$ 120.8		$ 120.8

GOODWILL AND INTANGIBLE ASSETS, NET - Finite-lived and Indefinite-lived Intangible Asset Impairments (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended	12 Months Ended
	Jun. 30, 2020	Jun. 30, 2020	Dec. 31, 2019
Segment Reporting Information [Line Items]
Indefinite-lived intangible assets		$ (33.1)	$ 0.0
Total Intangibles Impairment		(33.1)	$ 0.0
Operating segments
Segment Reporting Information [Line Items]
Indefinite-lived intangible assets	$ (8.6)	(33.1)
Total Intangibles Impairment	(8.6)	(33.1)
Revlon \| Operating segments
Segment Reporting Information [Line Items]
Indefinite-lived intangible assets	0.0	0.0
Total Intangibles Impairment	0.0	0.0
Portfolio \| Operating segments
Segment Reporting Information [Line Items]
Indefinite-lived intangible assets	0.0	(2.5)
Total Intangibles Impairment	0.0	(2.5)
Elizabeth Arden \| Operating segments
Segment Reporting Information [Line Items]
Indefinite-lived intangible assets	(8.6)	(30.6)
Total Intangibles Impairment	(8.6)	(30.6)
Fragrance \| Operating segments
Segment Reporting Information [Line Items]
Indefinite-lived intangible assets	0.0	0.0
Total Intangibles Impairment	$ 0.0	$ 0.0

GOODWILL AND INTANGIBLE ASSETS, NET - Summary of Intangible Assets (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Jun. 30, 2020	Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross carrying amount	$ 573.9	$ 573.3
Finite-lived intangible assets, accumulated amortization	(243.2)	(226.4)
Finite-lived intangible assets, impairment	0.0	0.0
Finite-lived intangible assets, net carrying amount	330.7	346.9
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets, gross carrying amount	144.0	143.8
Indefinite-lived intangible assets, impairment	(33.1)	0.0
Indefinite-lived intangible assets, net carrying amount	110.9	143.8
Intangible assets, gross carrying amount	717.9	717.1
Total Intangibles Impairment	(33.1)	0.0
Intangible assets, net carrying amount	441.6	490.7
Trade names
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets, gross carrying amount	144.0	143.8
Indefinite-lived intangible assets, impairment	(33.1)	0.0
Indefinite-lived intangible assets, net carrying amount	110.9	143.8
Trademarks and licenses
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross carrying amount	271.7	271.2
Finite-lived intangible assets, accumulated amortization	(119.3)	(110.9)
Finite-lived intangible assets, impairment	0.0	0.0
Finite-lived intangible assets, net carrying amount	$ 152.4	$ 160.3
Weighted average useful life	13 years	13 years
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross carrying amount	$ 248.0	$ 248.3
Finite-lived intangible assets, accumulated amortization	(103.1)	(96.5)
Finite-lived intangible assets, impairment	0.0	0.0
Finite-lived intangible assets, net carrying amount	$ 144.9	$ 151.8
Weighted average useful life	11 years	11 years
Patents and internally-developed intellectual property
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross carrying amount	$ 21.9	$ 21.5
Finite-lived intangible assets, accumulated amortization	(12.9)	(12.1)
Finite-lived intangible assets, impairment	0.0	0.0
Finite-lived intangible assets, net carrying amount	$ 9.0	$ 9.4
Weighted average useful life	5 years	5 years
Distribution rights
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross carrying amount	$ 31.0	$ 31.0
Finite-lived intangible assets, accumulated amortization	(6.6)	(5.6)
Finite-lived intangible assets, impairment	0.0	0.0
Finite-lived intangible assets, net carrying amount	$ 24.4	$ 25.4
Weighted average useful life	14 years	15 years
Other
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross carrying amount	$ 1.3	$ 1.3
Finite-lived intangible assets, accumulated amortization	(1.3)	(1.3)
Finite-lived intangible assets, impairment	0.0	0.0
Finite-lived intangible assets, net carrying amount	$ 0.0	$ 0.0
Weighted average useful life	0 years	0 years

GOODWILL AND INTANGIBLE ASSETS, NET - Estimated Future Amortization Expense (Details) - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
2020	$ 17.3
2021	33.3
2022	32.4
2023	30.9
2024	27.5
Thereafter	189.3
Finite-lived intangible assets, net carrying amount	$ 330.7	$ 346.9

ACCRUED EXPENSES AND OTHER - Components of Accrued Expenses and Other (Details) - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Schedule of Accrued Liabilities [Line Items]
Sales returns and allowances	$ 64.6	$ 89.7
Advertising, marketing and promotional costs	69.2	82.8
Taxes	49.9	57.6
Compensation and related benefits	31.3	42.1
Interest	34.8	34.0
Professional services and insurance	19.8	16.3
Short-term lease liability	19.7	14.5
Freight and distribution costs	7.4	13.2
Restructuring reserve	42.6	10.0
Software	3.1	4.0
Other	39.1	54.0
Total	$ 381.6	418.2
Employee Severance and Other Personnel Benefits \| Mr. Fabian Garcia
Schedule of Accrued Liabilities [Line Items]
Other		$ 2.3

DEBT - Components of Long-term Debt (Details) - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Long-term debt	$ 3,624.1	$ 3,194.2
Less current portion	(648.3)	(288.0)
Long-term debt	2,975.8	2,906.2
Short-term borrowings	2.6	2.2
2020 BrandCo Term Loan Facility due 2025
Debt Instrument [Line Items]
Long-term debt	1,582.5	0.0
Less current portion	(4.2)
2019 Term Loan Facility due 2023
Debt Instrument [Line Items]
Long-term debt	0.0	187.1
2018 Foreign Asset-Based Term Facility due 2021
Debt Instrument [Line Items]
Long-term debt	51.6	82.3
Amended 2016 Revolving Credit Facility due 2021
Debt Instrument [Line Items]
Long-term debt	247.2	269.9
Less current portion	(247.2)	(269.9)
2016 Term Loan Facility due 2023 and 2025
Debt Instrument [Line Items]
Long-term debt	911.8	1,713.6
Less current portion	(9.6)
5.75% Senior Notes due 2021
Debt Instrument [Line Items]
Long-term debt	$ 387.2	498.1
Stated interest rate (as a percent)	5.75%
6.25% Senior Notes due 2024
Debt Instrument [Line Items]
Long-term debt	$ 443.5	442.8
Stated interest rate (as a percent)	6.25%
Spanish Government Loan due 2025
Debt Instrument [Line Items]
Long-term debt	$ 0.3	$ 0.4

DEBT - Components of Long-term Debt, Footnotes (Details)					1 Months Ended	2 Months Ended	3 Months Ended			6 Months Ended		12 Months Ended
	May 07, 2020 USD ($)	May 04, 2020 EUR (€)	May 03, 2020	Apr. 30, 2020	May 31, 2020	Jun. 30, 2020 USD ($)	Jun. 30, 2020 USD ($)	Jun. 30, 2020 EUR (€)	Jun. 30, 2019 USD ($)	Jun. 30, 2020 USD ($)	Jun. 30, 2019 USD ($)	Dec. 31, 2019 USD ($)	Jun. 30, 2020 EUR (€)	Apr. 17, 2020 USD ($)	Apr. 30, 2018 USD ($)
Debt Instrument [Line Items]
Current portion of long-term debt						$ 648,300,000	$ 648,300,000			$ 648,300,000		$ 288,000,000.0
Net gain on extinguishment of debt							11,900,000		$ 0	11,900,000	$ 0
Outstanding borrowings						$ 3,624,100,000	$ 3,624,100,000			$ 3,624,100,000		3,194,200,000
5.75% Senior Notes due 2021
Debt Instrument [Line Items]
Stated interest rate (as a percent)						5.75%	5.75%			5.75%			5.75%
Aggregate principal amount outstanding						$ 387,200,000	$ 387,200,000			$ 387,200,000
Repayments of senior debt										99,600,000	0
Debt repurchased	$ 50,000,000					62,800,000	112,800,000
Net gain on extinguishment of debt							11,900,000			11,900,000
Outstanding borrowings						387,200,000	387,200,000			387,200,000		498,100,000
Amended 2016 Revolving Credit Facility due 2021
Debt Instrument [Line Items]
Current portion of long-term debt						247,200,000	247,200,000			247,200,000		269,900,000
Outstanding borrowings						247,200,000	247,200,000			247,200,000		269,900,000
Amended 2016 Revolving Credit Facility due 2021 \| Revolving credit facility
Debt Instrument [Line Items]
Maximum borrowing capacity						400,000,000.0	400,000,000.0			400,000,000.0
2020 BrandCo Term Loan Facility due 2025
Debt Instrument [Line Items]
Current portion of long-term debt						4,200,000	4,200,000			4,200,000
Outstanding borrowings						1,582,500,000	1,582,500,000			1,582,500,000		0
2020 BrandCo Term Loan Facility due 2025 \| Secured debt
Debt Instrument [Line Items]
Aggregate principal amount outstanding						1,720,400,000	1,720,400,000			1,720,400,000
2016 Term Loan Facility due 2023 and 2025
Debt Instrument [Line Items]
Current portion of long-term debt						9,600,000	9,600,000			9,600,000
Repayment of debt												18,000,000.0
Aggregate principal amount outstanding						924,800,000	924,800,000			924,800,000
Repayments of senior debt										6,900,000	9,000,000.0
Outstanding borrowings						911,800,000	911,800,000			911,800,000		1,713,600,000
2016 Term Loan Facility due 2023 and 2025 \| Revolving credit facility
Debt Instrument [Line Items]
Amount by which available liquidity does not exceed principal amount of other debt															$ 200,000,000
Roll-up and Junior Roll-up BrandCo Facilities due 2025 \| Secured debt
Debt Instrument [Line Items]
Aggregate principal amount outstanding						809,800,000	809,800,000			809,800,000
2019 Term Loan Facility due 2023
Debt Instrument [Line Items]
Debt issuance costs, prepayment premiums	33,500,000
Debt issuance costs, lenders fees	10,300,000
Repayments of senior debt	$ 200,000,000									200,000,000.0	0
Outstanding borrowings						0	0			0		187,100,000
2018 Foreign Asset-Based Term Facility due 2021
Debt Instrument [Line Items]
Aggregate principal amount outstanding						54,500,000	54,500,000			54,500,000			€ 48,500,000
Repayments of senior debt		€ 5,000,000						€ 28,500,000		31,400,000	$ 0
Maximum borrowing capacity \| €		€ 77,000,000											€ 77,000,000
Variable rate floor		0.50%
Basis spread on variable interest rate		7.00%
Outstanding borrowings						51,600,000	51,600,000			51,600,000		82,300,000
2018 Foreign Asset-Based Term Facility due 2021 \| EURIBOR
Debt Instrument [Line Items]
Variable rate floor			0.50%	0.50%	0.50%
Basis spread on variable interest rate			6.50%	6.50%	7.00%
Tranche A \| Revolving credit facility
Debt Instrument [Line Items]
Aggregate principal amount outstanding						249,500,000	249,500,000			249,500,000
Maximum borrowing capacity															400,000,000
Amount by which available liquidity does not exceed principal amount of other debt															200,000,000
Tranche A \| Sublimit, letters of credit
Debt Instrument [Line Items]
Aggregate principal amount outstanding						7,700,000	7,700,000			7,700,000
Tranche B \| Revolving credit facility
Debt Instrument [Line Items]
Maximum borrowing capacity															$ 41,500,000
Outstanding borrowings														$ 36,300,000
2016 Term Loan Facility due 2023
Debt Instrument [Line Items]
Aggregate principal amount outstanding						894,000,000.0	894,000,000.0			894,000,000.0
Extended Term Loans due 2025
Debt Instrument [Line Items]
Aggregate principal amount outstanding						$ 30,800,000	$ 30,800,000			$ 30,800,000
6.25% Senior Notes due 2024
Debt Instrument [Line Items]
Stated interest rate (as a percent)						6.25%	6.25%			6.25%			6.25%
Aggregate principal amount outstanding						$ 450,000,000	$ 450,000,000			$ 450,000,000
Outstanding borrowings						443,500,000	443,500,000			443,500,000		$ 442,800,000
2019 Senior Line of Credit Agreement \| Line of Credit
Debt Instrument [Line Items]
Outstanding borrowings						$ 0	$ 0			$ 0

DEBT - Consummation of 2020 BrandCo Refinancing Transactions (Details) - USD ($)

3 Months Ended

6 Months Ended

May 28, 2020

May 07, 2020

Jun. 30, 2020

Jun. 30, 2019

Paid-in-kind interest accrued on the 2020 BrandCo Facilities

$ 1,500,000

$ 0

Paid-in kind closing fees

29,100,000

Aggregate principal amount rolled-up

809,800,000

2020 BrandCo Facility due 2025 | Secured debt

^[1]

105,900,000

94,800,000

$ 65,000,000

Paid-in-kind interest accrued on the 2020 BrandCo Facilities

$ 815,000,000

$ 910,600,000

910,600,000

1,500,000

Paid-in kind closing fees

29,100,000

Covenant springing maturity, number of days prior to the maturity date

91 days

Covenant springing maturity threshold amount, minimum one

$ 100,000,000

Debt Issuance costs

$ 116,700,000

2020 BrandCo Facility due 2025 | Secured debt | LIBOR

1.50%

Basis spread on variable rate, payment In kind

10.50%

2.00%

Roll-up BrandCo Facility due 2025 | Secured debt

Maximum borrowing capacity

$ 950,000,000

Roll-up BrandCo Facility due 2025 | Secured debt | LIBOR

0.75%

Junior Roll-up BrandCo Facility due 2025 | Secured debt

3.50%

Maximum borrowing capacity

$ 3,000,000

Junior Roll-up BrandCo Facility due 2025 | Secured debt | LIBOR

0.75%

Roll-up and Junior Roll-up BrandCo Facilities due 2025 | Secured debt

3.50%

Aggregate principal amount rolled-up

809,800,000

809,800,000

Remaining borrowing capacity

143,200,000

2019 Term Loan Facility due 2023

$ 200,000,000

200,000,000.0

6.25% Senior Notes due 2024

$ 1,300,000

Stated interest rate (as a percent)

$ 450,000,000

6.25%

Extended Term Loans due 2025

Covenant springing maturity, number of days prior to the maturity date

$ 30,800,000

91 days

Covenant springing maturity threshold amount, minimum one

$ 75,000,000

Covenant springing maturity threshold amount, minimum two

$ 100,000,000

Extended Term Loans due 2025 | LIBOR

0.75%

2016 Term Loan Facility due 2023 and 2025

3.50%

924,800,000

6,900,000

$ 9,000,000.0

2016 Term Loan Facility due 2023

$ 17,000,000.0

$ 894,000,000.0

[1]	See Note 4, "Leases," for supplemental disclosure of non-cash financing and investing activities in relation to the lease liabilities arising from obtaining right-of-use assets following the implementation of ASC Topic 842, Leases.

DEBT - Repurchases of 5.75% Senior Notes due 2021 (Details) - USD ($)
$ in Millions

2 Months Ended

3 Months Ended

6 Months Ended

May 07, 2020

Jun. 30, 2020

Jun. 30, 2019

Jun. 30, 2020

Jun. 30, 2019

Jul. 27, 2020

Net gain on extinguishment of debt

^[1]

$ 105.9

$ 94.8

$ 11.9

$ 0.0

$ 11.9

$ 0.0

5.75% Senior Notes due 2021

Stated interest rate (as a percent)

Debt repurchased

$ 50.0

$ 62.8

$ 112.8

5.75%

Net gain on extinguishment of debt

$ 0.7

$ 11.9

5.75% Senior Notes due 2021 | Subsequent Event

Stated interest rate (as a percent)

5.75%

[1]	See Note 4, "Leases," for supplemental disclosure of non-cash financing and investing activities in relation to the lease liabilities arising from obtaining right-of-use assets following the implementation of ASC Topic 842, Leases.

DEBT - Prepayment of the 2019 Term Loan Facility due 2023 (Details) - USD ($)
$ in Millions

6 Months Ended

May 07, 2020

Jun. 30, 2020

Jun. 30, 2019

2019 Term Loan Facility due 2023

^[1]

$ 105.9

$ 94.8

$ 200.0

$ 0.0

Debt issuance costs, prepayment premiums

1.3

33.5

Debt issuance costs, lenders fees

10.3

2020 BrandCo Facility due 2025 | Secured debt

Debt issuance costs, prepayment premiums

33.5

Debt issuance costs, lenders fees

10.3

Legal Fees

0.3

Other third party fees

2.0

Debt Issuance costs

$ 116.7

[1]	See Note 4, "Leases," for supplemental disclosure of non-cash financing and investing activities in relation to the lease liabilities arising from obtaining right-of-use assets following the implementation of ASC Topic 842, Leases.

DEBT - Amendment to the 2018 Foreign Asset-Based Term Facility (Details) $ in Millions					1 Months Ended	3 Months Ended	6 Months Ended
	May 04, 2020 USD ($)	May 04, 2020 EUR (€)	May 03, 2020	Apr. 30, 2020	May 31, 2020	Jun. 30, 2020 EUR (€)	Jun. 30, 2020 USD ($)	Jun. 30, 2019 USD ($)	Jun. 30, 2020 EUR (€)
2018 Foreign Asset-Based Term Facility due 2021
Debt Instrument [Line Items]
Maximum borrowing capacity \| €		€ 77,000,000							€ 77,000,000
Variable rate floor	0.50%	0.50%
Basis spread on variable interest rate	7.00%	7.00%
Covenant springing maturity, number of days prior to the maturity date	91 days	91 days
Mandatory prepayment \| €		€ 5,000,000.0
Fees paid	$ 0.4
Aggregate principal amount outstanding							$ 54.5		€ 48,500,000
Repayments of senior debt		€ 5,000,000				€ 28,500,000	$ 31.4	$ 0.0
2018 Foreign Asset-Based Term Facility due 2021 \| EURIBOR
Debt Instrument [Line Items]
Variable rate floor			0.50%	0.50%	0.50%
Basis spread on variable interest rate			6.50%	6.50%	7.00%
5.75% Senior Notes due 2021
Debt Instrument [Line Items]
Stated interest rate (as a percent)							5.75%		5.75%
Aggregate principal amount outstanding							$ 387.2
Repayments of senior debt							$ 99.6	$ 0.0

DEBT - Incremental Revolving Credit Facility under the 2016 Term Loan Agreement (Details) - USD ($)	May 28, 2020	May 11, 2020	Apr. 30, 2020	Jun. 30, 2020
2020 Incremental Facility due 2021 \| Revolving credit facility
Line of Credit Facility [Line Items]
Maximum borrowing capacity			$ 65,000,000
Proceeds from long-term lines of credit		$ 1,500,000	$ 63,500,000
Covenant springing maturity, number of days prior to the maturity date			91 days
Upfront commitment fees	$ 2,900,000
2020 Incremental Facility due 2021 \| LIBOR \| Revolving credit facility
Line of Credit Facility [Line Items]
Basis spread on variable interest rate			16.00%
2020 Incremental Facility due 2021 \| Alternate base rate \| Revolving credit facility
Line of Credit Facility [Line Items]
Basis spread on variable interest rate			15.00%
5.75% Senior Notes due 2021
Line of Credit Facility [Line Items]
Stated interest rate (as a percent)				5.75%

DEBT - Amendments to 2016 Revolving Credit Agreement (Details) - USD ($)	May 17, 2020	May 07, 2020	Apr. 17, 2020	Jun. 30, 2020	Dec. 31, 2019	Apr. 30, 2018
Line of Credit Facility [Line Items]
Outstanding borrowings				$ 3,624,100,000	$ 3,194,200,000
Revolving credit facility \| Tranche A
Line of Credit Facility [Line Items]
Increase in interest margin		0.75%
Maximum borrowing capacity						$ 400,000,000
Revolving credit facility \| Tranche B
Line of Credit Facility [Line Items]
Increase in interest margin			0.75%
Lenders fees	$ 1,100,000
Outstanding borrowings			$ 36,300,000
Maximum borrowing capacity						$ 41,500,000
Repayments of long-term lines of credit			$ 5,200,000
Revolving credit facility \| Tranche B \| Adjusted LIBOR
Line of Credit Facility [Line Items]
Variable rate floor			0.75%

DEBT - Covenants (Details) - USD ($)	6 Months Ended
DEBT - Covenants (Details) - USD ($)	Jun. 30, 2020	Dec. 31, 2019
Amended 2019 Senior Line of Credit Facility
Debt Instrument [Line Items]
Commitment	$ 30,000,000.0
Aggregate principal amount outstanding	0
Availability	30,000,000.0
Revolving credit facility \| Amended 2016 Revolving Credit Facility due 2021
Debt Instrument [Line Items]
Commitment	400,000,000.0
Borrowing Base	307,900,000
Aggregate principal amount outstanding	249,500,000
Availability	$ 50,700,000
Covenant terms, consolidated fixed charge coverage ratio	100.00%
Sublimit, letters of credit
Debt Instrument [Line Items]
Standby and trade letters of credit for various corporate purposes	$ 7,700,000	$ 11,400,000
Sublimit, letters of credit \| Amended 2016 Revolving Credit Facility due 2021
Debt Instrument [Line Items]
Standby and trade letters of credit for various corporate purposes	$ 7,700,000

DEBT - Narrative (Details) - USD ($) $ in Millions	6 Months Ended
DEBT - Narrative (Details) - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Cash and cash equivalents	$ 338.5	$ 104.3
COVID-19
Debt Instrument [Line Items]
Percentage of employees furloughed	40.00%
Percentage reduction in Board and committee compensation	50.00%
Minimum \| COVID-19
Debt Instrument [Line Items]
Percentage reduction in executive and employee compensation	20.00%
Maximum \| COVID-19
Debt Instrument [Line Items]
Percentage reduction in executive and employee compensation	40.00%
2020 Refinancing Transactions
Debt Instrument [Line Items]
Cash on hand	$ 276.4
Foreign Subsidiaries
Debt Instrument [Line Items]
Cash and cash equivalents	$ 62.1

FAIR VALUE MEASUREMENTS - Schedule of Fair Values of Financial Liabilities (Details) - USD ($)	Jun. 30, 2020	Dec. 31, 2019
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Financial assets required to be measured at fair value	$ 0	$ 0
Financial liabilities required to be measured at fair value	0	0
Liabilities:
Long-term debt, including current portion, Fair Value	2,250,200,000	2,522,200,000
Long-term debt, including current portion, Carrying Value	3,624,100,000	3,194,200,000
Level 1
Liabilities:
Long-term debt, including current portion, Fair Value	0	0
Level 2
Liabilities:
Long-term debt, including current portion, Fair Value	2,250,200,000	2,522,200,000
Level 3
Liabilities:
Long-term debt, including current portion, Fair Value	$ 0	$ 0

FINANCIAL INSTRUMENTS - Narrative (Details) - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Standby letters of credit which support products corporations workers compensation, general liability and automobile insurance programs
Fair Value Measurements Of Financial Instruments [Line Items]
Standby and trade letters of credit for various corporate purposes	$ 5.3	$ 8.3
Sublimit, letters of credit
Fair Value Measurements Of Financial Instruments [Line Items]
Standby and trade letters of credit for various corporate purposes	$ 7.7	$ 11.4

PENSION AND POST-RETIREMENT BENEFITS - Components of Net Periodic Benefit Costs (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Net periodic benefit costs:
Total net periodic benefit costs	$ 1.5	$ 2.1	$ 2.7	$ 4.1	$ 7.2
Pension Plans
Net periodic benefit costs:
Service cost	0.4	0.5	0.8	1.0
Interest cost	3.7	5.0	7.4	9.9
Expected return on plan assets	(5.6)	(6.0)	(11.4)	(12.0)
Amortization of actuarial loss	2.9	2.6	5.6	5.0
Total net periodic benefit costs prior to allocation	1.4	2.1	2.4	3.9
Portion allocated to Revlon Holdings	(0.1)	(0.1)	(0.1)	(0.1)
Total net periodic benefit costs	1.3	2.0	2.3	3.8
Other Post-Retirement Benefit Plans
Net periodic benefit costs:
Service cost	0.0	0.0	0.0	0.0
Interest cost	0.1	0.1	0.2	0.2
Expected return on plan assets	0.0	0.0	0.0	0.0
Amortization of actuarial loss	0.1	0.0	0.2	0.1
Total net periodic benefit costs prior to allocation	0.2	0.1	0.4	0.3
Portion allocated to Revlon Holdings	0.0	0.0	0.0	0.0
Total net periodic benefit costs	$ 0.2	$ 0.1	$ 0.4	$ 0.3

PENSION AND POST-RETIREMENT BENEFITS - Narrative (Details) $ in Millions	3 Months Ended			6 Months Ended		12 Months Ended
	Jun. 30, 2020 USD ($)	Mar. 31, 2020 USD ($)	Jun. 30, 2019 USD ($)	Jun. 30, 2020 USD ($) plan	Jun. 30, 2019 USD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)
Retirement Benefits [Abstract]
Net periodic benefit cost	$ 1.5		$ 2.1	$ 2.7	$ 4.1		$ 7.2
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net periodic benefit cost	1.5		2.1	2.7	4.1		$ 7.2
Aggregate employer contributions during 2020	19.0			19.0
Scenario, Forecast
Retirement Benefits [Abstract]
Net periodic benefit cost						$ 5.5
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net periodic benefit cost						$ 5.5
Pension Plans
Retirement Benefits [Abstract]
Net periodic benefit cost	1.3		2.0	2.3	3.8
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net periodic benefit cost	1.3		2.0	2.3	3.8
Employer contributions	1.8			5.2
Pension Plans \| Qualified Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Employer contributions		$ 1.6
Employer contributions, expected deferral in 2020, CARES Act	9.4			$ 9.4
Number of qualified plans \| plan				2
Other Post-Retirement Benefit Plans
Retirement Benefits [Abstract]
Net periodic benefit cost	0.2		0.1	$ 0.4	0.3
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Net periodic benefit cost	0.2		$ 0.1	0.4	$ 0.3
Employer contributions	$ 0.1			$ 0.3

PENSION AND POST-RETIREMENT BENEFITS - Classification of Net Periodic Pension (Income) Costs (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Total net periodic benefit costs	$ 1.5	$ 2.1	$ 2.7	$ 4.1	$ 7.2
Selling, general and administrative expense
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Total net periodic benefit costs	0.4	0.4	0.8	0.9
Miscellaneous, net
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Total net periodic benefit costs	$ 1.1	$ 1.7	$ 1.9	$ 3.2

STOCK COMPENSATION PLAN - Narrative (Details) $ in Millions			1 Months Ended		3 Months Ended	6 Months Ended		10 Months Ended
STOCK COMPENSATION PLAN - Narrative (Details) $ in Millions	Sep. 05, 2019 USD ($) installment shares	Aug. 31, 2019	Sep. 30, 2019 shares	Jul. 31, 2014	Jun. 30, 2020 USD ($) shares	Jun. 30, 2020 USD ($) shares	Jun. 30, 2019 USD ($)	Jun. 30, 2020 USD ($) shares	Dec. 31, 2019 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for issuance (in shares)					6,565,000	6,565,000		6,565,000
Shares remaining available for grants (in shares)					1,100,000	1,100,000		1,100,000
Renewal term				7 years
Vesting period		3 years	2 years
Common stock not subject to vesting requirements (in shares)			250,000
Stock-based compensation amortization \| $						$ 3.5	$ 3.8
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Accelerated cost \| $								$ 1.0
Revlon 2019 Transaction Incentive Program \| Acquisition, Integration and Divestiture Costs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cash-based awards granted, amortization expense \| $					$ 1.1	2.6		3.8
Revlon 2019 Transaction Incentive Program \| Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Accelerated cost \| $					$ 0.1	$ 0.8
Revlon 2019 Transaction Incentive Program, Tier 1
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cash-based awards \| $	$ 6.8
Number of installments \| installment	2
Cash-based awards granted, net of forfeitures \| $								$ 4.9
Revlon 2019 Transaction Incentive Program, Tier 1 \| Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Proportion settled in cash						67.00%
Proportion settled in RSU's						33.00%
Number of shares authorized (in shares)	206,812
Awards granted and outstanding (in shares)					153,739	153,739		153,739
Accelerated vesting, number of awards (in shares)						22,798		22,798
Revlon 2019 Transaction Incentive Program, Tier 1 \| Restricted Stock \| First Tranche
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage						50.00%
Revlon 2019 Transaction Incentive Program, Tier 1 \| Restricted Stock \| Second Tranche
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage						50.00%
Revlon 2019 Transaction Incentive Program, Tier 2
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cash-based awards \| $	$ 2.5
Number of installments \| installment	1
Cash-based awards granted, net of forfeitures \| $								$ 2.4
Revlon 2019 Transaction Incentive Program, Tier 2 \| Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage						100.00%
LTIP Plan \| Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Accelerated vesting, number of awards (in shares)						25,321		30,781
LTIP Plan \| Time-Based RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period						3 years
Awards granted and outstanding (in shares)					950,500	950,500		950,500	721,500
Awards granted (in shares)						648,400
LTIP Plan \| Time-Based RSUs \| 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted and outstanding (in shares)					648,400	648,400		648,400
Awards granted (in shares)						648,400
LTIP Plan \| Performance-Based RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period						3 years
Awards granted and outstanding (in shares)					1,234,800	1,234,800		1,234,800	901,200
Awards granted (in shares)						648,400
Stock-based compensation amortization \| $					$ 1.5	$ 1.2
Deferred stock-based compensation \| $					$ 21.9	$ 21.9		$ 21.9
LTIP Plan \| Performance-Based RSUs \| 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted and outstanding (in shares)					648,400	648,400		648,400
Awards granted (in shares)						648,400
LTIP Plan \| Time-based and Performance-based RSU Awards \| 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted (in shares)					0	1,300,000
Total LTIP and TIP RSU's \| Time-Based RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted and outstanding (in shares)					1,104,200	1,104,200		1,104,200	922,100
Stock-based compensation amortization \| $					$ 2.1	$ 3.8
Deferred stock-based compensation \| $					$ 15.5	$ 15.5		$ 15.5
Total LTIP and TIP RSU's \| Performance-Based RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted and outstanding (in shares)					1,234,800	1,234,800		1,234,800	901,200

STOCK COMPENSATION PLAN - Awards Granted, Forfeited and Outstanding (Details) - $ / shares		1 Months Ended	3 Months Ended	6 Months Ended	10 Months Ended
	Aug. 31, 2019	Sep. 30, 2019	Jun. 30, 2020	Jun. 30, 2020	Jun. 30, 2020	Dec. 31, 2019
Weighted Average Grant Date Fair Value Per RSU
Vesting period	3 years	2 years
TIP Plan \| 2019 \| TIP
Restricted Stock Units
Outstanding, beginning of period (in shares)				200,600
Awards granted (in shares)				11,700
Awards vested (in shares)				(22,800)
Awards forfeited/canceled (in shares)				(35,800)
Outstanding, end of period (in shares)			153,700	153,700	153,700
Weighted Average Grant Date Fair Value Per RSU
Awards outstanding, weighted average grant date fair value (in USD per share)			$ 15.97	$ 15.97	$ 15.97	$ 16.44
Awards granted, weighted average grant date fair value (in USD per share)				10.24
Awards vested, weighted average grant date fair value (in USD per share)				16.44
Awards forfeited/canceled, weighted average grant date fair value (in USD per share)				$ 16.44
LTIP Plan \| Time-Based LTIP
Restricted Stock Units
Outstanding, beginning of period (in shares)				721,500
Awards granted (in shares)				648,400
Awards vested (in shares)				(290,000.0)
Awards forfeited/canceled (in shares)				(129,400)
Outstanding, end of period (in shares)			950,500	950,500	950,500
Weighted Average Grant Date Fair Value Per RSU
Vesting period				3 years
LTIP Plan \| Performance-Based LTIP
Restricted Stock Units
Outstanding, beginning of period (in shares)				901,200
Awards granted (in shares)				648,400
Awards vested (in shares)				(14,200)
Awards forfeited/canceled (in shares)				(300,600)
Outstanding, end of period (in shares)			1,234,800	1,234,800	1,234,800
Weighted Average Grant Date Fair Value Per RSU
Vesting period				3 years
LTIP Plan \| Restricted Stock
Weighted Average Grant Date Fair Value Per RSU
Accelerated vesting, number of awards (in shares)				25,321	30,781
LTIP Plan \| 2020 \| Time-Based LTIP
Restricted Stock Units
Awards granted (in shares)				648,400
Outstanding, end of period (in shares)			648,400	648,400	648,400
Weighted Average Grant Date Fair Value Per RSU
Awards outstanding, weighted average grant date fair value (in USD per share)			$ 14.96	$ 14.96	$ 14.96
Awards granted, weighted average grant date fair value (in USD per share)				$ 14.96
LTIP Plan \| 2020 \| Performance-Based LTIP
Restricted Stock Units
Awards granted (in shares)				648,400
Outstanding, end of period (in shares)			648,400	648,400	648,400
Weighted Average Grant Date Fair Value Per RSU
Awards outstanding, weighted average grant date fair value (in USD per share)			$ 14.96	$ 14.96	$ 14.96
Awards granted, weighted average grant date fair value (in USD per share)				$ 14.96
LTIP Plan \| 2020 \| Time-based and Performance-based RSU Awards
Restricted Stock Units
Awards granted (in shares)			0	1,300,000
LTIP Plan \| 2019 \| Time-Based LTIP
Restricted Stock Units
Outstanding, beginning of period (in shares)				425,600
Awards granted (in shares)				0
Awards vested (in shares)				(131,000.0)
Awards forfeited/canceled (in shares)				(79,800)
Outstanding, end of period (in shares)			214,800	214,800	214,800
Weighted Average Grant Date Fair Value Per RSU
Awards outstanding, weighted average grant date fair value (in USD per share)			$ 22.55	$ 22.55	$ 22.55	22.55
Awards granted, weighted average grant date fair value (in USD per share)				0
Awards vested, weighted average grant date fair value (in USD per share)				22.55
Awards forfeited/canceled, weighted average grant date fair value (in USD per share)				$ 22.55
LTIP Plan \| 2019 \| Performance-Based LTIP
Restricted Stock Units
Outstanding, beginning of period (in shares)				425,600
Awards granted (in shares)				0
Awards vested (in shares)				0
Awards forfeited/canceled (in shares)				(102,500)
Outstanding, end of period (in shares)			323,100	323,100	323,100
Weighted Average Grant Date Fair Value Per RSU
Awards outstanding, weighted average grant date fair value (in USD per share)			$ 22.55	$ 22.55	$ 22.55	22.55
Awards granted, weighted average grant date fair value (in USD per share)				0
Awards vested, weighted average grant date fair value (in USD per share)				0
Awards forfeited/canceled, weighted average grant date fair value (in USD per share)				$ 22.55
LTIP Plan \| 2018 \| Time-Based LTIP
Restricted Stock Units
Outstanding, beginning of period (in shares)				241,900
Awards granted (in shares)				0
Awards vested (in shares)				(105,600)
Awards forfeited/canceled (in shares)				(49,000.0)
Outstanding, end of period (in shares)			87,300	87,300	87,300
Weighted Average Grant Date Fair Value Per RSU
Awards outstanding, weighted average grant date fair value (in USD per share)			$ 19.44	$ 19.44	$ 19.44	19.00
Awards granted, weighted average grant date fair value (in USD per share)				0
Awards vested, weighted average grant date fair value (in USD per share)				19.31
Awards forfeited/canceled, weighted average grant date fair value (in USD per share)				$ 17.56
LTIP Plan \| 2018 \| Performance-Based LTIP
Restricted Stock Units
Outstanding, beginning of period (in shares)				364,700
Awards granted (in shares)				0
Awards vested (in shares)				0
Awards forfeited/canceled (in shares)				(101,400)
Outstanding, end of period (in shares)			263,300	263,300	263,300
Weighted Average Grant Date Fair Value Per RSU
Awards outstanding, weighted average grant date fair value (in USD per share)			$ 19.44	$ 19.44	$ 19.44	19.00
Awards granted, weighted average grant date fair value (in USD per share)				0
Awards vested, weighted average grant date fair value (in USD per share)				0
Awards forfeited/canceled, weighted average grant date fair value (in USD per share)				$ 17.87
LTIP Plan \| 2017 \| Time-Based LTIP
Restricted Stock Units
Outstanding, beginning of period (in shares)				54,000.0
Awards granted (in shares)				0
Awards vested (in shares)				(53,400)
Awards forfeited/canceled (in shares)				(600)
Outstanding, end of period (in shares)			0	0	0
Weighted Average Grant Date Fair Value Per RSU
Awards outstanding, weighted average grant date fair value (in USD per share)			$ 0	$ 0	$ 0	19.70
Awards granted, weighted average grant date fair value (in USD per share)				0
Awards vested, weighted average grant date fair value (in USD per share)				19.70
Awards forfeited/canceled, weighted average grant date fair value (in USD per share)				$ 19.70
LTIP Plan \| 2017 \| Performance-Based LTIP
Restricted Stock Units
Outstanding, beginning of period (in shares)				110,900
Awards granted (in shares)				0
Awards vested (in shares)				(14,200)
Awards forfeited/canceled (in shares)				(96,700)
Outstanding, end of period (in shares)			0	0	0
Weighted Average Grant Date Fair Value Per RSU
Awards outstanding, weighted average grant date fair value (in USD per share)			$ 0	$ 0	$ 0	$ 19.70
Awards granted, weighted average grant date fair value (in USD per share)				0
Awards vested, weighted average grant date fair value (in USD per share)				19.70
Awards forfeited/canceled, weighted average grant date fair value (in USD per share)				$ 19.70
LTIP Plan \| 2017 \| Time-based and Performance-based RSU Awards
Weighted Average Grant Date Fair Value Per RSU
Vesting period				2 years
Total LTIP and TIP RSU's \| Time-Based LTIP
Restricted Stock Units
Outstanding, beginning of period (in shares)				922,100
Outstanding, end of period (in shares)			1,104,200	1,104,200	1,104,200
Total LTIP and TIP RSU's \| Performance-Based LTIP
Restricted Stock Units
Outstanding, beginning of period (in shares)				901,200
Outstanding, end of period (in shares)			1,234,800	1,234,800	1,234,800
Revlon 2019 Transaction Incentive Program, Tier 1 \| Restricted Stock
Restricted Stock Units
Outstanding, end of period (in shares)			153,739	153,739	153,739
Weighted Average Grant Date Fair Value Per RSU
Accelerated vesting, number of awards (in shares)				22,798	22,798

INCOME TAXES - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
INCOME TAXES - Narrative (Details) - USD ($) $ in Millions	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Income Tax Disclosure [Line Items]
Benefit from income taxes	$ 9.6	$ 0.9	$ 46.5	$ 0.6
Increase in benefit from income taxes	$ 8.7		$ 45.9
Valuation allowance assumption, period of taxable loss			3 years

Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References + Details

ACCUMULATED OTHER COMPREHENSIVE LOSS - Components of Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Millions

3 Months Ended

6 Months Ended

Jun. 30, 2020

Mar. 31, 2020

Jun. 30, 2019

Mar. 31, 2019

Jun. 30, 2020

Jun. 30, 2019

Foreign currency translation adjustment, net of tax

$ (1,301.9)

$ (1,089.4)

$ (1,005.3)

$ (933.1)

$ (1,089.4)

$ (933.1)

10.3

2.6

5.1

1.3

Amortization of pension related costs, net of tax

^[1],[2]

4.0

2.7

6.5

4.9

14.3

^[3]

(2.7)

^[3]

5.3

^[3]

0.9

^[3]

11.6

6.2

Amortization of pension related costs, tax benefit

(1,411.7)

(1,301.9)

(1,059.1)

(1,005.3)

(1,411.7)

(1,059.1)

1.5

(0.3)

1.2

(0.6)

Accumulated Other Comprehensive (Loss) Income

Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]

(250.1)

(247.4)

(233.3)

(234.2)

(247.4)

(234.2)

^[3]

14.3

(2.7)

5.3

0.9

Foreign Currency Translation

(235.8)

(250.1)

$ (228.0)

$ (233.3)

(235.8)

$ (228.0)

Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]

Foreign currency translation adjustment, net of tax

(27.3)

5.1

5.1

Actuarial (Loss) Gain on Post-retirement Benefits

(22.2)

Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]

Amortization of pension related costs, net of tax

(219.8)

6.5

6.5

Amortization of pension related costs, tax benefit

(213.3)

1.2

Other

Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]

$ (0.3)

(0.3)

0.0

$ (0.3)

[1]	Net of a $1.5 million tax benefit and $0.3 million of tax expense for the three months ended June 30, 2020 and 2019, respectively, and net of a $1.2 million tax benefit and $0.6 million of tax expense for the six months ended June 30, 2020 and 2019, respectively.
[2]	This amount is included in the computation of net periodic benefit costs (income). See Note 10, "Pension and Post-Retirement Benefits," for additional information regarding net periodic benefit costs (income).
[3]	See Note 13, "Accumulated Other Comprehensive Loss," regarding the changes in the accumulated balances for each component of other comprehensive loss during the three months ended June 30, 2020 and 2019, respectively.

SEGMENT DATA AND RELATED INFORMATION - Net Sales and Segment Profit (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Segment Reporting Information [Line Items]
Net sales	$ 347.6	$ 570.2	$ 800.6	$ 1,123.4
Segment profit	(56.9)	(7.9)	(241.1)	(29.4)
Depreciation and amortization	36.4	38.7	73.2	85.7
Non-cash stock compensation expense	1.1	3.4	3.5	3.8
Non-Operating items:
Restructuring and related charges			45.5
Acquisition, integration and divestiture costs	1.2	0.0	3.3	0.6
(Gain) loss on divested assets	(0.2)	0.0	0.6	0.0
Impairment charges	19.8	0.0	144.1	0.0
Operating income (loss)	(56.9)	(7.9)	(241.1)	(29.4)
Interest Expense	60.9	47.8	109.3	95.5
Amortization of debt issuance costs	6.0	3.5	10.0	6.7
Foreign currency losses, net	2.3	1.2	18.9	1.4
Miscellaneous, net	20.6	4.6	16.5	5.9
Loss from continuing operations before income taxes	(134.8)	(65.0)	(383.9)	(138.9)
(Gain) loss on early extinguishment of debt, net	(11.9)	0.0	(11.9)	0.0
Operating segments
Segment Reporting Information [Line Items]
Net sales	347.6	570.2	800.6	1,123.4
Segment profit	47.3	48.5	77.7	89.1
Non-Operating items:
Operating income (loss)	47.3	48.5	77.7	89.1
Segment reconciling items
Segment Reporting Information [Line Items]
Depreciation and amortization	36.4	38.7	73.2	85.7
Non-cash stock compensation expense	1.1	3.4	3.5	3.8
Non-Operating items:
Restructuring and related charges	22.3	9.9	56.7	22.0
Acquisition, integration and divestiture costs	1.2	0.0	3.3	0.6
(Gain) loss on divested assets	(0.2)	0.0	0.6	0.0
Financial control remediation and sustainability actions and related charges	5.7	4.4	7.8	6.4
Excessive coupon redemptions	0.0	0.0	4.2	0.0
COVID-19 charges	17.9	0.0	25.4	0.0
Impairment charges	19.8	0.0	144.1	0.0
Revlon
Segment Reporting Information [Line Items]
Net sales	135.0	251.5	316.8	498.8
Revlon \| Operating segments
Segment Reporting Information [Line Items]
Net sales	135.0	251.5	316.8	498.8
Segment profit	13.0	26.3	29.4	52.7
Non-Operating items:
Operating income (loss)	13.0	26.3	29.4	52.7
Elizabeth Arden
Segment Reporting Information [Line Items]
Net sales	80.9	117.4	176.1	228.8
Elizabeth Arden \| Operating segments
Segment Reporting Information [Line Items]
Net sales	80.9	117.4	176.1	228.8
Segment profit	11.3	3.0	15.9	5.2
Non-Operating items:
Operating income (loss)	11.3	3.0	15.9	5.2
Portfolio
Segment Reporting Information [Line Items]
Net sales	88.5	118.7	198.5	235.9
Portfolio \| Operating segments
Segment Reporting Information [Line Items]
Net sales	88.5	118.7	198.5	235.9
Segment profit	15.0	6.4	22.7	11.3
Non-Operating items:
Operating income (loss)	15.0	6.4	22.7	11.3
Fragrance
Segment Reporting Information [Line Items]
Net sales	43.2	82.6	109.2	159.9
Fragrance \| Operating segments
Segment Reporting Information [Line Items]
Net sales	43.2	82.6	109.2	159.9
Segment profit	8.0	12.8	9.7	19.9
Non-Operating items:
Operating income (loss)	$ 8.0	$ 12.8	$ 9.7	$ 19.9

SEGMENT DATA AND RELATED INFORMATION - Narrative (Details)	Jun. 30, 2020 country
International
Segment Reporting Information [Line Items]
Number of countries in which entity operates	25

SEGMENT DATA AND RELATED INFORMATION - Schedule of Net Sales and Long-Lived Assets by Geographic Area (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 347.6	$ 570.2	$ 800.6	$ 1,123.4
Long-lived assets	$ 1,487.2		$ 1,487.2		$ 1,694.1
Travel Retail Sales business
Revenues from External Customers and Long-Lived Assets [Line Items]
Percentage of net sales by business	1.80%	5.30%	2.30%	5.00%
North America
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 176.9	$ 286.5	$ 410.4	$ 565.2
EMEA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	79.7	138.8	189.8	278.4
Asia
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	58.6	83.8	120.3	160.9
Latin America
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	13.9	32.2	34.4	58.1
Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	18.5	28.9	45.7	60.8
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-lived assets	$ 1,224.8		$ 1,224.8		$ 1,414.0
Percentage of long lived assets by geographic location	82.00%		82.00%		83.00%
International
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-lived assets	$ 262.4		$ 262.4		$ 280.1
Percentage of long lived assets by geographic location	18.00%		18.00%		17.00%
Revlon
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 135.0	251.5	$ 316.8	498.8
Revlon \| North America
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	80.1	134.7	179.2	267.9
Revlon \| EMEA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	26.5	51.5	63.8	105.2
Revlon \| Asia
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	6.8	24.4	21.5	48.3
Revlon \| Latin America
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	10.0	21.7	24.0	37.4
Revlon \| Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	11.6	19.2	28.3	40.0
Elizabeth Arden
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	80.9	117.4	176.1	228.8
Elizabeth Arden \| North America
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	15.0	26.2	36.4	54.4
Elizabeth Arden \| EMEA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	13.7	30.6	39.6	58.5
Elizabeth Arden \| Asia
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	49.1	53.9	92.2	101.6
Elizabeth Arden \| Latin America
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	0.2	2.2	1.0	5.0
Elizabeth Arden \| Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	2.9	4.5	6.9	9.3
Portfolio
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	88.5	118.7	198.5	235.9
Portfolio \| North America
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	52.1	73.0	122.9	143.1
Portfolio \| EMEA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	30.2	34.8	60.8	72.6
Portfolio \| Asia
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	0.7	1.4	1.2	2.2
Portfolio \| Latin America
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	3.4	6.5	8.3	11.7
Portfolio \| Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	2.1	3.0	5.3	6.3
Fragrance
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	43.2	82.6	109.2	159.9
Fragrance \| North America
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	29.7	52.6	71.9	99.8
Fragrance \| EMEA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	9.3	21.9	25.6	42.1
Fragrance \| Asia
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	2.0	4.1	5.4	8.8
Fragrance \| Latin America
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	0.3	1.8	1.1	4.0
Fragrance \| Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 1.9	$ 2.2	$ 5.2	$ 5.2

SEGMENT DATA AND RELATED INFORMATION - Schedule of Net Sales by Classes of Similar Products (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Revenue from External Customer [Line Items]
Net sales	$ 347.6	$ 570.2	$ 800.6	$ 1,123.4
Color cosmetics
Revenue from External Customer [Line Items]
Net sales	$ 70.6	$ 193.5	$ 200.6	$ 396.3
Percentage of net sales by classes of similar products	20.00%	34.00%	25.00%	35.00%
Fragrance
Revenue from External Customer [Line Items]
Net sales	$ 64.0	$ 117.1	$ 158.9	$ 227.4
Percentage of net sales by classes of similar products	18.00%	21.00%	20.00%	20.00%
Hair care
Revenue from External Customer [Line Items]
Net sales	$ 105.4	$ 129.8	$ 222.1	$ 258.5
Percentage of net sales by classes of similar products	30.00%	23.00%	28.00%	23.00%
Beauty care
Revenue from External Customer [Line Items]
Net sales	$ 45.4	$ 48.0	$ 91.5	$ 89.1
Percentage of net sales by classes of similar products	13.00%	8.00%	11.00%	8.00%
Skin care
Revenue from External Customer [Line Items]
Net sales	$ 62.2	$ 81.8	$ 127.5	$ 152.1
Percentage of net sales by classes of similar products	19.00%	14.00%	16.00%	14.00%

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

Condensed Income Statements, Captions [Line Items]

REVLON, INC. BASIC AND DILUTED EARNINGS (LOSS) PER COMMON SHARE - Narrative (Details) - shares	Jun. 30, 2020	Jun. 30, 2019
Earnings Per Share, Basic and Diluted [Abstract]
Stock options outstanding (shares)	0	0

REVLON, INC. BASIC AND DILUTED EARNINGS (LOSS) PER COMMON SHARE - Components of Basic and Diluted Earnings Per Share (Detail) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended				6 Months Ended
	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019
Numerator:
Loss from continuing operations, net of taxes	$ (125.2)		$ (64.1)		$ (337.4)	$ (138.3)
Income from discontinued operations, net of taxes	0.0		1.6		0.0	2.3
Net (loss) income	$ (125.2)	$ (212.2)	$ (62.5)	$ (73.5)	$ (337.4)	$ (136.0)
Denominator:
Weighted average common shares outstanding - Basic (in shares)	53,471,004		53,126,700		53,319,228	53,020,633
Effect of dilutive restricted stock (in shares)	0		0		0	0
Weighted average common shares outstanding - Diluted (in shares)	53,471,004		53,126,700		53,319,228	53,020,633
Basic and Diluted (loss) earnings per common share:
Continuing operations (in dollars per share)	$ (2.37)		$ (1.23)		$ (6.39)	$ (2.66)
Discontinued operations (in dollars per share)	0		0.03		0	0.04
Net loss (in dollars per share)	$ (2.37)		$ (1.20)		$ (6.39)	$ (2.62)
Restricted Stock and Restricted Stock Units
Basic and Diluted (loss) earnings per common share:
Unvested restricted stock and RSUs under the Stock Plan (in shares)	0		304,608		56,058	445,525

RELATED PARTY TRANSACTIONS - Narrative (Details) - USD ($)		1 Months Ended			3 Months Ended	6 Months Ended
	Jul. 28, 2020	Jul. 31, 2021	Jul. 31, 2020	Apr. 30, 2020	Mar. 31, 2020	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Related Party Transaction [Line Items]
Reimbursement Agreements termination notice period						90 days
Reimbursements
Related Party Transaction [Line Items]
Income from related party						$ 300,000
Expenses related party							$ 300,000
Payable to related party						4,300,000		$ 5,500,000
Reimbursements \| Scenario, Forecast
Related Party Transaction [Line Items]
Payments to related party		$ 1,400,000
Reimbursements \| Subsequent Event
Related Party Transaction [Line Items]
Payments to related party	$ 3,860,000
MacAndrews & Forbes \| Reimbursements
Related Party Transaction [Line Items]
Payable to related party						16,000		$ 200,000
Majority Shareholder \| Related Party Expense, Other Advertising, Coupon Redemption and Raw Material Supply
Related Party Transaction [Line Items]
Payments to related party						400,000	200,000
Expenses related party						14,200,000	11,000,000.0
Payable to related party						$ 300,000	$ 400,000
Ms. Perelman \| COVID-19
Related Party Transaction [Line Items]
Percentage salary reduction				40.00%
Annual base salary				$ 675,000
Ms. Perelman \| COVID-19 \| Subsequent Event
Related Party Transaction [Line Items]
Percentage salary reduction			25.00%
Mr. Beattie \| 2020 Consulting Agreement
Related Party Transaction [Line Items]
Consulting agreement renewal term					1 year
Annual consulting fee					$ 250,000

PRODUCTS CORPORATION AND SUBSIDIARIES GUARANTOR FINANCIAL INFORMATION - Narrative (Details)	Jun. 30, 2020
5.75% Senior Notes
Condensed Financial Statements, Captions [Line Items]
Stated interest rate (as a percent)	5.75%
6.25% Senior Notes
Condensed Financial Statements, Captions [Line Items]
Stated interest rate (as a percent)	6.25%

PRODUCTS CORPORATION AND SUBSIDIARIES GUARANTOR FINANCIAL INFORMATION - Balance Sheet (Details) - USD ($) $ in Millions	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018
Assets [Abstract]
Cash and cash equivalents	$ 338.5		$ 104.3
Trade receivables, less allowances for doubtful accounts	288.3		423.4
Inventories	511.2		448.4
Prepaid expenses and other	307.8		292.6
Intercompany receivables	0.0		0.0
Investment in subsidiaries	0.0		0.0
Property, plant and equipment, net	365.5		408.6
Deferred income taxes	211.1		158.1
Goodwill	562.7		673.7
Intangible assets, net	441.6		490.7
Other assets	117.4		121.1
Total assets	3,144.1		3,120.9
LIABILITIES AND STOCKHOLDERS’ DEFICIENCY
Short-term borrowings	2.6		2.2
Current portion of long-term debt	648.3		288.0
Accounts payable	224.6		251.8
Accrued expenses and other current liabilities	381.6		418.2
Intercompany payables	0.0		0.0
Long-term debt	2,975.8		2,906.2
Other long-term liabilities	322.9		343.9
Total liabilities	4,555.8		4,210.3
Stockholder’s (deficiency) equity	(1,411.7)	$ (1,301.9)	(1,089.4)	$ (1,059.1)	$ (1,005.3)	$ (933.1)
Total liabilities and stockholders’ deficiency	3,144.1		3,120.9
Eliminations
Assets [Abstract]
Cash and cash equivalents	0.0		0.0
Trade receivables, less allowances for doubtful accounts	0.0		0.0
Inventories	0.0		0.0
Prepaid expenses and other	0.0		0.0
Intercompany receivables	(6,817.4)		(6,165.0)
Investment in subsidiaries	(1,589.0)		(1,629.0)
Property, plant and equipment, net	0.0		0.0
Deferred income taxes	0.0		0.0
Goodwill	0.0		0.0
Intangible assets, net	0.0		0.0
Other assets	0.0		0.0
Total assets	(8,406.4)		(7,794.0)
LIABILITIES AND STOCKHOLDERS’ DEFICIENCY
Short-term borrowings	0.0		0.0
Current portion of long-term debt	0.0		0.0
Accounts payable	0.0		0.0
Accrued expenses and other current liabilities	0.0		0.0
Intercompany payables	(6,817.3)		(6,165.0)
Long-term debt	0.0		0.0
Other long-term liabilities	0.0		0.0
Total liabilities	(6,817.3)		(6,165.0)
Stockholder’s (deficiency) equity	(1,589.1)		(1,629.0)
Total liabilities and stockholders’ deficiency	(8,406.4)		(7,794.0)
Products Corporation \| Reportable Legal Entities
Assets [Abstract]
Cash and cash equivalents	271.9		0.8
Trade receivables, less allowances for doubtful accounts	73.5		95.5
Inventories	145.9		131.0
Prepaid expenses and other	224.8		219.7
Intercompany receivables	3,173.6		2,857.7
Investment in subsidiaries	1,574.2		1,598.3
Property, plant and equipment, net	189.0		208.7
Deferred income taxes	235.6		165.0
Goodwill	48.9		159.9
Intangible assets, net	(20.9)		13.0
Other assets	72.0		67.8
Total assets	5,988.5		5,517.4
LIABILITIES AND STOCKHOLDERS’ DEFICIENCY
Short-term borrowings	0.0		0.0
Current portion of long-term debt	648.2		287.9
Accounts payable	107.6		108.4
Accrued expenses and other current liabilities	257.7		124.1
Intercompany payables	3,317.2		3,030.3
Long-term debt	2,922.8		2,822.2
Other long-term liabilities	173.1		220.4
Total liabilities	7,426.6		6,593.3
Stockholder’s (deficiency) equity	(1,438.1)		(1,075.9)
Total liabilities and stockholders’ deficiency	5,988.5		5,517.4
Guarantor Subsidiaries \| Reportable Legal Entities
Assets [Abstract]
Cash and cash equivalents	5.9		6.4
Trade receivables, less allowances for doubtful accounts	59.4		92.3
Inventories	175.9		151.5
Prepaid expenses and other	38.1		26.4
Intercompany receivables	3,134.9		2,854.6
Investment in subsidiaries	14.8		30.7
Property, plant and equipment, net	73.8		89.5
Deferred income taxes	(53.6)		(37.8)
Goodwill	264.0		264.0
Intangible assets, net	333.8		346.9
Other assets	13.6		16.2
Total assets	4,060.6		3,840.7
LIABILITIES AND STOCKHOLDERS’ DEFICIENCY
Short-term borrowings	0.0		0.0
Current portion of long-term debt	0.0		0.0
Accounts payable	47.6		39.9
Accrued expenses and other current liabilities	(35.0)		70.0
Intercompany payables	2,954.4		2,668.7
Long-term debt	0.0		0.0
Other long-term liabilities	111.4		118.2
Total liabilities	3,078.4		2,896.8
Stockholder’s (deficiency) equity	982.2		943.9
Total liabilities and stockholders’ deficiency	4,060.6		3,840.7
Non-Guarantor Subsidiaries \| Reportable Legal Entities
Assets [Abstract]
Cash and cash equivalents	60.7		97.1
Trade receivables, less allowances for doubtful accounts	155.4		235.6
Inventories	189.4		165.9
Prepaid expenses and other	44.9		46.5
Intercompany receivables	508.9		452.7
Investment in subsidiaries	0.0		0.0
Property, plant and equipment, net	102.7		110.4
Deferred income taxes	29.1		30.9
Goodwill	249.8		249.8
Intangible assets, net	128.7		130.8
Other assets	31.8		37.1
Total assets	1,501.4		1,556.8
LIABILITIES AND STOCKHOLDERS’ DEFICIENCY
Short-term borrowings	2.6		2.2
Current portion of long-term debt	0.1		0.1
Accounts payable	69.4		103.5
Accrued expenses and other current liabilities	158.9		224.1
Intercompany payables	545.7		466.0
Long-term debt	53.0		84.0
Other long-term liabilities	38.4		5.3
Total liabilities	868.1		885.2
Stockholder’s (deficiency) equity	633.3		671.6
Total liabilities and stockholders’ deficiency	$ 1,501.4		$ 1,556.8

PRODUCTS CORPORATION AND SUBSIDIARIES GUARANTOR FINANCIAL INFORMATION - Statement of Operations and Comprehensive Income (Details) - USD ($)
$ in Millions

3 Months Ended

6 Months Ended

Jun. 30, 2020

Mar. 31, 2020

Jun. 30, 2019

Mar. 31, 2019

Jun. 30, 2020

Jun. 30, 2019

$ 347.6

$ 570.2

$ 800.6

$ 1,123.4

168.6

243.9

366.4

481.7

179.0

326.3

434.2

641.7

194.4

331.0

481.8

661.8

1.2

0.0

3.3

0.6

20.7

3.2

45.5

8.7

19.8

0.0

144.1

0.0

(0.2)

0.0

0.6

0.0

(56.9)

(7.9)

(241.1)

(29.4)

0.0

60.9

47.8

109.3

95.5

6.0

3.5

10.0

6.7

(11.9)

0.0

(11.9)

0.0

2.3

1.2

18.9

1.4

20.6

4.6

16.5

5.9

Loss from continuing operations before income taxes

77.9

57.1

142.8

109.5

(134.8)

(65.0)

(383.9)

(138.9)

(Loss) income from continuing operations, net of taxes

(9.6)

(0.9)

(46.5)

(0.6)

(125.2)

(64.1)

(337.4)

(138.3)

(Loss) income from discontinued operations, net of taxes

0.0

1.6

0.0

2.3

0.0

(125.2)

$ (212.2)

(62.5)

$ (73.5)

(337.4)

(136.0)

14.3

^[1]

$ (2.7)

^[1]

5.3

^[1]

$ 0.9

^[1]

11.6

6.2

Reportable Legal Entities | Products Corporation

(110.9)

(57.2)

(325.8)

(129.8)

Condensed Income Statements, Captions [Line Items]

93.8

155.5

210.2

311.0

54.4

72.2

112.9

140.2

39.4

83.3

97.3

170.8

58.8

109.3

163.2

239.0

2.0

3.2

0.5

17.1

0.8

40.7

2.4

19.8

144.1

(0.2)

0.6

(58.1)

(26.8)

(254.5)

(71.1)

(0.3)

(1.1)

(3.0)

(2.4)

59.2

46.1

105.7

92.0

6.0

3.5

10.0

6.7

(11.9)

6.2

1.8

0.6

0.3

24.9

(10.1)

0.9

(18.0)

Loss from continuing operations before income taxes

84.1

40.2

102.3

78.6

(142.2)

(67.0)

(356.8)

(149.7)

(Loss) income from continuing operations, net of taxes

(35.8)

(3.6)

(52.1)

(5.4)

(106.4)

(63.4)

(304.7)

(144.3)

(Loss) income from discontinued operations, net of taxes

0.0

4.7

1.1

(29.3)

8.5

(101.7)

(62.3)

(334.0)

(135.8)

14.3

5.3

11.6

6.2

Reportable Legal Entities | Guarantor Subsidiaries

(87.4)

(57.0)

(322.4)

(129.6)

Condensed Income Statements, Captions [Line Items]

78.2

124.8

190.7

254.1

43.5

64.1

97.9

129.2

34.7

60.7

92.8

124.9

45.2

81.5

116.1

156.6

(0.5)

0.0

0.1

3.0

0.8

4.3

2.9

0.0

0.0

(13.0)

(21.6)

(27.6)

(34.7)

0.6

0.7

1.1

1.4

0.0

0.0

0.0

0.5

0.3

2.4

0.3

(6.9)

(12.7)

(16.1)

(26.2)

Loss from continuing operations before income taxes

(5.8)

(11.7)

(12.6)

(24.5)

(7.2)

(9.9)

(15.0)

(10.2)

(Loss) income from continuing operations, net of taxes

21.6

(0.1)

1.4

0.4

(28.8)

(9.8)

(16.4)

(10.6)

(Loss) income from discontinued operations, net of taxes

0.0

(6.9)

6.3

(26.9)

11.7

(35.7)

(3.5)

(43.3)

1.1

7.9

(1.1)

14.4

(1.2)

Reportable Legal Entities | Non-Guarantor Subsidiaries

(27.8)

(4.6)

(28.9)

(0.1)

Condensed Income Statements, Captions [Line Items]

175.6

290.3

399.8

561.5

70.7

108.0

155.7

215.5

104.9

182.3

244.1

346.0

90.4

140.2

202.5

266.2

(0.3)

0.1

0.0

0.6

1.6

0.5

3.4

0.0

0.0

14.2

40.5

41.0

76.4

(0.3)

0.4

1.9

1.0

1.7

3.6

3.5

0.0

0.0

(4.4)

(0.9)

15.9

0.8

2.6

27.4

31.7

50.1

Loss from continuing operations before income taxes

(0.4)

28.6

53.1

55.4

14.6

11.9

(12.1)

21.0

(Loss) income from continuing operations, net of taxes

4.6

2.8

4.2

4.4

10.0

9.1

(16.3)

16.6

(Loss) income from discontinued operations, net of taxes

1.6

2.3

0.0

10.0

10.7

(16.3)

18.9

11.2

(0.5)

2.4

0.1

Condensed Income Statements, Captions [Line Items]

21.2

10.2

(13.9)

19.0

Eliminations

0.0

(0.4)

(0.1)

(3.2)

0.0

(0.4)

(0.1)

(3.2)

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Loss from continuing operations before income taxes

0.0

0.0

(Loss) income from continuing operations, net of taxes

0.0

0.0

(Loss) income from discontinued operations, net of taxes

0.0

2.2

(7.4)

56.2

(20.2)

2.2

(7.4)

56.2

(20.2)

(19.1)

1.6

(16.8)

1.1

$ (16.9)

$ (5.8)

$ 39.4

$ (19.1)

[1]	See Note 13, "Accumulated Other Comprehensive Loss," regarding the changes in the accumulated balances for each component of other comprehensive loss during the three months ended June 30, 2020 and 2019, respectively.

PRODUCTS CORPORATION AND SUBSIDIARIES GUARANTOR FINANCIAL INFORMATION - Statement of Cash Flow (Details)
€ in Millions

3 Months Ended

6 Months Ended

May 07, 2020

USD ($)

May 04, 2020

EUR (€)

Jun. 30, 2020

USD ($)

Jun. 30, 2020

EUR (€)

Jun. 30, 2019

USD ($)

Jun. 30, 2020

USD ($)

Jun. 30, 2019

USD ($)

Net cash (used in) provided by operating activities

$ (164,200,000)

$ (41,200,000)

Net cash (used in) provided by investing activities

(2,700,000)

(12,200,000)

Net decrease in short-term borrowings and overdraft

(7,000,000.0)

(18,800,000)

Tax withholdings related to net share settlements of restricted stock and RSUs

(101,200,000)

(1,400,000)

$ (1,200,000)

$ 0

(1,600,000)

Net cash provided by (used in) financing activities

(1,000,000.0)

(500,000)

408,400,000

28,600,000

Effect of exchange rate changes on cash, cash equivalents and restricted cash

(2,100,000)

500,000

Net increase (decrease) in cash, cash equivalents and restricted cash

239,400,000

(24,300,000)

Cash, cash equivalents and restricted cash at beginning of period

^[1]

104,500,000

87,500,000

Cash, cash equivalents and restricted cash at end of period

^[1]

343,900,000

63,200,000

343,900,000

63,200,000

2020 BrandCo Term Loan Facility due 2025

5.75% Senior Notes due 2021

880,000,000.0

Revolving Credit Facility Due 2021

(99,600,000)

59,900,000

2019 Term Loan Facility due 2023

(22,900,000)

2018 Foreign Asset-Based Term Facility due 2021

$ (200,000,000)

(200,000,000.0)

€ (5.0)

€ (28.5)

(31,400,000)

2016 Term Loan Facility

Reportable Legal Entities | Products Corporation

(6,900,000)

(9,000,000.0)

Net cash (used in) provided by operating activities

(148,300,000)

(36,800,000)

Net cash (used in) provided by investing activities

(2,700,000)

(6,300,000)

Net decrease in short-term borrowings and overdraft

(1,300,000)

(9,700,000)

Tax withholdings related to net share settlements of restricted stock and RSUs

(101,200,000)

(800,000)

(1,600,000)

Net cash provided by (used in) financing activities

(1,000,000.0)

(400,000)

414,100,000

38,400,000

Effect of exchange rate changes on cash, cash equivalents and restricted cash

Net increase (decrease) in cash, cash equivalents and restricted cash

263,100,000

(4,700,000)

Cash, cash equivalents and restricted cash at beginning of period

1,000,000.0

7,200,000

Cash, cash equivalents and restricted cash at end of period

264,100,000

2,500,000

264,100,000

2,500,000

Reportable Legal Entities | Products Corporation | 2020 BrandCo Term Loan Facility due 2025

Reportable Legal Entities | Products Corporation | 5.75% Senior Notes due 2021

880,000,000.0

Reportable Legal Entities | Products Corporation | Revolving Credit Facility Due 2021

(99,600,000)

59,900,000

Reportable Legal Entities | Products Corporation | 2019 Term Loan Facility due 2023

(22,900,000)

Reportable Legal Entities | Products Corporation | 2018 Foreign Asset-Based Term Facility due 2021

(200,000,000.0)

Reportable Legal Entities | Products Corporation | 2016 Term Loan Facility

(31,400,000)

Reportable Legal Entities | Guarantor Subsidiaries

(6,900,000)

(9,000,000.0)

Net cash (used in) provided by operating activities

14,600,000

4,800,000

Net cash (used in) provided by investing activities

(1,200,000)

Net decrease in short-term borrowings and overdraft

(6,200,000)

(6,600,000)

Tax withholdings related to net share settlements of restricted stock and RSUs

Net cash provided by (used in) financing activities

(6,200,000)

(6,600,000)

Effect of exchange rate changes on cash, cash equivalents and restricted cash

(9,000,000.0)

100,000

Net increase (decrease) in cash, cash equivalents and restricted cash

(600,000)

(2,900,000)

Cash, cash equivalents and restricted cash at beginning of period

6,400,000

6,600,000

Cash, cash equivalents and restricted cash at end of period

5,800,000

3,700,000

5,800,000

3,700,000

Reportable Legal Entities | Guarantor Subsidiaries | 2020 BrandCo Term Loan Facility due 2025

Reportable Legal Entities | Guarantor Subsidiaries | 5.75% Senior Notes due 2021

Reportable Legal Entities | Guarantor Subsidiaries | Revolving Credit Facility Due 2021

Reportable Legal Entities | Guarantor Subsidiaries | 2019 Term Loan Facility due 2023

Reportable Legal Entities | Guarantor Subsidiaries | 2018 Foreign Asset-Based Term Facility due 2021

Reportable Legal Entities | Guarantor Subsidiaries | 2016 Term Loan Facility

Reportable Legal Entities | Non-Guarantor Subsidiaries

Net cash (used in) provided by operating activities

(30,500,000)

(9,200,000)

Net cash (used in) provided by investing activities

(4,700,000)

Net decrease in short-term borrowings and overdraft

500,000

(2,500,000)

Tax withholdings related to net share settlements of restricted stock and RSUs

(600,000)

Net cash provided by (used in) financing activities

(100,000)

500,000

(3,200,000)

Effect of exchange rate changes on cash, cash equivalents and restricted cash

6,900,000

400,000

Net increase (decrease) in cash, cash equivalents and restricted cash

(23,100,000)

(16,700,000)

Cash, cash equivalents and restricted cash at beginning of period

97,200,000

73,700,000

Cash, cash equivalents and restricted cash at end of period

74,100,000

57,000,000.0

74,100,000

57,000,000.0

Reportable Legal Entities | Non-Guarantor Subsidiaries | 2020 BrandCo Term Loan Facility due 2025

Reportable Legal Entities | Non-Guarantor Subsidiaries | 5.75% Senior Notes due 2021

Reportable Legal Entities | Non-Guarantor Subsidiaries | Revolving Credit Facility Due 2021

Reportable Legal Entities | Non-Guarantor Subsidiaries | 2019 Term Loan Facility due 2023

Reportable Legal Entities | Non-Guarantor Subsidiaries | 2018 Foreign Asset-Based Term Facility due 2021

Reportable Legal Entities | Non-Guarantor Subsidiaries | 2016 Term Loan Facility

Eliminations

Net cash (used in) provided by operating activities

Net cash (used in) provided by investing activities

Net decrease in short-term borrowings and overdraft

Tax withholdings related to net share settlements of restricted stock and RSUs

Net cash provided by (used in) financing activities

Effect of exchange rate changes on cash, cash equivalents and restricted cash

Net increase (decrease) in cash, cash equivalents and restricted cash

Cash, cash equivalents and restricted cash at beginning of period

Cash, cash equivalents and restricted cash at end of period

$ 0

Eliminations | 2020 BrandCo Term Loan Facility due 2025

Eliminations | 5.75% Senior Notes due 2021

Eliminations | Revolving Credit Facility Due 2021

Eliminations | 2019 Term Loan Facility due 2023

Eliminations | 2018 Foreign Asset-Based Term Facility due 2021

Eliminations | 2016 Term Loan Facility